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ABSTRACT
Severe intrauterine growth restriction (lUGR) is recognised to be a major cause of perinatal 
morbidity and mortality. Identifying the fetus that is truly growth restricted and therefore 
compromised, from the one that is simply genetically small and not at risk is difficult. 
Recent work using umbilical artery (Ua) Doppler waveform studies have shown that a 
reduction in the diastolic component of the Ua Doppler waveform correlates strongly with 
poor perinatal outcome. Since this technique can be used to reliably distinguish the truly 
growth restricted fetus at risk, it is imperative, if we are to understand the pathophysiology of 
severe lUGR, that the mechanisms by which abnormal Doppler waveforms arise is 
established.
The elaboration pattern of blood vessels within stem villi from lUGR and gestationally age- 
matched control placentas, was first evaluated by measuring the diameter of 600 vessel 
profiles, identified by the antibody anti-a smooth muscle actin, within stem villi from 
randomly chosen areas of placental tissue . The vessels diameters, ranging from 10-160p.M, 
were plotted in 15pM bands and the two groups compared. There was no significant 
difference in the mean vessel diameter or in the distribution of vessel diameters in the lUGR 
and gestational age-matched control placentas. Simultaneously, the mean volume of all 
classes of villous tissue was calculated. There was significantly less villous tissue in the 
lUGR placentas than in the matched control placentas. This was the result of a selective 
reduction in the volume of peripheral (intermediate and terminal) villi in the lUGR placentas.
Having identified a quantitative difference in the volume of peripheral villi, scanning electron 
microscopy (SEM) was used to examine the three-dimensional structure of these villi and the 
blood vessels within them using vascular and villous tissue casts from pregnancies 
complicated by severe lUGR and normal preterm controls. The peripheral vascular network 
of capillaries was noted to be distinctly abnormal in the lUGR placentas. Fewer vessels were 
identified and when present, these resembled elongated drainpipes. This was in contrast to 
the normal preterm control vascular casts which were characterised by multiple capillaiy 
loops comprised of short, coiled, highly branched, networks with sinusoidal dilatations. 
Similarity, the peripheral villi of the lUGR placentas were abnormal. Terminal villous 
"buds", which provide a large syncytial surface area for materno-fetal exchange, were rarely 
identified. In contrast, the terminal villi of the lUGR placentas, like the vessels within them, 
resembled narrow tubes.
The ultrastastructure of these abnormal terminal villi was then determined using transmission 
electron microscopy (TEM) and compared with the ultrastructure of normal gestational age-
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matched teminal villi. The terminal villi from the lUGR placentas were significantly smaller 
in diameter than their preterm counterparts. In addition, there was an increased number of 
syncytial nuclei, fewer cytotrophoblast nuclei, thickening of the basement membranes and an 
increase in the number of collagen fibres and basal lamina like material within the villous 
stioma.
To verify these findings and establish if the reduction in cytotrophoblast cell nuclei number 
was due to increased turnover or depleted proliferation, the samples were examined with the 
proliferation marker MIB-I. After correcting for the volume of villous tissue present, this 
confirmed that there were significantly fewer proliferating cytotrophoblast cells in the lUGR 
placentas than in normal preterm controls. Likewise using antibodies directed against 
individual collagen types I, II, III, IV, V, laminin and fibronectin the increase in stromal 
collagen in the lUGR placental villi was confirmed and recognised to result from increased 
staining for coUagens I, HI, IV and laminin.
Together these data indicate that primary vascular and villous development is abnormal in 
placentas from pregnancies complicated by lUGR and abnormal Doppler, As a result, 
though the total number of stem villous vessels may be reduced, the pattern of their 
distribution is identical to that seen in normal preterm controls. However, quantitative and 
qualitative differences were seen in the peripheral villi of the lUGR placentas, the major site 
of gas and nutrient exchange. The alterations observed may explain both the metabolic 
adaptation of the lUGR fetus and the Doppler U a abnormalities seen in affected pregnancies. 
The regulation and expression of angiogenic and villous growth factors in placental 
development therefore requires urgent attention.
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CHAPTER 1
INTRODUCTION
I
$
:
%
I1.1 HISTORICAL PERSPECTIVE
It is now more than 250 years since William Hunter reported the existence of two distinct 
circulations within the human placenta, establishing that fetal and maternal blood remained 
isolated from each other throughout pregnancy;
"Œhougfi tfie pCacenta Be œmpkteCyfiBkd’Witfi any injection tftTOWn in the uterine vesseBs, none o f the zoa?c 
finds its zuay into any o f the umBUicat vesseBs; and In the same manner fBuids injected into the umBiBicaB 
vesseBs can never Be pushed into the uterine e?ccept By rupture or transudation "
(William Hunter; Anatomy of the Gravid Uterus 1774) ®
As most obstetricians were occupied in dealing with the ovei'whelming problems of puerperal 
sepsis and maternal death the placenta remained an organ of "respect" - a passive structure 
which occasionally elicited fear and anxiety if implanted either too low or too deep but which 
otherwise appeared of little clinical relevance and merited little investigation. More recently, 
our understanding of perinatal physiology, blood flow regulation, and the accumulating 
epidemiological data linking prenatal events with adult disease (Barker 1992; Rona,
■-iy:
1
:Gulliford & Chinn 1993) has created a renewed interest in the function of the placenta and its 
role in determining both fetal development and adult health. I
One of the major challenges facing obstetrics today is the problem of restricted fetal growth, 
attributed to "utero-placental insufficiency". Despite significant advances in neonatal care 
over the last two decades, there has been little improvement in the outcome of this group of 
pregnancies. Perinatal mortality is 4-8 times higher in very low birth weight babies and 
perinatal morbidity is significant with evidence of neurodevelopmental delay (Taylor &
Howie 1989; Todd et al. 1992; Mari & Russell 1992) learning difficulties, behavioural 
problems (Scottish Low Birthweight Study I & II) and cerebral palsy (Perkins 1987; Marlow,
Hunt & Chiswick 1988). Learning and social difficulties often persist into later childhood ■ !
and are particularly prominent amongst children born prematurely (<33 weeks gestation) : |
with severe intrauterine growth restriction (Semedler et al. 1992). These findings have large g
implications for health and education resource management.
Programmes directed towards the prevention and/or treatment of this condition and its long 
term consequences, can only be initiated if, by understanding the pathological processes 
which inhibit normal fetal growth and development, we are able to detect affected #
pregnancies antenatally
17-
1.2 INTRAUTERINE GROWTH RETARDATION
I
Ï
1Even in developed countries 5-10% of pregnancies result in the delivery of a small neonate 
(Ebrahim 1984). The majority of these are simply statistically small for their gestational age 'S'(SGA); they have grown at a constant velocity, achieving their pre-programmed growth 
potential and are otherwise healthy. A minority however, are born small as a result of growth
S 'restriction in-uUro, This may occur as a result of many pathological processes - congenital 
infections, structural malformations, karyotypic abnormalities (particularly triploidy and 
trisomy 18) - but in the majority of cases while there is neonatal evidence of intrauterine 
Starvation - dry, wrinkled skin, loss of adipose tissue and muscle wasting - no specific 
underlying aetiology can be identified (Snijders et al. 1993a). Since fetal growth and 
development are dependent on an adequate supply of nutrients and oxygen from the mother, ;
transported to the fetus across the placenta, these cases of "unexplained" intrauterine growth 
restriction (lUGR) have been attributed to 'utero-placental insufficiency'.
-i1.3 CLINICAL FEATURES OF lUGR PREGNANCIES
1.3.1. FETAL METABOLISM y!The ability to obtain pure samples of fetal blood, usually from the umbilical vein at the cord 
root (Daffos et al. 1983), has revealed a great deal of information regarding the fetal 
environment. The growth restricted fetus, in contrast to its normally grown counterpart, is 
hypoxic (Soothill et al. 1987; Nicolini et al. 1990), presumably chronically so, since plasma
erythropoietin is elevated (Snidjers et al. 1993b), has a metabolic acidosis (Nicolaides et al.
1989) and shows biochemical evidence of intrauterine starvation. Not only do these fetuses
have reduced circulating concentrations of certain amino acids (Economides, Crook & 
Nicolaides 1991; Cetin et al. 1990; Pardi et al. 1993) and glucose (Nicolini et al. 1989) but 
also elevated levels of cortisol, reduced insulin concentrations and increased serum
i:..triglycerides (Economides & Nicolaides 1989). The latter may be interpreted as an anaerobic 
state, triglycerides being required more urgently to provide a vital energy source for the fetus.
Increased concentrations of erythropoietin, are also present (Snijders et al. 1993b) and 
erythropoiesis stimulated. In contrast to adult tissue hypoxia in which elevated 
erythropoietin generates erythroblastosis (Zanzani & Ascendo 1989), fetal erythropoiesis in 
growth retai'dation would appear to be mediated by release of premature erythroblasts rather 
than actual increased erythrocyte production (Abbas et al. 1994).
Together these biochemical data would confirm the neonatal evidence which suggests that 
intrauterine starvation is a major contributing factor to poor fetal growth. By implication
-18-
therefore, in affected pregnancies, either the maternal substrate supply is deficient, or 
placental substrate transfer significantly impaired during intrauterine life. Since the feto- 
maternal ratios of amino acids (Bernardini et al. 1991) and glucose (Economides & 
Nicolaides 1989) are significantly reduced, despite increased or normal maternal 
concentrations, it would appear that impaired placental transport, is the primary factor 
effecting fetal substrate deprivation.
1.3.2. UTEROPLACENTAL BLOOD FLOW
Early histological studies in pregnancies complicated by lUGR demonstrated impaired 
trophoblast invasion and transformation of maternal spiral arteries (Sheppard & Bonnar 
1981). In conjunction with this, in-vivo blood flow studies using radioactive isotopes 
confirmed that placental blood flow was significantly reduced in lUGR pregnancies 
(Chatfield et al. 1975; Lunell et al. 1979). More recently, Doppler ultrasound studies of the 
uterine artery in pregnancies which are later complicated by lUGR have indicated that this 
lack of trophoblast invasion is reflected by an increase in uterine aitery Doppler resistance 
during the second trimester (Campbell et al. 1986; Bewley, Cooper & Campbell 1991). An 
isolated reduction of uterine blood flow in normal pregnancies does not alter fetal umbilical 
aitery blood flow. However, in a growth restricted pregnancy, progressive embolisation of 
the ovine uterine circulation results in abnormal umbilical artery blood flow patterns, 
suggesting that some feature of the 'growth restricted' placenta prevents the normal 
adaptation to reduced uterine blood flow (Clapp et al. 1980).
1.3.3. FETAL BLOOD FLOW DISTRIBUTION IN lUGR FETUSES
In combination with these changes in fetal metabolism, fetal blood flow is also altered in 
growth restricted pregnancies. Aortic blood flow is significantly depleted (Eik-Nes, Marsal 
& Kristofferson 1984; Griffin et al. 1984, 1985; Wladimiroff, Tonge & Stewart 1986) and as 
a consequence, renal perfusion diminished and urine output reduced (Arduini & Rizzo 1991). 
These adaptations can have longer term effects. Growth restricted neonates are particularly 
susceptible to necrotising enterocolitis, a condition associated with mesenteric hypoxia, and 
often demonstrate impaired renal function in the early neonatal period resulting in oliguria 
(Hackett et al. 1987).
While lower aortic blood flow is diminished in growth restricted fetuses, blood flow to the 
brain and coronary circulation is relatively increased, a phenomenon known as 'brain-sparing' 
and recognised for some time in animal models (Peeters et al. 1979). This may be due to a 
shift from right to left ventricular dominance, whereby the majority of left ventricular 
outflow is pre-ductal (Weiner et al. 1994). Normal or increased flow to cerebral tissue is 
sustained by a fall in cerebral resistance, thought to occur in response to hypoxia (Vyas et al.
1990). As hypoxia progresses however, maximal cerebral vasodilatation is reached,
-19-
preventing any further compensation. Beyond this nadir, further hypoxic insult results only 
in cardiac decompensation and cerebral vasoconstriction. These changes are recognised to be 
pre-terminal events which may occur up to two weeks before actual fetal demise. However, 
by this stage significant antenatal brain damage may already have occurred.
14 CONSEQUENCES OF INTRAUTERINE GROWTH RETARDATION
It is now clear that the effects of intrauterine growth restriction may also persist into adult 
life. Death rates from cardiovascular disease progressively rise as birthweight falls (Barker 
1992; Osmond et al. 1993). Hypertension is also related to low birthweight; systolic and 
diastolic blood pressure in adult life rising with falling birthweight (Gennser, Rymark & 
Isberg 1988; Barker et al. 1989), Moreover, serum cholesterol and low density lipoprotein 
concentrations, both additional cardiovasculai* risk factors, are elevated in adults who were 
low birthweight babies (Barker et al. 1993). Other organ systems are also affected. Reduced 
numbers of renal nephrons have been noted in fetuses and infants with severe intrauterine 
growth restriction (Hinchliffe et al. 1992). As renal function is intimately related with 
cardiovascular physiology the implications of these findings warrants further investigation. 
Adult lung function is also impaired in those who were low birth weight babies, even after 
correction for premature gestational age (Barker 1992; Rona, Gulliford & Chinn 1993).
In combination, these data suggest that there are critical periods of organ development during 
intrauterine life which determine future structure and function. Adverse influences, such as 
nutrient deprivation, during critical periods of fetal life may impair normal development and 
permanently alter the physiology of these organ systems; thus "programming" the fetus for 
adult disease. This phenomenon is well recognised in animal models (Hahn 1984; Lucas 
1991). As an example, chronic fetal hypoxia may activate the human fetal renin-angiotensin 
system (Graham et al. 1992). Since angiotensin is a vascular growth factor (Lever 1986) it 
may induce vascular hypertrophy, which has been demonstrated in placental vessels from 
lUGR pregnancies (Fok et al. 1990), and so alter the mechanical properties of vessels, 
increasing vascular resistance (Bertrand et al. 1993). In the spontaneously hypertensive rat, 
inhibition of angiotensin II production during early neonatal life can restore blood pressure 
recordings to "normal" physiological parameters, thus also demonstrating that early 
correction may prevent permanent damage and even restore normal function (Martin et al
1991).
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1.5 IDENTIFICATION OF THE GROWTH RESTRICTED FETUS
I
Ultrasound derived measurements of fetal size, employing head circumference (HC), 3f
abdominal circumference (AC) and femur length (FL) can identify the small fetus, though 
generally, the estimates will be accurate to within 10-15% of the actual birthweight (Neilson
1990). However, reliably distinguishing the fetus which is also growth restricted in-uterois §
more difficult (Seeds 1984). Recent studies evaluating perinatal outcome have highlighted 
two additional ultrasound features which differentiate the small fetus which is also 
compromised and therefore at risk of perinatal death from one which is healthy; these are 
reduced amniotic fluid volume and abnormal umbilical artery Doppler waveforms
#
1.5.1 AMNIOTIC FLUro VOLUME
The origins of amniotic fluid are still poorly understood. It is clear that during the second 
half of pregnancy, most amniotic fluid is produced from the fetal kidneys. It is then 
swallowed by the fetus, absorbed from the fetal gut into the fetal blood stream and then 
circulated through the renal glomeruli to produce fetal urine, excreted into the amniotic fluid 
(Brace 1994). Agenesis and maldevelopment of the fetal renal tract (Kaffe et al. 1977) or 
impaired fetal swallowing result in reduced or excessive amounts of liquor respectively, 
confiiming this circulation pathway (Brace 1991)
In the absence of structural abnormalities of the renal tract, reduced volumes of amniotic 
fluid correlate significantly with poor fetal outcome (Manning et al. 1981; Chamberlain et al.
1984; Rutherford et al. 1987; Moore et al. 1989). The reduction in amniotic fluid is thought 
to reflect impaired renal perfusion (Arduini & Rizzo 1991), a consequence of fetal hypoxia, 
when blood is redirected from non-vital organs such as muscle, skin and kidney to vital J
organs such as the heart and brain (Block et al. 1984; Al-Ghazali et al. 1989). Amniotic fluid
volumes are therefore an indirect marker of fetal hypoxia, particularly in the preterm fetus | |
(Philipson et al. 1983; Chamberlain et al. 1984).
1.5.2 UMBILICAL ARTERY DOPPLER WAVEFORMS
1.5.2.1 PRINCIPLES OF DOPPLER ULTRASOUND
Doppler ultrasound permits non-invasive, insvivo, evaluation of fetal blood flow by utilising 
the Doppler principle which states that a sound wave reflected from a moving target i.e. 
blood cells returns at different frequency from the incident soundwave. The change in 
frequency, proportional to the velocity of the moving object, is known as the frequency shift 
or Doppler shift (Trudinger 1994). |IIn ai'terial vessels, blood flow is more rapid during systole than diastole while in veins, blood 
flow velocity is generally constant. Blood also flows more rapidly in the centre of a vessel
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when compared to blood flow near the vessel wall. Thus at any one point in a vessel a 
spectrum of frequency shifts (proportional to the velocity of blood) are obtained. These can 
be averaged by computer and plotted against time to produce a smoothed waveform known 
as the flow velocity waveform (Figure 1.1).
The technique was first applied to the fetal umbilical circulation in 1977 (Fitzgerald & 
Drumm 1977). Using ultrasound estimates of vessel diameter and fetal weight, umbilical 
arteiy flow rates may be calculated from the flow velocity waveform (FVW) (Griffin, Cohen- 
Overbeck & Campbell 1983; Cohen-Overbeck , Pearce & Campbell 1985). These estimates 
are however, subject to large margins of error and therefore of limited value (Eik-Nes, Marsal 
& Kiistofferson 1984). A qualitative assessment of placental blood flow may be derived 
from the diastolic component of the FVW which reflects downstream placental impedance 
(Skidmore & Woodcock 1980) and is independent of these other variables.
1.5.2.2 FETAL UMBILICAL ARTERY DOPPLER STUDIES
During normal pregnancy placental vascular impedance falls with advancing gestational age 
(Pearce et al. 1988; Hendricks et al. 1989) and is not significantly altered by factors such as 
maternal exercise (Morrow, Ritchie & Bull 1989) and fetal blood viscosity (Giles & 
Trudinger 1986; Fairlie et al. 1989). Several studies have shown however, that profound 
reductions in fetal heart rate may prolong the cardiac cycle sufficiently that absent end 
diastolic flow velocity is seen (Mires et al. 1987; Van den Wijingaard, van Eyck & 
Wladimiroff 1988).
Studies in selected high risk pregnancies noted to be small for dates, have now demonstrated 
that in severe cases the diastolic component of the FVW is reduced, absent or even reversed 
(Jouppila et al. 1984; Laurin et al. 1987; Fairlie et al. 1991), indicating increased placental 
vasculai’ impedance (Adamson et al. 1990). This finding is significantly correlated with high 
perinatal morbidity and increased perinatal mortality rates of 50-90% (Brar & Platt 1988; Al- 
Ghazali et al. 1990; Woo et al. 1987). Seven randomised controlled trials have now 
demonstrated the clinical value of abnormal umbilical artery Doppler waveforms (Neilson & 
Grant 1989) and shown that by intensive monitoring and appropriate intervention, the 
perinatal loss in pregnancies with lUGR may be reduced (Divon et al. 1989).
In view of these results, umbilical artery Doppler studies have also been employed as a 
screening test for lUGR in unselected populations. Used as a single measurement, most 
studies have found Doppler to be of little use (Dempster et al. 1989; Low 1991); ultrasound 
estimated fetal weight measurements proving to be a better predictor (Divon et al. 1988). 
Furthermore, serial measurements in large, unselected antenatal populations at 28, 32
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(Sijmons et al. 1989) and 38 weeks (Beattie & Dornan 1989) did not improve the prediction 
rate of growth restricted neonates.
While umbilical artery Doppler studies appear to be of little value as a screening test, 
amongst high risk pregnancies it provides an excellent means by which to distinguish the 
small fetus which is growth restricted and at risk from the fetus which is simply small but 
healthy (Burke et al. 1991). Since AEDFV is so intimately associated with severe 
intrauterine growth restriction, it is imperative that we understand the mechanisms by which 
abnormal umbilical artery Doppler is generated; in so doing the mechanisms resulting in 
restricted fetal growth might also be elucidated.
1.6 PATHOLOGICAL BASIS OF ABNORMAL UMBILICAL DOPPLER.
1.6.1 ANATOMICAL DATA
Histological studies in placentas from human pregnancies complicated by lUGR and AEDFV 
have suggested a reduced number of arterial vessel profiles within small stem villi (Giles, 
Tmdinger & Baird 1985; McGowan, Mullen & Ritchie 1987). This was thought to occur as 
a result of vessel “occlusion” - possibly as a result of vessel spasm or thrombosis. Since 
growth restricted fetuses are also known to have reduced numbers of platelets (Van den Hof 
& Nicolaides 1990), despite an increase in platelet turnover (Wilcox & Trudinger 1991), it 
was proposed that the reduction in stem arterial profile number was a consequence of vessel 
obliteration by platelet emboli.
Fetal sheep studies confirmed that progressive embolisation of the umbilical circulation could 
reduce umbilical blood flow (Trudinger et al. 1987) and reproduce similar abnormal 
umbilical Doppler waveforms to those seen in lUGR pregnancies (Morrow et al. 1989). 
Further data from the sheep model demonstrated that the inverse relationship between 
umbilical blood flow, and the umbilical Doppler waveform was not linear, but exponential 
(Copel et al. 1990; Schmidt et al. 1991). With embolisation techniques, placental vascular 
impedance must be increased by up to 700% to reproduce AEDFV (Morrow et al. 1989). 
This equates, by mathematical modelling techniques, with at least a 50% obliteration of the 
placental vascular bed (Todros, Guiot & Planta 1992).
1.6.2 VASOMOTOR CONTROL OF FETOPLACENTAL BLOOD FLOW
1.6.2.1 HUMAN DATA
Vasomotor mechanisms have also been implicated in the pathophysiology of lUGR. Low 
dose aspirin (75mg/day) given to pregnant women at risk of lUGR has been shown to
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increase birthweight and gestation at delivery when compared with controls (Wallenberg & 
Rotmans 1987; Trudinger et al. 1988; Uzan et al. 1991), Since aspirin crosses the human 
placenta into the fetoplacental circulation (Jacobson et al. 1991), it may exert a direct 
therapeutic effect within the villous circulation as well as preventing damage within the 
uteroplacental circulation. There are two mechanisms whereby aspirin could work. Firstly it 
may counteract the excessive release of thromboxane A2, a known vasoconstrictor, resulting 
from increased fetal platelet turnover (Van den Hof & Nicolaides 1990; Wilcox & Trudinger
1991). Secondly aspirin may selectively inhibit placental villous production of thromboxane 
A2 (Nelson & Walsh 1989). Small stem villous arterioles from patients with pre-eclampsia 
(a condition which is often associated with lUGR) have been shown to exhibit spontaneous 
oscillations (haayatulla et al. 1993) which are inhibited by indomethacin. These data suggest 
abnormal local production of thromboxane A2 within the villous core; another potential site 
where aspirin could favourably influence fetoplacental blood flow. However, aspirin cannot 
restore umbilical artery Doppler waveforms to normal in pregnancies complicated by 
AEDFV (Trudinger et al. 1988).
Endothelial regulation of fetoplacental vascular tone may also be abnormal in pregnancies 
complicated by lUGR. Production of the vasodilator prostacyclin, by the umbilical artery has 
been shown to be reduced in pregnancies complicated by pre-eclampsia (McLaren et al. 
1987) and lUGR (Stuait et al. 1981) suggesting impaired vasodilatation. However, umbilical 
venous levels of another vasodilator, ANF, are elevated in lUGR pregnancies (Kingdom et al.
1992). and functional (guanylate cyclase-coupled) vascular receptor expression for ANP in 
fetoplacental vessels is actually increased (Kingdom et al. 1993) suggesting that ANP- 
mediated vasodilatation is likely to be enhanced in severe lUGR. This however, may be an 
adaptive mechanism to compensate for excessive vasoconstriction.
In keeping with this, elevated levels of ET-1, a potent vasoconstrictor, have also been found 
in samples of umbilical venous blood obtained from lUGR pregnancies complicated by 
abnormal Doppler (Hartikainen-Sorri et al. 1991, McCarthy et al. 1993). Moreover, the 
villous core receptors for ET-1 in such cases appear to be functional (McQueen et al. 1993). 
Hypoxia increases cultured endothelial cell production of ET-1 in-vitro (Heida 1990) 
suggesting a link to abnormal umbilical Doppler pregnancies. However perfusion of the 
normal human placental cotyledon under hypoxic and acidotic conditions failed to 
demonstrate increased release of ET-1 into the fetal venous perfusate (Kingdom et al. 1993).
Systemic regulation of the fetoplacental circulation, by fetal endocrine signals, may likewise 
be deranged. Fetal plasma levels of renin (Weiner & Robillard 1988; Tannirandorn et al. 
1990) and angiotensin II (Broughton-Pipkin et al. 1977; Kingdom et al. 1993) are elevated in 
cord venous blood in some cases of lUGR. This may relate to hypoxia-mediated activation
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of fetal renal production of renin (Graham et al. 1992). Local, as opposed to systemic, 
production of angiotensin II may also be altered in pregnancies complicated by lUGR but no 
data is yet available from pathological placentas.
1.6.2.2 ANIMAL DATA
Additional data is available from animal models. Acute hypoxia which has been postulated 
to induce vasospasm in lUGR pregnancies does not increase placental vascular impedance 
(Parer 1980) nor does it alter the Doppler waveform in the ovine model, despite redistribution 
of blood flow to the fetal coronary and cerebral circulation (Morrow et al. 1990). Moreover, 
fetal hypoxic acidemia produced (pH 7.0-7.2) only minor, insignificant changes in the 
umbilical Doppler waveform until severe acidosis (pH <6.8) induced fetal bradycardia, just 
prior to fetal death (Morrow et al. 1990).
Despite increasing ovine fetal blood viscosity by 60% (Morrow et al. 1990), significantly less 
than the increase noted in human growth restricted pregnancies (Giles, Trudinger & Palmer 
1986; Steel et al. 1989), no significant change in the FVW was noted. Several 
vasoconstrictive agents have also been evaluated but though they increased placental 
impedance and reduced placental blood flow, the majority have effected little change in the 
diastolic component of the FVW (Irion & Clark 1990; Irion, Mack & Clark 1990). The 
thromboxane mimetic U46619 infused continuously at high phaimacological concentrations 
increased impedance and reduced the diastolic FVW (Trudinger et al. 1989; Irion & Clark
1990). However, in human pregnancies, inhibition of thromboxane synthesis, produces no 
improvement in the FVW. Vasoconstriction alone therefore does not equate with changes in 
the diastolic FVW.
1.6.3 HOW ARE ABNORMAL DOPPLER WAVEFORMS GENERATED?
It can be seen from both the human and animal data presented, that there is no conclusive 
evidence to support a vasomotor basis for the generation of abnormal FVW. Moreover, 
vasoconstriction alone, despite increasing placental vascular impedance and reducing 
umbilical blood flow, does not necessarily result in an abnormal Doppler waveform. It is 
therefore unlikely that abnormal umbilical Doppler is the consequence of a primary 
vasomotor factor, though obviously, vasomotor agents may modify or compound other 
factors.
Anatomically, a reduction in stem villous arterial number has been suggested in lUGR 
pregnancies with AEDFV. The idea of placental embolisation is plausible and has been 
shown to effect appropriate changes in the ovine FVW. Areas of placental vessel obliteration 
are a feature of normal placentas (Bracero et al. 1989) but to date there is no evidence of 
excessive "emboli" in the placentas of growth restricted pregnancies. Therefore while an
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placental transport mediated in the normal developing placenta.
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anatomical basis for abnormal Doppler is realistic, the mechanisms by which it might be 
produced are still unproven.
The biochemical and clinical features of the growth restricted fetus (section 1.3.1) which 
indicate intrauterine starvation, primarily as a result of impaired placental transport 
(Bernardini 1989), also suggests an anatomical basis for the generation/presence of abnormal #
umbilical artery Doppler waveforms. Since placental transfer occurs maximally in the distal, 
intermediate and terminal villi, these peripheral villi are very likely to be quantitatively or at 
least qualitatively, abnormal in lUGR pregnancies with AEDFV.
These observations can be reconciled if the reduced numbers of arterial vessels seen in lUGR 
pregnancies with AEDFV arise as a consequence of abnormal or impaired placental 
development affecting not only proximal stem villi but also these distal "exchange" villi. To
dndate this avenue of investigation has not been pursued.
In order to evaluate if structural changes might generate abnormal Doppler waveforms in 
growth restricted pregnancies, we must first appreciate how low impedance is generated and iS
1.7 EARLY PLACENTAL DEVELOPMENT
Early placental development begins with adhesion and implantation of the hatched 
blastocyst. It is formed from the outer layer of the blastocyst, the syncytiotrophoblast, which 
penetrates between the endometrial cells through the basement membrane and into the 
endometrial stroma (Schlafke & Enders 1975). As it enlarges, the syncytiotrophoblast 
becomes vacuolated, forming a lacunar* system, engulfing maternal capillaries in its track.
Radial outgrowths of cytotrophoblast cells, the inner and proliferative cell layer of the 
blastocyst, invade the syncytiotrophoblast network to form primary villi. It is these cells f
which also reach the distal extremities of the syncytiotrophoblast and extend laterally to form 
the trophoblastic shell (Hertig & Rock 1945). Some of these cytotrophoblast cells 
differentiate and become invasive, extending the size of the placental bed. This controlled 
invasion of the endometrium, unlike that of malignant tumours is precisely regulated; the first
■3 :trimester trophoblast increasing its expression of type IV collagenase (Puistola et al. 1989), 
proteases (Fisher et al. 1985) and receptors for fibronectin, laminin and collagen (Loke et al.
1989). With advancing gestation, these enzymes and receptors are down regulated, and the 
invasive process thus modified (Tim 1993).
By the fourteenth day following conception the extraembryonic mesenchyme, derived from 
the embryonic disc (Luckett & Beier 1978), invades the cytotrophoblast creating secondary 
villi. The latter are vascularised from within (Demir 1989) and receive blood from the 
developing fetal circulation as early as the 6th week of gestation. At this stage there is no 
formal intervillous circulation as assessed by aortography (Burchill 1967) hysteroscopy 
(Hustin & Schapps 1987) or colour Doppler ultrasound (Schapps & Hustin 1988), so the 
developing placenta is effectively a barrier between the mother and embryo. First trimester 
transvaginal chorionic villous biopsy specimens confirm the absence of a formal intervillous 
circulation since these specimens are not normally contaminated by maternal blood (Hustin 
& Schapps 1987). Furthermore, the early developing placenta and embryonic tissues are 
hypoxic relative to the mother (Rodesch et al. 1992). With subsequent perfusion of the 
intervillous space, once maternal spiral arterioles are breached around 10-12 weeks following 
fertilisation (Hustin, Schapps & Lambotte 1988), the usual haemochorial arrangement 
between maternal and fetal blood is established. Oxygen tension in the placenta and fetus 
then appears to more closely match that of maternal blood (Rodesch et al. 1992). During 
these early weeks of pregnancy, relative hypoxia may protect the fetus and its developing 
organs from the damaging effects of free radicals produced at higher oxygen tensions.
It is not clear how the developing fetus obtains maternal nutrients during these first 12 weeks 
of pregnancy since no formal intervillous circulation exists. However, placental villi as early 
as three weeks post-implantation express high concentrations of insulin receptors (Desoye et 
al. 1994) suggesting that even at this early stage development of the fetoplacental unit is 
influenced by maternal factors, perhaps through plasma filtrates or uterine gland secretions.
The precise timing and order of early placental development is of unquestionable importance. 
There is now evidence to suggest that "unexplained" early pregnancy failure may be related 
to poor trophoblast invasion (Michel et al. 1990), resulting in an incomplete trophoblastic 
shell (Hustin et al. 1990) and the untimely entry of oxygenated maternal blood, under 
relatively high pressure to the intervillous space (Schapps et al. 1988).
1.8 DEVELOPMENT OF THE FETO PLACENTAL CIRCULATION
The early developing placenta and umbilical cord can be clearly visualised with transvaginal 
ultrasound (Hustin & Schapps 1988). During the first trimester, the umbilical circulation is 
characterised by high impedance seen as absent end-diastolic flow velocity (AEDFV) in 
umbilical artery Doppler studies (Kurjak et al. 1990; Jauniaux et al. 1992). At this time, 
impedance within the uterine circulation is also high and mean blood flow in the uterine
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artery low (Thaler et al. 1990). There is then a dramatic increase in uterine artery blood flow 
around 12-14 weeks gestation as extravillous cytotrophoblast cells invade the maternal spir al 
arteries (Pijnenborg et al. 1981). This invasion results in destruction of the arterial elastic 
media and the formation of flaccid, low-impedance uteroplacental vessels, unresponsive to 
vasoactive agents which are thus able to accommodate increased uterine blood flow 
(Brosens, Robertson & Dixon 1967; de Wolf, Robertson & Brosens 1980). The changes 
occurring in spiral artery structure are reflected by an increase in uterine artery diastole flow 
velocity, together with a loss of the dichrotic notch (Bewley, Cooper & Campbell 1991; 
Bower, Bewley & Campbell 1993). This also co incides with the appearance of end-diastolic 
flow in the umbilical circulation (Jauniaux et al. 1992; Kurjak et al. 1990). By 18-20 weeks 
gestation, in normal pregnancy, the uterine circulation consistently demonstrates a low 
impedance Doppler waveform. Likewise, end-diastolic flow velocity is consistently present 
in the umbilical artery, indicating that even at this early stage, impedance within the placental 
vascular bed is falling (Hendricks et al. 1989).
The appearance of umbilical artery end-diastolic flow velocity, inferring low placental 
vascular impedance, is thus a physiological event in early pregnancy and necessary to 
accommodate the large volume of fetal blood which enters the umbilical circulation. Using 
isotope-labelled microspheres in the sheep, this has been calculated to be 50% of the fetal 
cardiac output (Rudolph & Heymann 1967) and a similar value has been obtained the human 
fetal circulation using Doppler ultrasound (Eik-Nes 1980; Giles et al. 1986).
Since the fetoplacental circulation is not innervated (Reilly & Russell 1977; Fox & Khong
1990), low impedance to blood flow must be conferred by the anatomy of the circulation, 
vasomotor influences on vascular smooth muscle, or a combination of both of these 
mechanisms.
1.9. VASOMOTOR CONTROL OF FETOPLACENTAL IMPEDANCE
The rami and ramuli chorii branches of the fetoplacental arterial circulation containing fetal 
ai’teiies and arterioles are muscularlsed. Thus total impedance to blood flow may be altered 
through changes in the smooth muscle tone of these vessels.
1.9.1 VASODILATOR MECHANISMS
Smooth muscle contractility is influenced by substances produced within the overlying 
endothelial cells (Vane, Anggard & Botting 1990). Prostacyclin has both vasodilator and
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platelet anti-aggregatory properties, and is synthesised in greater amounts in the umbilical 
artery than in subchorionic vessels (Benedetto et al. 1987). However its role in mediating 
local placental vasodilatation is questioned since inhibition of synthesis has no effect on 
perfusion pressure in the dually-perfused cotyledon (Jacobson et al. 1991) or the isolated 
umbilical artery (Templeton 1991).
Endothelial-derived relaxing factor (EDRF), or nitric oxide, which is produced from the 
conversion of L-arginine to citrulline by the enzyme nitric oxide synthase (NOS) (Palmer, 
Feriige & Moncada 1987) is another local vasodilating agent. The activity of EDRF was first 
demonstrated in the umbilical vessels (Van der Voorde, Yanderstichele & Leusen 1987) 
followed by the pre-constricted dually-perfused cotyledon (Myatt, Brewer & Brockman 
1991). Interestingly the vascular sensitivity to EDRF may increase in the more distal 
branches of this circulation (Chaudhuri et al. 1991). NOS has now been located by 
immunocytochemistry in both fetoplacental vascular endothelium and interestingly also in 
the villous syncytiotrophoblast (Myatt et al. 1993a). The regulation of EDRF production 
within the placenta in-vivo is not understood at the present time but mechanical stretch of 
endothelial cells, and vasoconstrictor mechanisms are likely to be important factors. EDRF 
probably has an important physiological role in the local regulation of villous blood flow.
Smooth muscle cells have specific receptor sites for atrial natriuretic peptide (ANP) which 
have been characterised in placental stem vessels (Salas et al. 1991; McQueen et al. 1991). 
ANP does not appear to be synthesised within the normal term placenta (Inglis et al. 1993), 
suggesting an endocrine action from peptide released into the circulation from the fetal heait 
(Wharton et al. 1988), though a more recent study suggests that umbilical vein endothelial 
cells may synthesise ANP (Cai et al. 1993). Umbilical cord levels of ANP are higher than 
corresponding maternal levels, and are in the range that would stimulate smooth muscle 
relaxation (Kingdom et al. 1992); a similar concentration of ANP antagonised the 
vasoconstrictor effects of angiotensin II in the perfused cotyledon (McQueen et al. 1991) 
suggesting that it has a role in promoting smooth muscle relaxation under resting conditions. 
ANP levels increase following intravascular transfusion suggesting that ANP-mediated 
vasodilatation may increase to assist the fetus to cope with blood volume expansion 
(Kingdom et al. 1991). Other peptides may have endocrine or paracrine actions to reduce 
smooth muscle contractility such as parathyroid hormone, its related peptide and calcitonin 
gene related peptide (Mandsager et al 1993).
1.9.2 VASOCONSTRICTOR MECHANISMIS
The anatomy of the fetoplacental circulation, together with the vasodilator mechanisms 
described above create the conditions for a low-impedance system but there are several
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mechanisms whereby vascular tone may be raised. Locally, within the placenta, the 
trophoblast produces thromboxane; platelets may also release both thromboxane and 5- 
hydroxytryptamine - each of which constricts the fetoplacental circulation m-vitro (Mak et al.
1984). The arterial smooth muscle layers synthesise thromboxane; production of which, is 
stimulated by oxygen. This mechanism may be important for closure of the umbilical arterial 
circulation at birth (Templeton et al. 1991). The latter mechanism may be inactive in-utero 
due to the low oxygen tension, particularly as pregnancy advances (Soothill et al. 1986). 
Arachidonic acid products of the lipoxygenase pathway, such as leucotriene B4, are less 
potent vasoconstrictors than is thromboxane (Thorp, Walsh & Brath 1988).
Endothelial cells are now known to synthesise the vasoconstrictor peptide endothelin (ET-1) 
(Yanagisawa et al. 1988). Synthesis of ET-1 has been demonstrated within the human 
placenta (Benigni et al. 1991; Hemsen et al 1991) and specific receptor sites have been 
demonstrated on smooth muscle cells within stem villi (Wilkes et al. 1990; Roubat et al.
1991). ET-1 is a powerful and direct vasoconstrictor of the fetoplacental circulation (Myatt 
et al. 1991). Shear stress is an important mechanism regulating ET-1 release (Milner et al.
1990) and it is thus likely that ET acts in a local manner to regulate villous blood flow, in 
conjunction with EDRF production.
The perfused placental cotyledon constricts to angiotensin II (McQueen et al. 1991) and 
interestingly to renin (Glance et al. 1984). Specific binding sites for these substances have 
been identified in the fetoplacental vasculature (Cook Craven & Symonds 1981; Tence & 
Petit 1989). Renin, and angiotensin II, are produced in the developing fetal kidney indicating 
an endocrine mechanism of action within the fetoplacental circulation (Graham et al. 1992). 
Since the necessary components for angiotensin II production are expressed locally (Ihara, 
Tail & Mori 1987; Keyurrangual et al. 1991) it is possible that local generation of 
angiotensin II also occurs within the stem villus.
More extensive reviews of substances which can influence fetoplacental vascular tone are 
available (Boura & Walters 1991; Myatt 1992 ). It is very likely that several factors act in 
concert to regulate fetoplacental blood flow, both from a regional (endocrine) perspective, 
such as ANP, and locally in a paracrine manner (EDRF, prostaglandins and ET-1). 
Establishing the effect of gestational age on the production and action of both vasodilator and 
vasoconstrictor agents is difficult, and complicated by the structural changes which occur 
during pregnancy within the placental vasculature. For example, the expression of functional 
ANP receptors in fetoplacental vascular smooth muscle increases with gestation (McQueen et 
al. 1993) which might imply greater vascular bed sensitivity to ANP as gestation advances, 
but these findings may merely arise from increased vascularisation of the placenta.
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Such studies emphasise that though vasoactive agents may be involved in umbilical 
resistance, their role, even in normal pregnancy, can only be interpreted in the light of 
placental vascular anatomy. Moreover, under conditions of maximal vasodilatation it is 
likely that maximal impedance is generated in the non-muscularised mature intermediate villi 
and their terminal buds: smooth muscle activity must favour vasoconstriction if ramuli chorii 
(tertiaiy stem villi) are to significantly influence overall vascular impedance. In pathological 
pregnancies therefore, it is vital that placental anatomical structure is first established in order 
that further studies which locate the production, or action of autocoids in-situ may be reliably 
interpreted and the pathophysiological processes resulting in restricted fetal growth clarified.
1.10 DEVELOPMENT OF THE MATURE PLACENTA
New villi are all derived from buds of proliferating trophoblast, known as villous sprouts, 
which obtain a stromal core and are vascularised by local fetal blood vessels to form 
primitive mesenchymal villi. During the first and second trimester, further differentiation of 
these villi produces immature intermediate villi which following stromal fibrosis are 
transformed into stem villi. By the 20th week of gestation mature intermediate villi are 
formed in preference to their immature counterparts. These villi do not differentiate into 
stem villi and therefore few new stem villi are added beyond this gestation. When growth of 
mature intermediate villi is exceeded by growth of their capillary loops, outpockets of 
terminal villi are passively formed.
Together, these villi form the functional unit of the mature placenta known as the 
"placentone", a villous tree suspended in the intervillous space and perfused by a central 
spiral arteriole. The branching arrangement of the villi, and the vessels within, is complex 
but important to appreciate (Castellucci et al. 1989; Leiser et al. 1991) and is illustrated in 
Figures 1.2 a-c. The chorionic artery penetrates through the chorionic plate into the truncus 
chorii; this divides to produce about 4 divisions of rami chorii, each of which divides 
dichotomously to form a further 3-30 (mean 11) generations of ramuli chorii. Rami and 
ramuli chorii represent the stem villi which are characterised by the presence of fetal ar teries 
and veins and/or fetal arterioles and venules. Distally, the mature intermediate villi give rise 
to terminal villi, the final ramification of the villous tree and the site of maximal feto- 
maternal exchange. By term terminal villi account for 40% of total placental volume and 
provide a surface area for exchange of 8m^ (Leiser, Kosanke & Kaufmann 1991)
There is now abundant evidence to confirm that the placenta is not merely a passive 
membrane separating maternal and fetal circulations but a functional organ, ensuring 
adequate substrate transfer from mother to fetus. This is achieved by two principle
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mechanisms, facilitated diffusion and active transportation. Glucose for example, is 
transferred by facilitated diffusion, bound to a carrier in the micovillous membrane of the 
syncytiotrophoblast while amino acids are actively transported by specific carrier proteins 
also located in the syncytium. The development of peripheral villi with extensive expansion 
of the syncytial surface area is therefore crucial to meet the metabolic requirements of the 
growing fetus.
1.11 ANATOMICAL BASIS OF FALLING IMPEDANCE
The maturation of the villous tree is undoubtedly a major factor in the development of a low- 
impedance high-flow circulation on the fetal side of the placenta. The umbilical arteries may 
communicate both within the cord (Gupta et al. 1993) and in Hyrtl's anastomosis at the cord 
root (Norvendall et al. 1991). Distally they branch without any further communication until 
terminal villous capillaries are formed (Leiser et al. 1991), though Boe (1953) has 
demonstrated the presence of arterio-arterial anastomosis in more peripheral areas. Shunting 
through these vessels is of little significance in normal circumstances, when vascular pressure 
is low, but may be important in pathological situations. Resistance to blood flow within the 
vascular tree increases continuously towards the muscularlsed arterioles of the small stem 
villi (small ramulii). Thereafter, due to rich branching of the mature intermediate villi, blood 
flow resistance is reduced. Under normal term conditions, the capillaries of the mature 
intermediate and terminal villi are long (2000 to 4000pM), winding, branched tubes with 
focal sinusoidal dilatations (up to 40pM in diameter) (Kaufmann et al. 1985a) which serve to 
further reduce impedance to blood flow (Kaufmann 1988). It is still a matter of discussion 
how far these terminal structures contribute to overall feto-placental vascular impedance but 
in view of these findings it is likely that not only the properties of arteries and arterioles but 
also the dimensions and structure of the capillary bed are of importance for overall vascular 
impedance in the fetoplacental circulation.
As impedance in the umbilical circulation is falling, the structure of both the placental villi 
and the placental villous tree is also changing to expand the placental vascular bed and the 
villous surface area available for exchange (Jackson, Mayhew & Boyd 1992). Within each 
villus, both the number of capillaries, and the volume of each villus occupied by capillaries, 
rise dramatically with advancing gestation (Jauniaux et al. 1991; Jackson, Mayhew & Boyd
1992) thus increasing the diffusive conductance to oxygen 80 fold from 10-12 weeks until 
38-41 weeks.
These changes, in association with the increase in uterine blood flow, result in a more 
efficient haemochorial arrangement between maternal and fetal blood reducing the matemo-
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fetal diffusion distance from more than 50 |iM to a mean of 4 pM at term (Bernischke and 
Kaufmann 1990) and increasing oxygen diffusion conductance significantly (Mayhew,
Jackson & Boyd 1993).
1.12 HYPOTHESIS 3 ; .
In view of these findings it is clear that as the placenta and the fetoplacental vascular network 
continuously develop during pregnancy, vascular impedance progressively falls, resulting in i |
a proportionate increase in feto-placental blood flow, an increased villous surface area and 
therefore improved materno-fetal exchange of nutrients and oxygen sufficient to meet the 
demands of the growing fetus. |
If this process of placental villous and vascular development is interrupted, placental vascular 
impedance will remain high, placental blood flow restricted and placental transport impaired 
resulting in poor fetal growth and the clinical picture of severe intrauterine growth restriction 
with AEDFV in the umbilical artery.
113 AIMS OF THE THESIS
In the placentas of pregnancies complicated by severe lUGR and abnormal umbilical artery 
Doppler waveforms we wish therefore; I
(1) To characterise the branching pattern of stem villous vasculature (chapter 3)
(2) To study the external appearance of peripheral (intermediate and terminal) villi and the 
arrangement of the capillary networks within them (chapters 4 and 5).
(3) To study the internal structure of terminal villi (chapter 6, 7 and 8)
'3'
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Figure 1.1 Doppler flow velocity waveform of an umbilical artery (Ua) and the umbilical 
vein (Uv). The peaks in the U a correspond to systole (S) in the cardiac cycle while the 
troughs reflect diastole (D)
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Fig 1.2 a - b .
Diagrammatic representation of the branching patterns of the villous tree. Ch P = Chorionic 
plate; BP = basal plate; T = truncus chorii; I-IV = for generations of rami; 1-11 = eleven 
generations of ramuli. The vessels are shown within the villous tree
Ic.
Fetal vessel architecture of an ending stem villous of the last ramulus (line hatched) and a 
terminal convolute composed of one mature intermediate villus (slightly point shaded) 
together with its terminal villi (unshaded). Arterioles are point shaded, capillaries are black 
and venules are unshaded. Note the long capillary loops supplying several terminal villi in 
series.
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CHAPTER 2
MATERIALS AND METHODS
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2.1 GENERAL METHODS
2-1.1. Transmission electron microscopy
Even with the best optics available, light microscopy has limited resolution - approximately 2 
micrometers - and is therefore unsuitable for the evaluation of cellular ultrastructure. The 
discovery that electron beams could be focused through a magnetic field opened the way for 
the development of transmission electron microscopy (TEM) by Ruska and Knoll in 1931.
Though the first images obtained were limited (Knoll 1935), the technique has now been 
significantly refined such that modern transmission electron microscopes resolve images of 
approximately 1-2 nm.
The "light source" of the TEM is an electron beam generated by the passage of an electric 
current through a tungsten filament. The latter is enclosed in a metal case (the cathode) 
maintained at a higher negative potential. This ensures that the electron cloud produced by 
the filament is repelled from the cathode and attracted through a small defect in the cathode 
case to an anode plate, at zero potential, below. The wavelength (and therefore speed) of the 
electron beam is inversely proportional to the potential between the anode and the tungsten 
filament and thus can be adjusted.
The electron beam is focused onto the specimen through a system of electromagnetic coils 
(the lenses). Some of the electrons pass straight through the specimen while others are 
deflected by atoms within the specimen. The resultant emerging beam is focused by a further 
powerful electromagnetic lens - the objective lens - positioned just below the specimen and 
projected onto a fluorescent viewing screen. Undeflected electrons, which passed straight 
through the specimen, form visible fluorescence on the screen while the deflected electrons 
leave dark areas in the image. The final image seen is therefore a density map, reflecting 
different atomic masses within the specimen field.
While highly magnified, well focused images can be obtained, only tiny areas of tissue (< 0.5 
mm^) can be examined at any one time. This is obviously of importance in a tissue such as 
placenta which demonstrates significant heterogeneity within each cotyledon (Fox 1964). To 
ensure that an accurate representation of placental structure is obtained, multiple samples, :
from randomly chosen areas of the cotyledon, must therefore be examined (Habashi, Burton 
& Steven 1983).
Furthermore since cellular ultrastructure is sensitive to even short periods of ischaemia or 
anoxia (Kaufmann 1985c), the speed of tissue fixation is of utmost importance. Using 
vascular perfusion techniques rapid fixation of placental tissue can be achieved within
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minutes. It is however, critical that identical fixation techniques are applied to all the tissue 
specimens obtained.
2.1.2. Scanning electron microscopy
In contrast to the transmission electron microscope the scanning electron microscope (SEM) 
evaluates three dimensional structure, utilising the electron beam to examine the external 
surface topography of unsectioned tissues at a magnification of up to 500 times that of optical 
microscopes.
As with the TEM, the electron beam is generated by passing an electric current through a 
tungsten filament. It is then propagated through a series of electromagnetic lenses which 
focus the beam to a diameter of approximately lOnm and direct it onto the specimen. A 
lower voltage of beam is used for SEM thus ensuring that the majority of electrons do not 
pass through the specimen, but rather interact with the specimen surface forming low voltage 
secondary electrons. These are reflected from the specimen surface and attracted to a 
scintillator located near the tissue which converts the electrons into an electric current. Since 
secondary electrons cannot travel far, few electrons will reach the scintillator from troughs in 
the tissue and therefore little current will be generated, while a larger number of electrons 
will be detected from peaks in the tissue surface. The current produced controls the light 
intensity of a spot on a cathode ray tube, moving in synchrony with the incident beam. 
Therefore, the number of secondaiy electrons detected, and the intensity of the light spot will 
reflect changes in the surface topography.
However, the images obtained are only meaningful if the tissue or vessel cast examined
■ A?;
SEM is an excellent medium by which tissue and vessel topography may be appreciated, 
accurately reflects the in^^vo structure.
I:
2.1.3. Vascular cast perfusion
Conventional methods of tissue fixation cannot demonstrate the architecture of vascular beds, 
buried within tissues. For this purpose, casts of the vascular bed must be prepared and 
examined with the SEM.
Vi
Initial placental vascular studies employed vinyl acetate (Boe et al. 1950) as a casting 
medium. Once infused into the placental chorionic arteries, the medium was allowed to
hai'den prior to digestion of the villous tissue with potassium hydroxide solution. Though the 
cast formed demonstrated the distribution of large vessels within the placenta it was too 
viscous to enter smaller vessels. With the introduction of low viscosity plastics which can
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perfuse capillary vessels this problem was overcome and the three-dimensional arrangement 
of these vessels appreciated (Habashi, Burton & Steven 1983; Leiser & Kohler 1983; Leiser
1985).
It is difficult to establish how accurately vessel casts reflect the in-^iw structure of blood 
vessels. Injection of casting medium into vessels has been reported to induce vasospasm, 
resulting in incomplete perfusion of the vessels and/or a reduced calibre of the vessels casted 
(Tompsett 1970). Initial perfusion with muscle relaxing agents inhibits vasoconstriction; 
while the cast formed from these vasodilated vessels is not a true reflection of the in-vivo 
vessel calibre, is still suitable for evaluating the branching pattern and number of vessels 
present. Simple measures such as the use of warmed perfusates also prevent induced 
vasospasm. However, the main focus of the current study, was the structure of capillary 
vessels. Since these vessels are non-muscularised they are unlikely to be subject to these 
ai'tefacts arising from vasospasm.
The size of vessels in a vascular cast may also be distorted by inappropriate perfusion 
pressures (Hodde & Nowell 1980) particularly as it is impossible to determine the "normal" 
perfusion pressure for each placenta, nor to quantify the effect of intrauterine pathology such 
as lUGR on "normal" placental perfusion pressures. Regulating perfusion pressures by the 
use of a syringe pump system or preset manual infusion rates ensures standardised fixation 
conditions but in spite of these manoeuvres caution is required when interpreting only vessel 
diameters from such casts.
As with any placental study, there is always concern that the area examined is not 
representative of the whole organ. However, several groups (Fox 1964; Boyd, Brown & 
Stewart 1980; Schuhmann & Wynn 1980; Habashi, Burton & Steven 1983) have now shown 
that differences within placental cotyledons are more marked than those between cotyledons. 
If therefore, the whole cotyledon is examined, a representative picture of the vascular bed 
will be obtained.
2.1.4. Immunohistochemistry
Iramunohistochemical techniques permit specific antigens to be localised in-situ. The method 
was first described in 1942 by Coon et al. who demonstrated the pnuemococcal antigen using 
fluroscein coupled to antibody fractions of antisera generated against the bacteria.
Modern techniques utilise the same basic principles. The antigen is first localised using 
immune serum generated by immunising animals with the antigen (polyclonal antibodies) or 
from hybridomas (monoclonal antibodies). Polyclonal serum often contains unwanted
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antibodies directed against other constituents of the original human antigen and is therefore 
less specific than monoclonal serum. Moreover, while specificity within a batch of 
polyclonal serum may be well defined, there is often great variation between batches of the 
serum. For these reasons, with the increasing availability of monoclonal serums, polyclonal 
antibody serums will soon become redundant.
Bound antibody is visualised using a fluorescent marker (fluroscein, texas red or rhodamine) 
or an enzyme:anti-enzyme reaction which yields a stable, visible reaction product 
(peroxidase:anti-peroxidase [PAP]; alkaline phosphatase:anti-alkaline phosphatase 
[APAAP]). Since enzyme reactions can be visualised with the light microscope, these 
sections can be counterstained and the antigen site localised more accurately.
The markers may be attached directly to the antibody or applied indirectly using single or 
multiple inteimediate antibody steps. Indirect methods are more sensitive and were therefore 
employed for all the immunohistochemical reactions described in this thesis. The 
intermediate antibody used, directed against the primary antibody, was labelled with the 
vitamin biotin which has a high affinity for the protein streptavidin (Chaiet & Wolf 1964). 
By complexing the peroxidase enzyme complex to streptavidin, strong indirect binding of the 
enzyme system to the antigen was ensured (Figure 2.1). The bound complexes were 
visualised by addition of a hydrogen peroxide/chromagen mixture which was catalysed by 
the bound peroxidase to yield a visible product; the chromagen AEG forming a red deposit 
and DAB a brown deposit.
The exact protocols employed for ch experiment utilising methods 2.2.2., 2.2.3. and 2.2.4 
aie described under the methods s/ ion of chapters 3, 4, 5, 6 and 7.
2.1.5. Pipetting
Solution volumes in the range 0.1 to 5mls were transfeiTed using adjustable Finnpipettes. 
Larger volumes were dispense ising standard laboratory glassware.
2.1.6. Weighing
All quantities were measure using a Mettler AT250 electronic balance.
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2.1.7. pH Measurement
Measurements of pH were performed using a digital pH/temperature meter obtained from 
Electronic Instruments Ltd. (UK.). The apparatus was standardised with a solution of pH 7 
prepared from buffered tablets.
2.2 CLINICAL MATERIAL
Many previous studies which have attempted to address the question of placental structure in 
lUGR have been hampered by studying term pregnancies which were small-for- gestational 
age but many of which were healthy and not truly growth restricted in-utero.
Though single ultrasound measurements of fetal weight will establish if the fetus is small for 
gestational age additional ultrasound features - oligohydramnios (Manning et al. 1981) and 
abnormal umbilical artery Doppler waveforms are required to select the growth restricted 
fetus at risk (Erskine & Ritchie 1985; Fleischer et al. 1985; Freidman et al. 1985; Hackett et 
al. 1987; Woo, Laing & Lo 1987; Rochelson et al. 1987)
2.2.1 Selection criteria
Specific criteria were therefore used to define the growth restricted study group (Gabbe
1991); an estimated fetal weight <10th centile in a structurally normal fetus, no underlying 
maternal or fetal condition other than pre-eclampsia, absent end-diastolic flow velocity in the 
umbilical artery by Doppler ultrasound and oligohydramnios ([AFI] < 5th centile) as in other 
studies from this department (McQueen et al. 1993; Kingdom et al. 1994)
Pre-eclampsia was defined as the development of hypertension [blood pressure persistently 
>140/100 mm Hg] occurring after 24 weeks gestation and significant proteinuria [>300mg in 
a 24 hour collection] (Davey & MacGillivary 1988).
Since placental structure varies with gestational age (Kaufmann 1982), a gestational age 
matched control group were also required. These pregnancies fulfilled the following criteria; 
normal growth parameters, with birthweight >25th centile; umbilical arteiy RI < 90th centile; 
no fetal abnormalities; no maternal disease which would affect placental/fetal development.
-41-
2.3 IDENTIFICATION OF PATIENTS
The patients included in this study were all identified and delivered at either The Royal 
Maternity Hospital or The Queen Mother's Hospital, Glasgow during 1992 and 1993. Since 
the placenta is normally discarded following delivery, formal ethical approval was not 
mandatory. However, all the patients in this study gave informed verbal consent for the use 
of the placental tissue prior to delivery. In each case placental weight and macroscopic 
features were recorded in the notes and a sample of placental tissue sent for conventional 
histological examination.
In order to exclude the possibility of dating errors, gestational age in each case was 
confirmed by a booking ultrasound prior to 16 weeks of gestation. Immediately preceding 
delivery, a further ultrasound examination was performed by the author to confirm the 
estimated fetal weight, measure liquor volume and assess umbilical artery perfusion with 
Doppler ultrasound. Pregnancies complicated by structural or chromosomal fetal 
abnonnalities were all excluded.
2.3.1 Estimation of fetal weight
Fetal weight was estimated by ultrasound from the fetal abdominal circumference, as 
described by Campbell and Wilkin (1975), on a transverse section of the fetal abdomen, 
perpendicular to the fetal spine in which the umbilical vein and stomach could be identified. 
The values obtained were converted to fetal weights using standard tables from the British 
Medical Ultrasound Society (BMUS). These were plotted against gestational age and related 
to birthweight centiles obtained from a local database (Smalls & Forbes 1983).
2.3.2. Amniotic fluid volume
Though the maximum depth of a single liquor pool is often used as an indicator of total 
liquor volume, evidence from the pregnant sheep model would suggest that summating the 
maximum depth of liquor within each of four uterine quadrants (the amniotic fluid index 
[AFI]) more accurately reflects total amniotic fluid volume (Moore & Brace 1988). A 
reduced AFI is significantly correlated with fetal outcome (Manning et al. 1981).
The patients in this study were therefore evaluated as follows; the uterus was divided into 
four quadrants and the single deepest amniotic fluid pool in each quadrant, free of umbilical 
cord and fetal limbs was measured; the transducer remained parallel to the patient's sagittal 
plane throughout. The four measurements obtained were summated to derive the AFI. Since
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amniotic fluid volume varies with gestational age, the values were plotted against a reference 
range (Moore 1990) and values <5th centile defined as oligohydramnios.
2.3.3 Assessment of umbilical artery perfusion
The principles of Doppler ultrasound have been described in section 1.5.2.1. Umbilical 
artery Doppler waveforms may be obtained using either a pulsed or continuous Doppler 
ultrasound system. Pulsed Doppler emits short pulses of ultrasound which are received by 
the transducer before further pulses are emitted. Signals from a specific depth can therefore =
be analysed separately. Pulsed Doppler is frequently used in conjunction with real time 
ultrasound (duplex system) so that the vessel in question, the umbilical artery, may first be 
visualised, the portion of umbilical cord to be assessed localised and the pulse depth set
2.4 PATIENT GROUPS
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appropriately. With continuous Doppler, ultrasound is continuously emitted and received.
iThus signals from all moving objects within the beam will be received and plotted, limiting the specificity of this system.
With both systems low frequency movements from the walls of blood vessels can be 
excluded by the use of a filter (thump filter). If set too high, however, the filter will also 
exclude echoes from slow moving blood cells within the vessel, giving the false impression 
of reduced blood flow velocity. Thump filters of 50-100 Hz will exclude vessel wall 
movements yet still take account of low velocity blood flow.
For this study, Doppler studies of the umbilical artery were performed using duplex pulsed 
Doppler (Acuson 128, Mountain View, CA), with the patient in a semi-recumbent position to 
ensure minimal occlusion of the vena cava. Free floating loops of the umbilical cord, near 
the cord root were initially identified using colour flow imaging and during a period of fetal 
apnoea (Indik & Reed 1990), a minimum of ten consecutive waveforms recorded. The mean 
RI was calculated over three waveforms. These values were plotted against a reference range 
(Hendricks et al. 1989) and values <90th centile considered to be normal. When umbilical 
artery diastolic flow velocity was absent this was recorded as AEDFV. All Doppler '
wavefoims were recorded with the high pass filter set at 50 Hz.
2.4.1 lUGR group
Twenty women with pregnancies complicated by severe lUGR were identified. Birthweight 
was confirmed to be <10th centile for gestational age, the majority being <3rd centile, in all
but one case. There were three neonatal deaths within this group; two as a result of 
prematurity and the third from post natal septicaemia. Post-natally all the neonates showed 
evidence of growth restriction, reflected by muscle wasting and dry, wrinkled skin. The 
clinical details of these cases are listed in Table 2.1.
2.4.2 Control group
Twenty women with gestational age-matched control pregnancies were identified. The 
reasons for preterm delivery were as follows; 4 women had a history of cervical 
incompetence and were admitted to the labour suite at full dilatation which was ineversible 
and delivered vaginally, 3 patients had previous uterine scar ruptures and were therefore 
delivered electively on this occasion between 32-34 weeks by caesarean section, 3 had 
unrelated medical problems which necessitated preterm delivery by elective caesarean 
section (bilateral pneumothorax, suspected breast carcinoma and a cerebral aneurysm which 
was due to be electively clipped post-natally to prevent a cerebral bleed; all were otherwise 
fit and well and in particular, the patient with a cerebral aneurysm showed no evidence of 
hypertension); the remainder were women admitted in spontaneous, unexplained preterm 
labour. Of those admitted in spontaneous preterm labour, 3 were delivered by caesarean 
section and the remainder had a spontaneous vaginal delivery. It was not always possible to 
perform a full ultrasound examination just prior to delivery in the latter cases. However, 
birthweights were all appropriate for gestational age, there was no clinical evidence to 
suggest intrauterine malnutrition and the neonates were both structurally and chromosomally 
normal. The majority of pregnancies were evaluated by ultrasound prior to delivery. In each 
case umbilical artery RI, AFI and estimated fetal weight were all within the normal range for 
gestational age. Birthweights were confirmed to be >25th centile. There were no neonatal 
deaths within this group of pregnancies. A summary of the clinical details are given in Table
2.5 COLLECTION OF SPECIMENS
The author was present at each of the deliveries. The umbilical cord was clamped 
immediately following delivery of the fetus, while cord pulsations were still present. 
Delivery of the placenta in both city hospitals was augmented by the use of 10 iu syntocinon 
im, before application of controlled cord traction to expedite delivery. The placenta, 
complete with membranes and a standard length of umbilical cord was then weighed and any 
gross pathology noted. Details of the specific methods used to prepare the placenta for each 
part of the project are outlined in the methods section of chapters 3, 4, 5, 6 and 7.
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2.2 (Case numbers 21-40)
2.6. MATERIALS
2.6.1 Transmission Electron Microscopy
Agar Scientific, (Cambridge, England) supplied Araldite, 25% EM grade glutaraldehyde, 
Kodak D19 solution. Rapid fix solution A and B, dodecenyl succinic anhydride (DDSA), 
Kodak 4489 EM grade film, tri-dimethylaminomethyl phenol (DMP 30) and Kodak 4489 
thick base EM film. Absolute alcohol was obtained from Hay man Ltd. (Essex, England). 
Lead nitrate, uranyl acetate, sodium citrate and sodium hydroxide were purchased from 
Sigma Chemical Company (Poole, Dorset). Osmium tetroxide, glass stripes for 
ultramicrotomy, disposable vials and trufs for the glass knives were bought from Leica UK 
Ltd (Milton Keynes, England) Disposable blades were purchased from Bayer Diagnostics 
(Hampshire, England).
2.6.2 Immunohistochemistry
Highly purified anti-goat type I and type IV collagen antibodies were obtained from Europath 
Ltd (Cornwall, England). Biogenesis Ltd (Bournmouth, England), provided the purified anti­
rabbit type III collagen antibody and Serotec (Oxford, England) the purified anti-mouse type 
VII collagen. Antibodies to laminin and fibronectin were also purchased from Europath Ltd 
(Cornwall, England) and Dako (Buckinghamshire, England) respectively. The other reagents 
required were obtained from the following companies; Bio tin conjugate anti-mouse and 
extravidin peroxidase kit (Sigma Chemical Company, Poole, Dorset), Methanol (Hayman 
Ltd, Essex, England), Hydrogen peroxide (BDH supplies, Poole, England), Phosphate buffer 
concentrate (Mercia Diagnostics, Guildford, England), Phosphate buffer tablets (Unipath Ltd, 
Hampshire, England), Swine anti-rabbit, rabbit anti-goat and peroxidase anti-peroxidase 
(Dako, Buckinghamshire, England ). HA West (Clydebank, Scotland) supplied EPY 135mm 
fhm for photomicrographs.
2.6.3 Morphometry studies
The following reagents were obtained from Sigma Chemical Company (Poole, Dorset): 
aminopropyltriethothoxysilane (APES), xylene, ethyl alcohol, methanol, hydrogen 
peroxidase, phospate buffered saline powder (pH 7.4), citric acid and bovine serum albumin. 
The Histostain-SP Kit was bought from Zymed Laboratories (San Francisco, California). 
Primary antibodies, anti a-smooth muscle actin and MIB-1 were obtained from Sigma 
(Deisenhofen, Germany).
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2.6.4 Vascular casts
Mercox ^  and catylyst (made by Japan Vilene Hospital) were bought from Otto Nordwald, 
Hamburg, Germany. BDH Supplies Ltd (Poole, England) provided methylmethacrylate and 
potassium hydroxide pellets. Photographic film, Ilford PanF 50, was purchased from HA 
West (Clydebank, Scotland).
2.6.5 Placental tissue casts.
Cylinder stubs and storage boxes were bought from Agar Scientific (Cambridge, England). 
Mounting glue for the stubs was purchased from Neubauer Chemikalien (Munster, 
Germany). HA West, (Clydebank, Scotland) provided Ilford Pan F150 photographic film.
2.6.6 General materials
Venflons and 3-port connectors were obtained from Viggo Spectramed (Helsingborg, 
Sweden). Baxter (Norfolk, England) provided 250ml bags of normal (0.9%) saline solution. 
Sutures (2/0 chromic gatgut) were bought from Ethicon (Edinburgh, Scotland). Syringes (5, 
10, 30 and 60 mis) and needles (19 and 21 gauge) were purchased from Bee ton Dickinson 
(Dublin, Ireland)
2.6.7. Apparatus used
The following equipment was also used; Finnpipettes (Jencons Scientific Ltd., Bedfordshire, 
UK.; critical point drier [CPD 750] (Biorad, Microscience Division (Hertfordshire, England); 
Digital scanning electron microscope [DSM-940] and stereomicroscope (Zeiss, Switzerland); 
Edwards coating unit and plate degasser (VG Scientific, Crawley, England); light microscope 
(Leitz Labovert, Wetzlar, Germany); LKB ultramicrotome (Leica (UK) Ltd, Milton Keynes, 
England); Graticule (Graticules Ltd, Kent, England); light microscope (Olympus Optical Co. 
(UK) Ltd, London, UK); Gallenkamp Prelude Incubator (Scotlab, Lanarkshire, Scotland); 
electronic balance (Mettler AT250, Zurich, Switzerland); glassware (BDH Ltd, Poole, 
Dorset, England); Acuson 128 Ultrasound machine (Mountain View, California).
S
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jzc. Biotin Streptavidin
Enzyme (peroxidase or alkaline p h osp hatase)
Figure 2.1. The streptavidinrbiotin technique for indirect immunohistochemistry. The 
enzyme system, conjugated to streptavidin is pre-formed thus reducing the number of 
incubation steps. Though streptavidin binds strongly to its ligand, biotin, high affinity 
antibody binding is required at the primary and intermediate stages to ensure reliable 
staining.
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Case No. Gestation(weeks)
Birthweight
g/[centile]
Placental weight (g)
Doppler
1 28 800 [10th] 198 AEDFV2 34 1480 [3rd] 260 AEDFV3 * 32 840 [<3rd] 300 AEDFV4 30 780 [<3rd] 160 AEDFV5 33 1280 [3rd] 242 AEDFV
6 36 1700 [3rd] 325 AEDFVq * 31 1200 [10th] 280 AEDFV
8 * 28 780 [5-lOth] 300 AEDFV9 sH 30 1000 [10th] 270 AEDFV10* 34 1700 [10th] 490 AEDFV11 * 28 940 [10-50th] 240 AEDFV12* 30 890 [3-5th] 200 AEDFV13 29 700 [<3rd] 280 AEDFV14 33 1300 [5-10th] 320 AEDFV15 32 900 [<3rd] 200 AEDFV16* 28 800 [10th] 200 AEDFV
17 33 1280 [3~5th] 242 AEDFV18 * 28 600 [<3rd] 300 AEDFV19 34 1350 [<3rd] 300 AEDFV20* 27 720 [10-50th] 210 AEDFV
Table 2.1 Clinical details of the pregnancies complicated by lUGR and absent end-diastolic 
flow velocity (AEDFV) on umbilical artery Doppler studies. * indicates those pregnancies 
which were in addition complicated by pre-eclampsia.
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Case No. Gestation(weeks)
Birthweight
(g)/[centile] Placental weight (g)
Doppler Indication for delivei-y
21 30 1450 [50th] 370 RI-0.79 PTL22 32 1900 [50-90th] 430 not done pnemothorax23 29 1540 [50-90th] 360 RI-0.70 PTL24 26 960 [50-90th] 405 RI-0.68 a25 26 840 [50-90th] 310 RI-0.74 a26 32 1500 [10-50th] 360 RI-0.77 scar mpture27 34 2010 [10-50th] 380 RI-0.65 PTL
28 35 2140 [10~50th] 480 not done PTL29 31 2040 [50-90th] 580 not done Breast Ca.30 33 1890 [10-50th] 370 not done PTL31 32 2150 [50-90th] 500 RI-0.74 scar rupture32 27 1140 [50-90th] 450 RI-0.78 PTL
33 34 2520 [50-90th] 498 RI-0.77 PTL34 35 2290 [10-50th] 520 not done aneursym35 31 1600 [50th] 325 not done a36 32 2100 [50-90th] 562 not done PTL37 33 1860 [10-50th] 450 not done scar mpture38 34 2600 [50-90th] 680 RI-0.68 PTL39 32 1910 [50-90th] 630 RI-0.77 PTL40 28 1120 [50th] 380 not done a
Table 2.2 Clinical details of the gestational-age matched preterm control pregnancies used in 
the study. Where possible, Doppler studies were performed and the resistance index (RI) 
calculated. The indications for delivery were as follows; PTL-unexplained preterm labour; 
Cl-cervical incompetence; scar rupture-previous uterine scar rupture; aneursym- a cerebral 
aneursym which required intervention; pneumothorax-spontaneous unexplained bilateral 
pneumothorax
-49-
CHAPTER 3
VASCULAR ELABORATION 
IN STEM VILLI
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3.1 INTRODUCTION
It is now well established that vascular impedance is dependent in part on the structure and 
distribution of blood vessels within the vascular bed. Great interest was therefore aroused 
when Giles et al. (1985) and McGowan et al. (1987) noted reduced numbers of small 
arteriole vessels within the tertiary stem villi of placentas from pregnancies complicated by 
severe lUGR and abnormal umbilical artery Doppler. This was thought to be the 
consequence of an obliterative process occuiTing within the tertiary stem villi; subsequent 
work in the pregnant ovine model confirmed that progressive arterial obliteration of the 
placenta using microspheres of 50|iM diameter could induce similar Doppler changes to that 
seen in the lUGR fetus (Morrow et al 1989b). Having recognised that the lUGR fetus has a 
reduced number of circulating platelets (Van den Hof & Nicolaides 1990) possibly due to 
increased platelet consumption (Wilcox & Trudinger 1991), it was postulated that platelet 
emboli formed within the feto-placental circulation, gradually obliterate the small stem 
arterial vessels in lUGR pregnancies.
However, the definition of small arterial vessels in each of these studies was broad and 
included vessels with diameters between 20 and 90|_iM. It is likely that feto-placental 
vascular impedance will increase towards the lower end of this range since the cross- 
sectional area is increasing. In addition, the findings of the pathological (typically preterm) 
pregnancies were at times compared with gestationally unmatched (i.e. term) controls 
(McGowan, Mullen & Ritchie 1987; Bracero et al. 1989). Finally to date, no evidence exists 
to substantiate the platelet emboli theory in any portion of the vascular tree. How such an 
embolic process might be initiated is also unclear.
There is now also evidence to suggest that pregnancies complicated by lUGR and abnormal 
Doppler waveforms are characterised by a global defect in vascularisation, i.e. involving all 
villous classes (Jackson et al. 1995). Though the absolute number of arterial vessels would 
therefore be reduced, a global defect would imply that the proportion of small and large 
arterial vessels would be similar to that seen in control cases.
■The primary aim of this study was therefore to establish if the reduction in stem arterioles 
was the result of primary vascular maldevelopment or a consequence of later vessel 
obliteration. The pattern of vessel elaboration in both lUGR and gestational age-matched 
control placentas was examined by evaluating specifically the relative propoitions of vessel 
profiles within well-defined vessel diameter groups using an antibody to a-smooth muscle 
actin contained in contractile smooth muscle cells - this approach can therefore distinguish 
muscularised arterioles from large capillary vessels in the 10-20pM range. Moreover, as 
other vascular systems affected by increased vascular resistance demonstrate "extension" of
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smooth muscle cells into tissue which is normally non-muscularised (Rabinovitch et al.
1986), our secondary aim was to evaluate whether actin positive cells, representing 
muscularised cells were present in normally non-muscularised intermediate and terminal 
villi.
3 2 METHODS 
3.2.1 Clinical Details
Eight pregnancies complicated by severe lUGR were selected. All met the criteria defined in 
Section 2.2.1, The clinical details of these cases are given in Table 2.1 [Case numbers 5, 10- 
16]. Four of these pregnancies were also complicated by pre-eclampsia [Section 2.2.1]. 
Following delivery, birthweights, except that of case 11, were confinned to be less than the 
10th centile. All the neonates, including case 11, showed evidence of m-wtero starvation with 
reduced pondéral indexes and diy, wrinkled skin.
For comparison purposes, a further 8 pregnancies with normally grown fetuses and normal 
umbilical artery Doppler studies were identified. These pregnancies were matched with the 
study group for smoking and gestational age. The clinical details of the eight cases are given 
in Table 2.2 [Case numbers 25, 26, 29, 30, 32-35]. Four women in each of the lUGR and 
control groups were smokers.
3.2.2 Collection of specimens
PREPARATION OF PHOSPHATE BUFFER: 0.02M phosphate buffer solution (PBS) was
formed by dissolving 1 tablet of phosphate buffered saline (section 2.6.2) in 100 mis of 
double distilled water.
NEUTRAL BUFFERED FORMALIN: Prior to delivery 4% neutral buffered formalin was
constituted as follows; 10.8 mis of formaldehyde (37% formalin) were added to 89.2 mis of 
PBS and the solution thoroughly stiired.
Within five minutes of delivery, four full-thickness sections of the placenta were excised 
from randomly chosen areas of the placenta, though areas with obvious gross pathology, such 
as infarcts, were excluded. The excised tissue was immersion fixed in the freshly constituted 
formalin for 8-24 hours (mean 14 hours) then transferred to 50% ethyl alcohol for a 
minimum of 12 hours and not longer than 24 hours. The sections were dehydrated through 
ascending concentrations of graded alcohol (70, 80, 90 and 100%) then transferred to acetone 
before embedding in paraplast. Dehydration and embedding was performed using an 
automated processor.
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3.2.3 Preparation of sections
The glass slides used for imraunohistochemistry were washed in ethyl alcohol, immersed for 
20 seconds in 2% APES solution then washed in pure acetone (1 minute) and aqua dest (1 
minute). This process improved adhesion of the paraffin embedded sections to the slides.
Serial sections (3-5 pM) of the paraffin embedded material were mounted onto the pre­
treated slides and incubated at 37° C overnight. The following morning the sections were 
deparaffinised as follows; each section was immersed twice in xylene for 2 x 10 minutes then 
transferred through a graded series of alcohol (100, 95 and 90%) for 5 minutes in each grade.
3.2.4 Immunohistochemistry
A commercial kit (Zymed Laboratories, San Francisco) using a standardised sequence based 
on the streptavidin-biotin technique was employed for immunohistochemistry. The primary 
antibodies were all diluted in PBS with 1.5% bovine serum albumin (BSA).
Sections were first incubated with 1% hydrogen peroxide in methanol to block endogenous 
peroxidase activity, then washed in PBS. After a further 20 minute incubation with 10% 
non-immune goat serum, to prevent non-specific background staining, they were covered 
with primary antibody - anti a-smooth muscle actin [dilution 1:300; (Skalli et al. 1986)] for 
60 minutes. Thereafter the slides were washed for 3 x 5  minutes in PBS then incubated with 
the second biotinylated antibody (goat anti-mouse antibody) for a further 30 minutes. After a 
further wash in PBS, the sections were incubated for 5 minutes with the streptavidin 
peroxidase conjugate (prepared according to the kit instructions). To visualise the bound 
antibody, the sections were washed in PBS before incubating with 3-amino-9-ethylcarbazole 
[AEG] for 15 minutes. The sections were rinsed in distilled water for 2 x 5  minutes, 
counterstained with haematoxylin for 3 minutes then washed in tap water for 10 minutes.
The sections were all mounted with c overslips using an aqueous mounting solution (Kaisers 
glycerol gelatine). All the incubations were performed at room temperature. Controls were 
generated by replacing the primary antibody by non-immune rabbit serum (10%). All the 
controls remained negative.
3.2.5 Analysis
3.2.5.1 Analysis of stem villous vessel number
A grid box (22 x 22 mm) containing 400 squares was formed and 100 squares marked by 
random allocation. The grid boxes were placed over each section using an identical 
orientation for each case, from chorionic to basal plate. Counting of the vessels was
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performed with a MOP Videoplan Image Analysis system (Kontron, Munich, Germany) and 
all measurements were perfonned by the author.
Within the randomly chosen fields, the diameter of 600 consecutive stem arterial vessels, 
between 10-160p,M (Kaufmann & Burton 1994) was measured in pM, using on-screen 
callipers. Arterial vessels were identified by the presence of a continuous ring of smooth 
muscle (stained by anti a-smooth muscle actin antibody) around the vessel lumen. 
Measurements were taken at the widest transverse diameter of the vessel, peipendiculai* to the 
axis of the vessel, and included the muscularised vessel wall (Figure 3.1). Villi which 
contained branching arterial vessels were also included, but in such cases measurements were 
taken perpendicular to the axis of the branches.
The 600 vessel diameters were then plotted in bands of 15 pM intervals from 10-160 pM 
diameter. The percentage of vessels within each diameter band was calculated and a mean 
diameter derived from the 600 counts.
3.2.5.2 Verification of sample size
Vessel measurements were repeated for 300, 450, 600 and 750 consecutive vessels. The 
mean diameter (and standard deviations) for each vessel count were as follows; 27 pM [20.8 
pM]; 30 pM [28.8 pM]; 29.5 pM [28.14 pM]; 29.6 pM [20.6 pM]. Since there was no 
significant difference in the mean vessel diameter obtained when 450 vessels or more were 
examined, 600 vessels were deemed sufficient to provide a reliable sample.
To ensure reproducibility, vessel measurements were repeated on the same section at 
different time intervals. There was no significant difference in the mean vessel diameter or 
the distribution pattern of vessel diameters obtained at each count.
3.2.5.3 Analysis of villous volume
Since the proportion of villous tissue may differ between placental sections, the villous cross- 
sectional surface of each placental section was estimated using a standard 20 point counting 
technique (Mayhew & Burton 1988) and the proportion of stem and peripheral villi (defined 
as all non-muscularised intermediate and terminal villi) was calculated.
3.2.5.4. 'Extension* of smooth muscle cells
The presence of any actin positive cells within the villous stroma of peripheral villi was 
evaluated during the above process.
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3.2.5.5. Statistical Analysis
The % of vessels within each diameter category and the mean stem vessel diameter are 
expressed as mean and standard deviation. The villous volumes were also normally 
distributed and are therefore expressed mean and standard deviation. Differences between 
the lUGR and control groups were assessed using a Student's unpaired t-test with p values < 
0.05 considered to be significant.
3.3 RESULTS
3.3.1 Comparison of the study groups
The mean gestational age at the time of delivery was similar for the two groups (lUGR group 
30.75 weeks [SD 2.5] vs. control group 31.8 weeks [SD 2.4]; p=0.767). The birthweight of 
the lUGR group was significantly less than that of the controls (1076g [SD 320] vs. 1718g 
[SD 443]; p<0.05). Similarly, the lUGR placentas were significantly lighter than those of the 
controls (264g [SD 49.4] vs. 426g [SD 99.6]; p<0.05).
3.3.2. Villous volume
The proportion of villous tissue within each case is summarised in Table 3.1. There was 
significantly less villous tissue in the lUGR placentas when compared with gestational age 
matched controls (57.38 [SD 7.4] vs. 70.375 [SD 10.8]; p<0.05); in particular the volume of 
placental tissue occupied by terminal villi was significantly less in the lUGR placentas than 
in the control placentas (14 [SD 3.4] vs. 20 [SD 4.2]; p<0.05). There was no significant 
difference in the proportion of placental tissue occupied by stem villi (41 [SD 8.9] vs. 49.6 
[SD 8.8]; p=0.07).
Within the lUGR group, there was no significant difference between the lUGR placentas 
from pregnancies with pre-eclampsia and those without in either the villous volume (62% 
[SD 2.9] vs 52.8 [SD 7.9]; p=0.07); the volume of stem villi (45.8 [SD 5.4] vs 36.3 [7.9]; 
p=0.14); or the volume of terminal villi present (13.5 [SD 4.4] vs 14.5 [SD 2.6]; p=0.7).
3.3.3. Pattern of vessel branching
A typical histogram plot for an lUGR (case 3) and preterm control (case 26) are shown in 
Figure 3.2. There appeared to be a smaller percentage of vessels in the 10-26pM diameter 
group of the lUGR placentas when compared to the preterm control cases, but this difference 
was not statistically significant. The mean percentage of vessels (SD) within each vessel 
diameter class for both groups is shown in Figure 3.3. There was no significant difference in
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the mean vessel diameter (Table 3.1) of either group (31.96p.M [SD 3.14] vs. 29.759pM 
[SD2.6];p=0.13).
3.3.4 'Extension' of muscularised cells
Actin positive cells were consistently obseiwed in five of the eight lUGR cases (5, 11, 12, 15 
and 16). None of the preterm control cases demonstrated positive actin staining within the 
stroma of intermediate/terminal vilh.
3.4 DISCUSSION
Light microscopic histological studies of the placenta in pregnancies complicated by lUGR 
have suggested a reduction in the numbers of small muscularised vessels within stem villi 
(Giles, Trudinger & Baird 1985; McGowan, Mullen & Ritchie 1986) which has led to the 
view that they are somehow obliterated by fetal platelets (Wilcox & Trudinger 1991). 
However, recent work has indicated that reduced vascularisation is not simply a feature of 
small stem arterioles (10-90pM) but of the whole vascular bed, suggesting a basic problem of 
placental vascular growth and development in lUGR pregnancies (Jackson et al. 1995). In 
order to understand the pathophysiology of intrauterine growth retardation, these two 
hypotheses, hypovascularisation and vessel obliteration, must be clarified.
The total proportion of villous tissue within each lUGR placental section was significantly 
less than that present in the control cases. Most of the data published previously on lUGR 
placentas has shown no reduction in total villous volume (Aherne & Dunhill 1966; Teasdale 
1984; Boyd & Scott 1985), but this can probably be explained on the basis of case selection, 
as these studies evaluated only term SGA infants, where few babies born <10th centile will 
be lUGR. More recently, when true lUGR pregnancies with AEDFV were assessed, total 
villous volume was less (Hitschold et al. 1993; Jackson et al. 1995)
Closer evaluation of our data demonstrated that the smaller proportion of villous tissue 
present in lUGR placentas reflected a significant depletion in the volume of peripheral villi; 
there was no significant difference in the volume of stem villi between lUGR and control 
cases. During the evaluation of stem arterial numbers by Giles et al. and others (Giles, 
Tradinger & Baird 1985; McGowan, Mullen & Ritchie 1986), the total number of stem villi 
examined in each case was comparable, however, we have now confirmed that the total 
proportion of stem villi in lUGR placentas matches that of gestational age-matched control 
cases. A reduction in the number of stem villous vessels in lUGR placentas is not therefore 
secondary to a diminished population of stem villi but implies a global defect in the 
elaboration of the vascular tree (Kaufmann & Burton 1994). The 'reduced' stem arterial
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;;æI"Stheories do not, however, address the underlying pathology of fetal hypoxia, characteristic of 
the lUGR fetus as stem villous arterioles merely conduct blood into the intermediate/terminal 
villi where nutrient and gas exchange occurs (Macara, Kingdom & Kaufmann 1993). Since !|
terminal villi are the site of maximal feto-maternal exchange the relative absence of 
peripheral villi which we noted should not be ignored. The lack of essential fetal substrates 
in the growth retarded fetus may well result from the depletion of these exchange villi.
Previous unmatched (Aherne & Dunhill 1966; Teasdale 1984) and recent matched control 
studies (Hitschold et al. 1993; Jackson et al. 1995) have also made similar' observations on 
the volume of tenninal villi and therefore the structure of this portion of the placental villous 
and vascular tree merits further evaluation using sensitive 3-dimensional imaging and 
ultrastructural studies of tissue and vascular casts. ?
In this study, the elaboration of stem villous vessels was determined by the distribution of 
vessel profiles in lUGR and gestational age-matched control placentas. The number of 
"vessel profiles" was specifically evaluated since it is not possible to reliably distinguish 
arterial/arteriolar from venous/venular profiles in paraffin sections, particularly at the lower 
end of the vessel diameter range. However, as stem villous vessels branch dichotomously, it 
is reasonable to assume that the vessel profile counts obtained reflect in a qualitative way the 
pattern of arterial/arteriolar vessel elaboration (Leiser, Kosanke & Kaufmann 1991).
Previous studies evaluating stem villous vessel numbers have examined only small arterial 
vessels and failed to relate their findings to the rest of the vascular tree (Giles, Trudinger &
Baird 1985; Bracero et al. 1986; McGowan, Mullen & Ritchie 1986). Stem arterial vessels 
follow the same pattern of dichotomous replication as stem villi themselves, and therefore, 
the percentage of arterial vessels of any given diameter is fairly constant for all placentas 
(Lucas et al. 1994). Obliteration or loss of the small stem arterioles should therefore result in 
a specific reduction in the percentage of small arteries, while the percentage of large vessels 
would remain similar or increase. Unfortunately, there is no indication in any of the three 
stem vessel studies mentioned previously (Giles, Trudinger & Baird 1985; McGowan,
Mullen & Ritchie 1986; Bracero et al. 1987) that the number of larger stem arteries was i
confir med to be normal in the lUGR placentas.
aFurthermore, the definition of small arterioles used in previous studies was very broad (20- 
90jtM), vessels at the lower end of the range having a cross-sectional vessel area almost one f
twentieth that of vessels at the upper limit (Jauniaux & Burton 1993). The contribution of the 
20|iM and 90|iM vessel to placental vascular resistance would therefore vary enormously.
As platelet or other emboli are most likely to occlude the vessels at the lower end of this 
spectrum, the methods described by Giles and others would lack the sensitivity to detect such
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,changes. By the use of anti a-smooth muscle actin antibody, we were able to visualise and 
measure vessels to lOpM, prior to becoming mature intermediate villus capillaries.
By evaluating the percentage of vessels within small well defined vessel diameter groups we 
were able to establish that there was no evidence of a selective reduction in the percentage of 
small arterioles, even amongst the smallest vessel diameters, which might indicate embolic 
vessel obliteration. In contrast, the proportion of vessels within each class was similar for 
both lUGR and control cases suggesting that the normal pattern of stem arterial development 
was undisturbed. Since the number of fields required for adequate sampling was calculated 
at the beginning of the study we can be sure our findings were not biased by sampling 
methods. The trend towards fewer vessels in the 10-25|iM diameter group in the lUGR 
placentas obviously requires further investigation, using larger numbers of placentas, to 
establish if this does indeed reflect a genuine difference between the two groups. It is 
possible that these smaller vessels may be affected by a thrombotic/occlusive process. 
Alternatively, reduced numbers of very small arterioles may simply reflect further 
impairaient of vascular development. Interestingly, the addition of maternal pre-eclampsia to 
the equation did not appear to alter these findings; suggesting that these changes were 
primarily related to the fetal condition.
Our findings, in conjunction with those of Jackson et al. (1995), have demonstrated that the 
lack of "small stem arterioles" previously reported (Giles, Trudinger & Baird 1985; 
McGowan, Mullen & Ritchie 1985) reflects a generalised depletion of the stem villous 
arterial tree. Stem villi are formed principally during the first and second trimester, at a time 
when EDFV is beginning to become apparent. Therefore a generalised depletion in stem 
villous vessel counts may reflect poor development of stem vilh at this stage of gestation.
Anti a-smooth muscle actin positive cells were identified within the peripheral villous stroma 
of five lUGR cases but were never seen in any of the control cases. This obseiwation was 
unexpected, as intermediate and terminal villi do not contain a muscularised vessel system 
and have been assumed to be unresponsive to vasoactive agents. The contractile filament 
actin is widely expressed in most birds and mammals, as one of several isoforms, a-actin 
isofonn is specifically found in smooth muscle cells and is absent from fibroblasts (Skalli et 
al. 1984), though it is now also recognised to stain pericytes within the placental stroma 
(Skalli et al. 1989). However, the actin positive cells in the lUGR terminal villi were not 
found in association with any capillary vessels. The origin of these cells in the placenta is 
unclear, however in some pathological conditions and during wound healing fibroblasts in 
other tissues may differentiate into cells with contractile properties, known as myofibroblasts 
(Gabbiani et al. 1972; Skalli et al. 1986), which are positive for the anti a-smooth muscle 
actin antibody. It is interesting to speculate that terminal villous stromal fibroblasts may
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under certain conditions such as impaired villous blood flow, altered oxygen tension or 
abnormal growth factor expression, also acquire these contractile properties.
In children with congenital heart defects and increased pulmonary artery pressure, smooth 
muscle cells and precursor smooth muscle cells are found to 'extend' into normally non- 
muscularised peripheral portions of the lung (Rabinovitch et al. 1986), changes which are 
similar to those found in the rat with hypoxic induced pulmonary hypertension (Meyrick & 
Reid 1978: Rabinovitch et al. 1979). It is clear that many severely growth retarded fetuses 
show evidence of increased placental vascular resistance, reflected by changes in the Doppler 
waveform. Though these primary Doppler changes may result from defective development 
of the placental vascular bed, a-actin  positive cells being contractile and therefore 
vasoresponsive, may compound the effects and further impair blood flow within the terminal 
villous circulation.
We have demonstrated that obliteration of small arterial vessels is unlikely to play a 
significant role in the pathogenesis of abnormal Doppler waveforms in the lUGR pregnancy, 
since the percentage of all arterial vessel classes is similar in both lUGR and control 
placentas. Rather, our data would support the concept that the stem villi of lUGR 
pregnancies are characterised by widespread depletion of the vascular bed. These changes 
could contribute to the increase in placental vascular resistance and the development of 
abnormal Doppler waveforms in lUGR pregnancies.
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Figure 3.1 A cross-section of villous tissue stained with the antibody anti a-smooth muscle 
actin. Positive antibody staining is seen as a red colour. SV - stem villi; TV- terminal villi. 
The presumed long axis of the vessels are shown by the broken black line and the maximum 
diameter obtained displayed as the unbroken black line, (magnification x 100)
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Figure 3.2 Histogram plot of the distribution of vasculai' profiles, identified by anti a- 
smooth muscle actin, within each vessel diameter group [10-25|iiM; 26-40p.M; 41-55|iM; 56- 
70jaM; 71-85|uM; 86-100|xM; 101-115|rM; 116-130|aM; 13M 45qM  and 146-160|tM) of an 
lUGR (case 3) and normal gestational age-matched (case 26) control placenta.
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Figure 3.3 The mean (SD) percentage of vascular profiles within each diameter class (10-25, 
26-40, 41-55, 56-70, 71-85, 86-100, 101-115, 116-130, 131-145, 146-160 |iM) for the lUGR 
(upper graph) and gestational age-matched control groups (lower graph). As the SD was 
tightly distributed around the mean in the majority of cases, error bars can only be seen in the 
smaller vessel diameter groups, where the SD was larger. There was no significant 
difference in the distribution pattern of either group.
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lUGR CASES
Patient number % villous tissue % stem villi % terminal villi MVDi
5 59% 38% 11% 29.5
10 43% 24% 11% 28.0
11 57% 40% 17% 33.9
12 61% 47% 14% 34.3
13 60% 50% 9% 34.0
14 64% 49% 15% 31.3
15 65% 46% 19% 33.0
16 50% 34% 16% 30.1
PRETERM CONTROL CASES
Patient Number % villous tissue % stem villi % terminal villi MVD (mm)
9 60% 42% 18% 27.1
10 81% 53% 18% 27.8
11 83% 62% 21% 27.9
12 78% 48% 30% 28.7
13 52% 34% 18% 27.5
14 75% 57% 18% 32.8
15 67% 48% 19% 32.9
16 67% 53% 18% 33.8
Table 3.1 The % of villous tissue and the mean vessel diameter (MVD) within each lUGR 
and gestation age-matched control placenta.
63-
:
5.*
1
'I
I
CHAPTER 4
THE TERMINAL VILLOUS CAPILLARY
NETWORK
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4.1 INTRODUCTION
Anatomical studies of the placenta from lUGR pregnancies with AEDFV have reported 
reduced numbers of small stem arterial vessels when compared with gestational age matched 
controls (Giles, Trudinger & Baird 1985; McGowan, Mullen & Ritchie 1987; Bracero et al, 
1989), presumed to occur as a result of vessel obliteration by platelet emboli However, to 
the author's knowledge, there have been no reports demonstrating the presence of excessive 
platelet emboli within stem vessels of affected human cases. Moreover we have shown in 
chapter 3 that there is no evidence to suggest a selective reduction in the number of small 
arterial vessels.
Planar data such as numbers of arterial vessels may be more accurately interpreted when 
related to specific placental components such as placental volume, villous volume or surface 
area, a technique known as stereology (Mayhew & Burton 1988). Recent stereological 
studies of placentas from lUGR pregnancies complicated by AEDFV have demonstrated 
widespread depletion of the vascular network, indicating that the lUGR placenta is 
hypovascularised thus raising the possibility that the reduced number of arterial vessels noted 
previously are the result of impaired vascular development (Hitschold et al. 1993; Jackson et 
al. 1995). In particular the volume of peripheral (intermediate and terminal) villi was 
significantly depleted in the lUGR placentas when compared to gestational age-matched 
controls (Jackson et al. 1995). Falling placental vascular impedance with gestation is 
associated with the development of the distal placental vascular bed during the late second, 
and third trimesters of pregnancy (Kaufmann & Burton 1994). Interruption to, or 
modification of this stage of vascular growth could therefore, alter normal placental vascular 
impedance. It is interesting to note that AEDFV in the umbilical artery is observed primarily 
in the third trimester of pregnancy; once the stem villous arterial population is complete but 
before complete development of these peripheral villi has occurred.
The development of peripheral villi and their vascular network increases the trophoblast 
surface area available for materno-fetal exchange (Jackson, Mayhew & Boyd 1992), 
minimising the transfer distance between maternal and fetal blood (Mayhew et al. 1993). 
This process is vital to ensure that the metabolic requirements of the developing fetus are 
assured. Thus depletion of peripheral capillary vessels may also restrict fetal nutrition.
Though the peripheral vascular network which is central to placental vascular 
haemodynamics and fetal nutrition appears to be reduced in lUGR pregnancies (Hitschold et 
al. 1993; Jackson et al. 1995), it is unclear if this is simply due to diminished numbers of 
normal capillaries or maldevelopment of the capillary bed. In order to address this issue,
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vascular casts from lUGR and control placentas were examined in a 3-dimensional way using 
scanning electron microscopy (SEM).
4.2 METHODS
4.2.1 Clinical details
Ten pregnancies complicated by severe lUGR, which met the criteria outlined in Section 
2.1.1, were identified antenatally. The clinical details of these cases are given in Table 2.1 
[Case numbers 1-7, 9,10,20]. Five of the pregnancies were normotensive and the remaining 
five were complicated by pre-eclampsia as defined previously in Section 2.1.1. There were 
no other underlying maternal or fetal conditions present. Birthweight in each case, based on 
a local database (Smalls and Forbes 1983), was confirmed to be less than the 10th centile for 
gestational age, the majority being less than the 3rd centile. All the neonates showed 
evidence of intrauterine starvation. There was one neonatal death in this group resulting 
from overwhelming septicaemia and severe respiratory distress.
For direct comparison 10 women with normally grown pregnancies, who were delivered 
prematurely, were also identified. The clinical details of the 10 cases are given in Table 2.2 
[Case numbers 21, 22, 24, 28, and 36-40].
4.2.2 Preparation of vascular casts
Following delivery of the placenta, a chorionic branch of the umbilical artery together with 
its corresponding venous outflow, supplying a peripheral cotyledon were identified. The 
artery was cannulated with a 16 gauge cannula and secured with a single stitch (2/0 chromic 
catgut) to prevent backflow or extrusion. A three port polyethylene connector was attached 
to the cannula, permitting multiple perfusates. The venous outflow was also punctured, at a 
site proximal to the cord root to allow free venous drainage throughout the procedure. The 
vascular network of the cotyledon was initially flushed with a minimum of 100 mis of normal 
(0.9%) saline over a period of at least 8 minutes, at a constant rate, to remove residual fetal 
blood. Once the venous effluent contained only clear saline solution, the plastic polymer was 
constituted thus; 0.5g of catalyst was dissolved in 5 mis of methylmethacrylate. The 
resultant mixture was added to 20 mis of Mercox CL-2B base resin in a disposable glass 
container and stirred thoroughly for 20-40 seconds (Lametschwandtner, Lametschwandtner 
& Weigner 1990). The saline infusion was stopped and the mixed resin then injected through 
the second port at a constant pressure over a period of 3 minutes until the venous effluent 
consisted of pure plastic. The venous outflow was then ligated with a catgut suture and 
plastic perfusion continued until resistance to injection was felt. The arterial side was
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IIclamped and the cotyledon was left untouched for a further 20-30 minutes to allow curing of
the plastic. i?
Once hardened, the area of casted cotyledon was immersed in 20% potassium hydroxide at 
40^ C for a period of 6 hours, washed in running water then immersed in distilled water |
overnight. This process was repeated 6 times to ensure that all the surrounding placental 
tissue was digested, leaving the vascular cast intact and free of debris (Figure 4.1).
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The casts were fractured into 3-4 parts along natural lines of cleavage under water. These 
portions were oven dried for 8 hours at 40°C, mounted on stubs then sputtered with gold for 3 
minutes. The coated specimens were kept in a desiccator at all times (Leiser 1985).
a?,;a
4.2.3 Analysis of vascular casts
All the casts were coded and therefore examined by scanning electron microscopy (DSM- 
940) blind to the clinical information. The casts were initially viewed at low power (x 100) 
to evaluate the general quality of preservation, the degree of plastic extravasation and the 
distribution of vessels within the cast, particularly to locate areas containing terminal 
capillaries.
All quantitative analysis was performed at higher magnification (x 500). A minimum of 20 
terminal capillaries from different areas of the cast were viewed. The casts were rotated such 
that each terminal capillary structure was viewed in the horizontal plane. The following 
parameters were recorded; (1) the length of the capillary loop was measured from its base, at 
the arteriole junction to the tip of the loop; (2) within each capillary loop the number of 
visible branching points were counted; (3) the degree of capillary coiling was assessed and 
assigned a value from 1-3 [l=no coiling; 2=moderate coiling; 3=highly coiled]; (4) the mean 
diameter of each capillary loop was then estimated by measuring the capillary diameter 
(perpendicular to the vessel walls) at 20 qM intervals from the base to the tip of the capillary 
loop. Pictures were taken of each capillary loop as a permanent record. A typical normal 
terminal capillary network viewed by SEM (case 36) is shown in Figure 4.2 and the capillary 
cast from an lUGR placenta (case 3) demonstrated in Figure 4.3. '14.2,4 Verification of methods
To ensure that an adequate sample of terminal capillaries were analysed, the measurements 
obtained on four casts were repeated using measurement data from 10, 15, 20, 25, 30 and 35 f
terminal capillaries. There were no difference in the means and standard deviations obtained 
for measurements of 15 or more capillary loops and thus analysis of 20 capillary loops was 
deemed to be representative.
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Statistical analysis of vascular casts
The data for capillary diameter and the number of capillary branches were expressed as 
means (standard deviation). Since terminal capillary length within each cast showed a wide 
distribution these data were log transformed [log (x)] before analysis and the data expressed 
as geometric mean and standard deviation. The number of branches, being small count data, 
was square root transformed prior to analysis.
From the three point scale of coiling, the proportion of capillaries within each cast which
demonstrated no coiling was calculated. For each parameter, differences between the two 
groups were evaluated using a Chi^ analysis.
4.3 RESULTS
4.3.1 Comparison of the study cases
The two groups were comparable in terms of the mean gestational age at the time of delivery 
(lUGR group 31.5 weeks [SD 2.83] vs. Control group 31.3 weeks [SD 2.87]). The 
birthweight of the lUGR group was significantly less than those of the controls (1150g [SD 
379.5] vs. 1782g [SD 519.5]; p<0.05) as was the placental weight (273g [SD 90.7] vs. 487g 
[SD 111]; p<0.05). There was no difference in the placental/fetal weight ratio between the 1
lUGR and control cases (0.245 [SD 0.58] vs. 0.285 [0.66]; p=0.17).
4.3.2 Vascular casts :.:S.The mean capillary lengths of the capillary loops in each cast are illustrated in Figure 4.4.
Capillary loops in the lUGR casts (Figure 4.3) tended to be very sparse and were 
significantly longer than those in the control placentas (217.8 qM[SD 71.9] vs. 136.9 qM[SD 
29.8]; p<0.05). The number of visible branches within each capillary loop is shown in Figure
4.5. Though longer, the lUGR capillary loops had fewer branches than the control cases 
(4[SD 1.9] vs. 6.1[SD 2.2]; p<0.05). Moreover, a significantly greater proportion of the f
lUGR capillary loops demonstrated no coiling (79% vs. 18%; p<0.05), the majority of 
capillaries in the control cases were very coiled. These data are illustrated in Figure 4.6. The 
mean capillary diameter of the lUGR capillary loops displayed in Figure 4.7 did not differ 
significantly from those of the control capillaries (12.7|iM [SD 3.76] vs. 12.73qM [4.28]).
Within the lUGR group, casts from pregnancies which were complicated by maternal pre­
eclampsia, showed no significant difference from the unaffected cases in the number of 
capiUary branches (2.0 [SD 0.17] vs 1.99[SD 0.08]; p=0.8); the capillary length (2.29 [SD I
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0.07] vs 2.37 [SD 0.07 ]; p=0.11); or the percentage which demonstrated no capillary coiling 
(73% [SD 8.4] vs. 85% [SD 12.7]; p=0.12).
4.4 DISCUSSION
Until recently, the structure and function of peripheral villi in lUGR pregnancies has been 
largely ignored. Anatomical studies have generally concentrated on stem villi, focusing in 
particular on the number of arterial vessels within each villus (Giles, Trudinger & Baird 
1985; McGowan, Mullen & Ritchie 1987; Bracero et al. 1989). However, stem villi account 
for only a small portion of the feto-placental vascular tree when compared to more distal villi. 
In addition, peripheral villi play a central role in metabolic transfer to and from the fetus. In 
view of these facts, attention has been redirected to the possible role of intermediate and 
terminal villi (peripheral villi) in the pathogenesis of growth restriction.
To investigate the three-dimensional structure of the distal capillary network, we used a well 
defined group of severely growth restricted pregnancies chai*acterised by abnormal umbilical 
artery Doppler (Section 2.2.1). Moreover, since the dimensions of the peripheral vascular 
bed are particularly gestation dependant we were careful to ensure that an appropriate group 
of normal, gestational age-matched pregnancies were identified to serve as controls.
Vascular casting techniques were first described in the placenta as early as 1950 (Boe 1950) 
but because of the highly viscous materials available, could only perfuse and fix large 
placental vessels. With the development of low viscosity plastic polymers, smaller capillaty 
vessels may be successfully perfused, thus permitting vascular casting of the microvascular 
placental circulation (Leiser 1985; Lee & Yeh 1986).
Vascular casts from lUGR placentas contained relatively fewer vessels and substantially 
fewer capillary loops when compared to gestational age-matched control casts. In addition, 
the lUGR capillaries were straighter, significantly longer and less branched than the control 
capillaries.
During the latter part of the second and throughout the third trimesters of pregnancy, as 
longitudinal growth of the capillaries within mature intermediate viUi exceeds that of the villi 
themselves, the capillaries coil and form loops. These loops gradually bulge from the villous 
surface, eventually forming grape like outgrowths, known as terminal villi. The capillary 
loops form a rich network of vessels, with many intercalated branches and random, focal 
dilatations known as sinusoids within the longer capillaiy loops (Kaufmann et al. 1985a). 
These focal dilatations, by increasing capillary diameter, decrease the vascular impedance of
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long capillary loops thus ensuring even perfusion of both long and short capillary loops.
Fetal blood may pass through up to five capillary loops in series before entering a post 
capillary venule. From there it returns via venules and the veins of stem villi to enter the 
umbilical vein. Tenninal capillary loops are therefore not formed by active proliferation but 
as the passive result of differential growth rates (Berniscke & Kaufmann 1992). The | | |
development of this vascular bed is vital to reduce placental vascular impedance and thus 
accommodate the significant increase in placental blood flow during the second and third 
trimesters of pregnancy. The finding of long, uncoiled, non-sinusoidal capillary loops in the 
lUGR placental casts would suggest that terminal capillary growth is impaired to such an 
extent that few bud-like capillary networks are not formed.
There is now increasing evidence to suggest that the mechanisms which regulate 
angiogenesis in the normal placenta are complex and involves the interaction of many 
cytokines and growth factors (Librach et al. 1994; Saito et al. 1994).
Placental hypoxia is thought to be responsible for the changes seen in the placentas of pre­
eclamptic women and those living at high altitude. Such placentas are characterised by 
excessive numbers of terminal villous buds containing extensive networks of, highly 
branched capillary vessels (Kaufmann, Luckhart & Leiser 1988; Jackson et al. 1985; Jackson 
et al. 1988). Detailed experimental studies in the pregnant guinea-pig have confirmed the 
effects of placental hypoxia, demonstrating clearly that hypercapillarisation occurs (Bacon et 
al. 1984), with the formation of multiple, short, highly branched capillary buds. Such 
adaptation facilitates blood flow and expands the surface area available for materno-fetal 
exchange (Scheffen et al. 1988), thus increasing total oxygen diffusion to the fetus.
Isotope (Chatfield et al. 1975; Kaar et al. 1980) and more recent Doppler studies (Bewley,
Cooper & Campbell 1991; Bower, Schuchter & Campbell 1993) have demonstrated that 
uterine blood flow is significantly reduced in growth retarded pregnancies; thought to result 
from defective trophoblast invasion (Brosens, Dickson & Robertson 1977; Khong et al.
1986). Since the severely growth restrictedd fetus is hypoxic (Nicolaides et al. 1988 ) it has 
been assumed that this change is the consequence of placental bed hypoxia resulting from the 
reduction in uterine blood flow. However, since hypoxia promotes excessive capillary 
growth (Bacon et al. 1984; Scheffen et al. 1988) our findings of impaired rather than 
proliferative capillary growth, clearly suggest that placental hypoxia does not appear to be the 
dominant factor regulating placental development in lUGR pregnancies complicated by 
AEDFV. In addition, the presence of maternal pre-eclampsia, commonly associated with 
"placental ischaemia", did not alter these changes. Other factors must therefore modify 
lUGR placental growth patterns to induce the changes we have demonstrated and additional 
mechanisms must therefore be responsible for the fetal hypoxia seen in growth retardation.
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The mean diameter of the capillary loops did not vary between the lUGR and control 
placentas. However, this observation may not reflect the in-^vo situation, as calculations of 
capillary diameter are subject to several methodological limitations. It is well recognised that 
the diameter of cast vessels are dependant not only on the perfusion pressure applied but also 
on the resistance of the intervillous space (Karimu & Burton 1994) and the extracellular 
matrix. Moreover, there is a wide distribution of diameters in the normal placenta with 
narrower segments adjacent to the large sinusoidal dilatations (Kaufmann, Luckhart & Leiser 
1985), Simple measurements of mean capillary diameters did not allow for the physiological 
variation present. The mean figures obtained however, were in keeping with the 12.2 ]xm 
calculated by others from term placental casts. This would indicate that despite the depletion 
in the size of the vascular bed, compensating mechanisms such as dilatation and shortening 
of the capillary vessels, which would reduce vascular impedance, did not occur.
Our study did not evaluate the capillary surface area perse but the images we obtained would 
support the findings of Hitschold et al. (1993) and Jackson et al. (1995), which demonstrated 
a reduced intravascular volume, and a diminished vascular surface area, in peripheral villi 
from lUGR pregnancies. Moreover we were clearly able to demonstrate that the reduction in 
vascular tissue was the result of abnormal capillary development and not simply the 
consequence of depleted numbers of normal vessels. In addition, the lUGR capillaries were 
largely devoid of any sinusoidal dilatations as Hitschold had previously postulated from two - 
dimensional analysis (Hitschold et al. 1993).
The structural changes we have demonstrated in the capillary network of lUGR placentas 
may affect the function of capacity of the placenta. If the peripheral placental vascular 
network fails to develop during pregnancy, as we have shown, placental vascular impedance 
which normally falls with the expansion of the capillary bed, is likely to remain elevated. 
Furthermore since the capillaries which form are elongated, unbranched and relatively 
naiTow, impedance to blood flow may actually rise, producing the characteristic changes seen 
in the Doppler wavefoim of the lUGR fetus. Since placental blood flow increases with 
advancing gestation, irrespective of the failed vasculai' bed expansion, blood pressure within 
the placental circulation is likely to rise. Under such conditions the arterio-arterial channels 
(Boe 1969), which are normally closed and insignificant in the low pressure placental 
circulation, may become functional, shunting placental blood past the terminal villous loops, 
by-passing the materno-fetal exchange surface area and thus restricting fetal oxygen uptake 
and nutrient provision.
Even in the absence of such shunts, our images and the calculations of Hitschold (Hitschold 
et al. 1993) and Jackson (Jackson et al. 1995) clearly show that the capillary surface area 
available for perfusion, and therefore materno-fetal exchange is reduced. If the villous
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surface ai*ea is likewise depleted, reducing the availability of substrate carriers, as Jackson 
has suggested (Jackson et ah 1995), fetal substrate uptake will be further impaired, and in- 
utero fetal starvation ensue.
Using vascular casts we have demonstrated that vascular development in lUGR pregnancies 
with AEDFV is abnormal and may contribute to the clinical picture of intrauterine growth 
restriction. Furthermore, we have shown that the pattern of vessel growth is not 
characteristic of placental ischaemia or hypoxia, assumed to result in the fetal hypoxia seen 
in lUGR pregnancies, rather the features suggest a primary developmental defect in placental 
angiogenesis.
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Figure 4.1 A vascular cast of a placental cotyledon following digestion of the placental 
tissue by potassium hydroxide. The chorionic plate vessels by which the plastic medium is 
introduced to the cotyledon are identified (CPV).
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Figure 4.2 Scanning electron micrograph of the terminal vascular network in a normal 
preterm placenta. The terminal capillary "buds" (C) are formed of multiple, short, highly 
branched vessels.
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Figure 4.3 Scanning electron micrograph of the peripheral vascular network in a placenta 
from a pregnancy complicated by lUGR and AEDFV. Terminal capillary "buds" are absent 
from these placentas and are replaced by elongated, unbranched "hose-pipe" type vessels (V).
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Figure 4,4 Mean capillary length
The mean length of capillaries in each of the 10 lUGR and 9 gestationally age-matched 
control placental vascular casts is marked by a box ( |— | indicate one standard deviation). 
Capillaries in the lUGR placental casts were significantly longer than those seen in the 
control cases; p<0.05
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Figure 4.5 Mean number of capillaiy branches
Each box represents the mean number of branches present within the capillary loops of an 
individual case. |—| demonstrate one standard deviation. There were significantly fewer 
capillary branches present in the lUGR vascular casts than in the gestationally age-matched 
controls casts; p<0.05.
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Figure 4.6 Capillary coiling
Degree of capillary coiling in the terminal capillary loops of lUGR and gestational age- 
matched control placental vascular casts. Significantly more lUGR capillaries were uncoiled 
when compared with the control capillary loops (79% vs. 18%; p<0.05). lUGR coiling- 
proportion of lUGR capillary loops which demonstrated coiling; Prem coiling - proportion of 
preterm control capillary loops which demonstrated coiling.
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Figure 4.7 Mean (SD) diameter of terminal capillary vessels from 10 lUGR casts and 9 
gestational age-matched preterm control vascular casts. |—| indicate one standard deviation 
of each value. There was no significant difference between the mean capillary diameter of 
vessels in lUGR and control vascular casts.
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CHAPTER 5
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SCANNING ELECTRON MICROSCOPY OF TERMINAL VILLI
5.1 INTRODUCTION
The role of intermediate and terminal villi (peripheral villi) in the pathogenesis of intrauterine 
growth restriction has been largely ignored. However, the severely growth restricted fetus 
demonstrates biochemical and clinical evidence of intrauterine starvation (Nicolaides, 
Economides & Soothill 1989; Economides et al. 1989) and it is at the level of these 
peripheral villi that maximal feto-matemal exchange of oxygen and substrates occurs.
The obliterative theory of increased umbilical artery vascular resistance (Giles, Trudinger & 
Baird 1985, McGowan, Mullen & Ritchie 1987; Bracero et al. 1989) assumes that the 
biochemical changes, which occur in the lUGR fetus result from the functional loss of large 
areas of peripheral placental villi secondary to small stem arteriole occlusion. This is 
somewhat surprising as the normal placenta, which has a large functional reserve and can 
withstand inactivation of up to 40% of its villous tissue (Robinson et al 1979; Fox 1986), is 
capable of proliferation and adaptation throughout pregnancy. Placental size increases 
dramatically in pregnancies complicated by maternal anaemia for example, to compensate for 
the diminished content of oxygen available (Agboola 1975). In the event of stem vessel 
obliteration, compensatory growth in unaffected areas of the placental villous tree would 
therefore be expected.
Surprisingly therefore, stereological analysis of placentas from growth restricted pregnancies 
complicated by AEDFV have shown that the volume of peripheral villi in placentas from 
lUGR pregnancies is significantly diminished (Jackson et al. 1995), implying that rather than 
compensatoiy growth, peripheral villous growth may actually be impaired.
In chapter 4 we demonstrated that peripheral capillary growth within placentas from lUGR 
pregnancies was abnormal when compared to gestationally matched controls. Together with 
the results of other workers which have shown reduced intravascular capillary volumes in 
lUGR placentas (Hitschold et al. 1993), our findings would indicate that angiogenesis is 
impaired in placentas from growth restricted pregnancies and thus placental perfusion 
hmited.
Fetal substrate provision requires not only adequate placental perfusion but also the effective 
transfer of these metabolites from the maternal uterine circulation across the 
syncytiotrophoblast membrane. The reduction of syncytial surface area suggested by 
stereology (Hitschold et al. 1993; Jackson et al. 1995) would therefore restrict the transfer of 
fetal substrates thus "starving" the fetus in-utero.
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In order to determine three-dimensional villous structure in placentas from lUGR 
pregnancies, and thus establish if the reduction of villous tissue reported (Jackson et al. 1995; 
Hitschold et al. 1993) was simply due to depleted numbers of normal terminal/intermediate 
villi or as with the capillaries in chapter 4, the consequence of abnormal villous development, 
we examined tissue casts from XUGR and control placentas by scanning electron microscopy 
(SEM).
5.2 METHODS 
5.2.1 Clinical details
Placental tissue from the ten lUGR and ten control patients used in Chapter 4 for the vascular 
cast study were also used on this occasion. The clinical details of the IÜGR cases are shown 
in Table 2.1 [Case numbers 1-7, 9, 10 and 20] and details of the preterm control cases in 
Table 2.2 [Case numbers 21,22, 24, 28 and 36-40]
5.2.2 Collection of material
5.2.2.1 Preparation of buffer
0.2M solution of disodium hydrogen orthophophate (DHO) was prepared by dissolving 2.83g 
DHO in 100 mis of distilled water [Sol A]. 2.81g of citric acid was then dissolved in 100 mis 
of distilled water to give a O.IM solution of citric acid [Sol B]. Neutral phoshphate buffer 
was prepared by adding 86 mis of Sol A to 17.7 mis of Sol B. Prepared solutions were all 
stored in a refrigerator at 4®C.
5.2.2.2 Preparation of 2.5% glutaraldehyde
2.5% buffered glutaraldehyde was prepared by adding 5 mis of 25% aqueous glutaialdehyde 
to 50 mis of phosphate buffer. Fresh buffered glutaraldehyde was prepared just prior to the 
specimen collection.
5.2.2.3 Specimen collection
Immediately following delivery of the placenta, a further two chorionic plate arteries 
supplying two randomly chosen peripheral cotyledons were cannulated with a 16 gauge 
venous cannula. These were secured with a black silk suture to prevent backflow or 
extrusion of the cannulae. Cotyledons affected by infarction were excluded. The chorionic 
veins draining each cotyledon were punctured at a point proximal to the cord root ensuring 
free venous drainage throughout the procedure and limiting artefacts which might arise from 
feto-maternal fluid shift (Burton, Ingram & Palmer 1987). The cotyledons were initially 
flushed with 5 mis of isotonic saline to irrigate the vascular bed then immediately perfusion- 
fixed at a constant pressure with 20 mis of 2.5% neutral buffered glutaraldehyde over a 5
-82-
minute period. The perfused area blanched with fixation and a minimum of 10 blocks of the 
fixed tissue ( 5 x 5 x 5  mm) were then excised from an area just above the basal plate. These 
were transferred into fresh 2.5% phosphate buffered glutaraldehyde for storage prior to 
processing. The total time from delivery of the placenta to fixation in glutaraldehyde was 
typically 2-3 minutes and never longer than 5 minutes.
5.2.2.3 Critical point drying
The expansion of intra and extra cellular fluid can cause structural artefacts in the tissue 
morphology. Tissue for SEM must therefore be processed in such a way that most of the 
intra and extra cellular fluid is removed simultaneously, a process known as critical point 
drying. Tissue for examination was prepared as follows; cubes of the fixed placenta were 
dehydrated through ascending concentrations of alcohol to replace tissue fluid with alcohol, 
then placed in the pre-cooled pressure chamber of a critical point dryer. Liquid carbon 
dioxide was then instilled through the pressure chamber over a period of 10 minutes until all 
the intermediate fluid - alcohol- was replaced. The temperature of the chamber was 
increased and the carbon dioxide converted into a gaseous form. By gradually reducing the 
pressure of the chamber, gaseous carbon dioxide was released ensuring the complete removal 
of extracellulai* and intracellular fluid with only minimal distortion of the villous structure.
During scanning electron microscopy, electrons may accumulate on the tissue surface, 
producing high electrostatic charges and impairing the quality of the image obtained. To 
limit this, the specimens were placed in a sputtering machine and coated with a thin layer of 
gold prior to SEM examination.
5.2.3. Analysis of the tissue casts
The specimens were all coded independently and viewed blind in a Zeiss 940 DSM scanning 
electron microscope. A minimum of three tissue blocks were examined from each case.
The tissue casts were examined first at low power (x 100) to assess the quality of tissue 
fixation, the degree of electrostatic charging and the amount of extravillous fibrin present. 
Areas comprised of terminal and intermediate villi were then identified at higher 
magnification (x 200). The distribution, shape and size of terminal villi were recorded. 
Thereafter the texture of the syncytiotrophoblast was evaluated and the microvillous surface 
examined at high magnification (x 5000) to assess the density of microvilli present.
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5.3 RESULTS
5.3.1 Comparison of the study groups
The two groups were appropriately matched for gestational age. The mean gestational age of 
the lUGR group was 31.5 weeks [SD 2.83] and that of the control group 31.3 weeks [SD 
2.87]. The mean birth weight of the lUGR group was significantly less than that of the 
controls (1150g [SD 379.5] vs. 1782g [SD 519.5]; p<0.05).
5.3.2 Terminal villous structure
Qualitatively, fewer villi were present in the lUGR placental casts than in the control casts. 
The peripheral villi, comprising intermediate and terminal villi, of the control placentas were 
characterised by a dense population of multiple, small bud-like villi, with areas, 
corresponding to sinusoidal dilatations present at the villous tips and randomly throughout 
most villous buds (Figure 5.1). In contrast the peripheral villi of the lUGR placental casts 
appeared as elongated drainpipes (Figure 5.2) with only tiny isolated areas showing any 
resemblance to the small villous buds seen in the control casts. There was little variation in 
the diameter of peripheral villi in the XUGR casts. The size, shape and pattern of peripheral 
villi matched the appearance of the capillary vessels in the vascular casts examined 
previously in chapter 4.3.2. Lai'ge plaques of fibrin, often extending between several villi, 
were present on the syncytial surface of 75% of the lUGR casts, particularly cases 1, 3 and 8, 
and was not specific for only those lUGR cases which were complicated in addition by 
maternal pre-eclampsia. In contrast, only one of the preterm control casts showed significant 
fibrin present. Furthermore, the syncytiotrophoblast surface over the lUGR terminal vilh 
appeared to be piled up, forming characteristic wrinkles, bands and folds in the
5.4 DISCUSSION
syncytiotrophoblast surface (Figure 5.3). These "wrinkles" were never seen in any of the 
control cases. No differences were detected in the density or appearance of microvilli on the 
syncytiotrophoblast surfaces of either XUGR or control cases.
•I
I
Villous development follows a specific pattern in normal pregnancy. During the first and 
most of the second trimester, intermediate villi differentiate primarily into support stem villi 
while during the latter half of pregnancy exchange, terminal villi are formed in preference 
(Castellucci et al. 1989; Jackson, Mayhew & Boyd 1992). Since the majority of severely 
growth restricted pregnancies with abnormal umbilical Doppler are delivered prematurely, 
these placentas would naturally differ from normal term control cases. However, using 
appropriate gestational age-matched control pregnancies we have demonstrated that the 
placentas of growth restricted pregnancies demonstrate abnormal villous structure which is
■“84-
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the elongated, uncoiled capillary loops demonstrated in chapter 4 by vascular casting.
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not simply the consequence of preterm delivery. In contrast to the control placentas which 
were characterised by multiple globular terminal villous buds, the lUGR placentas were 
composed of elongated, non-budded villi (Figure 5.2); these bore a striking resemblance to |
!
Terminal villi arise passively as outpockets from intermediate villi during the late second and 
the third trimesters of pregnancy, when longitudinal capillary growth exceeds that of the villi 
themselves (Bernischke & Kaufmann 1990). The development of these peripheral villi i
expands the villous surface area dramatically, providing a syncytial surface area of 8m ^  by 
term (Leiser, Kosanke & Kaufmann 1991). The syncytiotrophoblast layer of the placenta is .' r,part of the interface between fetal and maternal blood and via several transport mechanisms 
is the means of transferring vital substrates from the maternal circulation to that of the fetus.
The dramatic expansion of the syncytial surface area during the third trimester is therefore 
vital to cope with the increasing metabolic demands of the growing fetus. Our findings of 
elongated, non-budded villi, would suggest that villous growth and development is is
significantly deranged in placentas from XUGR pregnancies and the syncytial surface ai’ea
thus diminished.
Xn chapter 4 we demonstrated, using vascular casts, that the structure of the capillaiy bed was 
abnormal in XUGR placentas; the appearance of the capillaries present suggested that 
capillary growth was defective. The three-dimensional structure of the placental villi and the if;
external appearance of the syncytiotrophoblast (Figures 5.2 and 5.3) in the XUGR placental I
tissue casts which we examined would confirm this impression. The size and shape of the 
XUGR peripheral villi virtually mirrored that of the XUGR capillary casts. Furthermore, the 
syncytiotrophoblast over the XUGR placental villi was aggregated into wrinkles and folds 
which would suggest that the rate of villous growth, exceeded that of the capillaries to such 
an extent that "redundant" syncytiotrophoblast resulted, necessitating the formation of these
I
syncytial folds. Since terminal villous development is intimately linked to longitudinal 
capillary growth (Kaufmann et al. 1985), the potential mechanisms regulating placental g
angiogenesis are valid in this setting also. |
Capillary growth may not be the only determinant of terminal villous development. Since 
terminal villi arise from intermediate villi, alterations to the intermediate villous population 
would also influence teiminal villous development. From the tissue cast images we obtained, 
it would appear that the total villous density of the XUGR placentas were significantly less in 
those of the controls. This is in keeping with the results of two-dimensional placental ÿ  
morphology studies which have indicated that villous volume is reduced in XUGR 
pregnancies (Boyd & Scott 1985; Hitschold et al. 1993; Jackson et al. 1995), though 
unfortunately, none of these studies have calculated specific villous class volumes. In I
addition, gross studies in placental morphology would also suggest that villous proliferation 
is impaired in lUGR pregnancies as placentas from affected pregnancies have fewer 
cotyledons and ai'e thinner than those from healthy control cases (Nordenvall et al. 1991).
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The fetus depends on the transfer of maternal oxygen and nutrients across the trophoblast 
membrane and therefore a reduction of peripheral villous tissue will deplete the surface area
Ill-available for nutrient transfer. Moreover, large portions of the syncytiotrophoblast in the 
lUGR placentas were covered with fibrin, often extending between several villi. Since it is 
the microvillous membrane of the syncytiotrophoblast which contains many of the receptors S
and carrier proteins necessary for substrate transfer, these plaques may additionally reduce 
the functional transport area available, limiting further, nutrient provision for the lUGR fetus.
It is not clear why excessive fibrin plaques might accumulate around the XUGR |
syncytiotrophoblast. Xn the normal placenta, fibrin may be deposited secondary to 
syncytiotrophoblast damage and in association with villi which are surrounded by slow 
intervillous blood flow. It is possible in the XUGR placentas that abnormal villous |
development may alter the circulation of blood around the placental bed and encourage fibrin 
deposition. Alternatively, in addition to the structural changes we have demonstrated, the 
functional capacity of the trophoblast layer may also be deranged. Under such II
circumstances, the anti-platelet and anticoagulant activity (Xloka et al. 1993; Uszynski 1991) |
of the normal syncytiotrophoblast may also be deficient resulting in fibrin deposition.
We have demonstrated that the reduction in peripheral villous tissue noted previously in 
XUGR pregnancies complicated by AEDFV, is the consequence of abnormal villous i
development and not simply due to reduced numbers of normal peripheral villi. The 
consequent reduction in the syncytiotrophoblast surface area may explain in part the fetal I
substrate deprivation characteristic of the XUGR fetus. It is likely that the lack of villous J
tissue reflects primary abnormalities in the expression of genetically controlled regulators of 
cytotrophoblast proliferation and highlights the vital need for the role and expression of these
■:Ufiagents in placental maldevelopment to be established.
Figure 5.1 SEM of peripheral villi in an uncomplicated preterm placenta.
The peripheral villi in the control placentas were composed of multiple small, squat, wide- 
based buds, which correspond to the capillary loops identified in the vascular casts 
(magnification x 2(X)).
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Figure 5.2 SEM of peripheral villi within a placenta from a pregnancy complicated by 
lUGR.
The peripheral villi present in the lUGR placental casts showed little "bud" formation and 
appeared rather as elongated drainpipes. This appearance was in keeping with the elongated, 
uncoiled unbranched capillary loops previously identified in the lUGR vascular casts. To 
allow the entire length of the villi to be included the magnification is x 165.
mFigure 5.3 SEM of peripheral vilh from an lUGR placental cast.
The syncytiotrophoblast (S) surface appeared to be compressed, forming characteristic folds 
and "wrinkles" (W) on the syncytiotrophoblast surface (x 500).
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CHAPTER 6
THE ULTRASTRUCTURE OF 
TERMINAL VILLI
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6.1 INTRODUCTION
Terminal villi are the site of maximal feto-matemal exchange and since umbilical venous 
blood is frequently observed to have a low oxygen content in AEDFV pregnancies 
(Nicolaides, Economides & Soothill 1989), it has been assumed that the placenta, at the level 
of these exchange villi, where transfer occurs, must also be hypoxic. Previous ultrastructural 
studies of the placenta in cases of fetal growth retaliation have shown inconclusive results, 
primarily because these studies used varying definitions of growth retardation and in the 
main were confined to small-for-gestational age term pregnancies (Standstedt 1979; Aherne 
& Dunhill 1966). Since only a tiny proportion of these latter pregnancies are truly growth 
restricted in~utero, few of these placentas would have been pathological.
One recent study, in which the pathological and control group were both well defined and 
appropriately matched, demonstrated that the volume of terminal villi was significantly 
reduced in lUGR placentas with AEDFV (Jackson et al. 1995). This study however, 
addressed only the question of villous number and did not assess if the terminal villi present 
were normal in appeaiance. In the preceding chapters (Chapters 4 and 5), we presented 
evidence to show that both the external appearances of the terminal villi, and the 
fetoplacental capillaries within them, are grossly abnormal in AEDFV pregnancies and did 
not indicate hypoxia as a major determinant of placental development.
To evaluate if the internal appearance of terminal villi was also abnormal in lUGR 
pregnancies, and to assess in particular if these villi showed evidence of hypoxic change, we 
used placental tissue from our homogeneous group of lUGR pregnancies to conduct a 
detailed ultrastmctural study of placental terminal villi.
6.2 m e t h o d s
6.2.1 Clinical details
The clinical details of the 10 cases selected are shown in Table 2.1 (Case numbers 1-10). All 
the pregnancies were complicated by severe lUGR as defined in Chapter 2 (Section 2.2.1) 
and all were delivered by caesarean section. Five pregnancies were normotensive and five 
were complicated by pre-eclampsia as defined previously in 2.2.1, Birth weights after 
delivery, based on a local database (Smalls & Forbes 1983), were confirmed to be <10th 
centile - the majority being <3rd centile - in all but one case.
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For comparison purposes a control series of eight preterm pregnancies were also selected. 
These pregnancies were uncomplicated and were matched for gestational age and smoking 
habit. Their clinical details are shown in Table 2.2 (Case numbers 20-27). s. . . r v ,
I6.2.2 Perfusion - fixation of specimens
Immediately following delivery, the placenta was examined for evidence of gross pathology
and weighed. Chorionic plate arteries supplying two separate peripheral cotyledons, chosen é
, -''I'at random, were cannulated with a 16 gauge venous cannula (Venflon) and secured with a î |
black silk suture to prevent backflow or extrusion of the cannulae. Cotyledons affected by 
infarction were excluded. To each cannula, two syringes, one filled with 0.9% isotonic saline 
and the other with 2% neutral phosphate buffered glutaraldehyde, were connected via a 
polyethylene three port connector. The chorionic veins draining each cotyledon were |
punctured at a point distal to the cannulae. This ensured free venous drainage throughout the 
procedure and limited artefacts which might arise from feto-maternal fluid shift (Burton, |
Ingram & Palmer 1988). The cotyledons were initially flushed with 5 mis of isotonic saline 
then immediately perfusion-fixed at a constant pressure with 20 mis of 2% neutral buffered 
glutaraldehyde over a 5 minute period. The perfused area blanched with fixation and a 
minimum of 10 blocks of the fixed tissue ( 5 x 5 x 5  mm) were then excised from an area just 
above the basal plate. These were transferred into fresh 2% phosphate buffered f
glutaraldehyde for storage prior to processing. The total time from delivery of the placenta 
to fixation in glutaraldehyde was typically 2-3 minutes and never longer than 5 minutes.
I#
6.2.3 Tissue Processing
Tissue blocks were rinsed twice in phosphate buffer (5.2.2.1), then post-fixed for 45 minutes 
in 1% osmium tetroxide. Following a further 2 brief washing in phosphate buffer the tissue 
blocks were dehydrated in ascending concentrations of ethyl alcohol then embedded in 
araldite resin and polymerised at 60® C for 24 hours. T
6.2.4 Transmission Electron Microscopy
The tissue specimens were examined blind to the clinical information, Semithin sections 
were prepared with an LKB ultramicrotome, stained with toludine blue and viewed with a 
Leica microscope, to identify areas free of perivillous fibrin in which terminal villi, as 
defined below, predominated. Three suitable blocks from each case were selected, the areas 
were isolated using a standard paring technique and ultrafine sections cut with the LKB 
ultramicrotome using a fresh glass knife. The cut sections were floated into a water filled 
truf and a minimum of three sections then retrieved onto a copper plated grid. These were 
subsequently stained for 10 minutes with uranyl acetate then submerged in lead citrate for a 
further 2 minutes. The grids were viewed in a Philips CM 10 transmission electron 
microscope. A minimum of 10 terminal villi (usually 15-20) seen in cross-section were
Î  
I
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Iwhich were viewed in longitudinal or oblique sections, and those which showed evidence of i
' I
photographed individually at standard final magnifications (x 2025, x 4950, x 14850). Villi 
 
branching patterns were excluded.
The diameter of each terminal villus was measured in two randomly chosen perpendicular 
planes and averaged; for each case studied, the mean value was calculated. Each terminal 
villus cross section was then described according to set criteria as follows;
6.2.5.1 TROPHOBLAST
The numbers and position of both syncytiotrophoblast and cytotrophoblast nuclei were 
counted. Evidence of syncytial nuclear senescence, such as syncytial nuclear clumping and 
increased electron density of the nuclear chromatin, was sought (Jones & Fox 1977). 
Vasculosyncytial membranes, defined as anuclear areas of syncytiotrophoblast where the 
fetal capillary endothelium is closely opposed, were identified and the shape and pattern of 
the syncytiotrophoblast microvillus surface, both in general and in particular over the 
vasculosyncytial membranes, was assessed in a minimum of 4 views (final magnification x 
14850).
6.2.5.2 TROPHOBLAST BASAL LAMINA
Well-defined areas of trophoblast basal lamina (lamina densa) viewed in cross section were 
identified at a final magnification of x 14850 and the mimimum membrane thickness 
measured.
6.2.5.3 VILLUS STROMA
The density of the villus stroma was assessed qualitatively, looking in particular for the 
presence of collagen fibres and the density of background fibrillar material (Castellucci & 
Kaufmann 1982; Jones & Fox 1991), The type and number of cells within the stroma, and 
the presence of basal lamina-like material surrounding connective tissue cells [myofibroblasts 
(Gabbiani & Majno 1972)] was also noted for each case.
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6.2.5 Description of terminal villi
Terminal villi were defined as terminal ramifications of villus trees, characterised by the 
absence of fetal arteries, arterioles, veins and venules. Since smooth muscle cells are not 
present in the vessel walls, the terminal villous vascular system is composed solely of 
capillaries with dilated segments known as sinusoids (Kaufmann et al. 1985). The effect of 
lUGR on the standard morphometric characteristics used to define normal terminal villi, such 
as the percentage of the villus occupied by capillaries, or the percentage of villus surface 
made up by vasculosyncytial membrane (Sen, Kaufmann & Schwiekhart 1979), is unknown. f
These features were therefore not included as mandatory in our identification of terminal villi ( |
,,
6.2.7 Light microscopy studies
Two semithin sections (3 -5  |llM ) were cut from each paraffin block and mounted on glass 
slides. The mounted sections were dipped in haematoxylin, washed 3 times then immersed 
in water soluble eosin. Thereafter, they were dipped in grades of alcohol from 70% through 
to absolute alcohol, washed twice in xylene, then covered.
Congestion of fetal capillaries within terminal villi was evaluated in ten random fields (xlOO) 
from each case. Congestion was considered to be present in a field where the majority 
(>90%) of the fetal capillaries demonstrated densely packed erythrocytes.
■.......“I III
6.2.5.4 FETAL CAPILLARIES
Capillary endothelial cells were assessed for evidence of damage and the presence of luminal 
obstruction by platelet clumps, thrombus or red cell aggregates.
6.2.6 Immersion fixation
6.2.6.1 Preparation of buffered formalin
Phosphate buffer was prepared as follows; 3.12g of sodium dihydrogen orthophosphate was f
dissolved in 100 mis of distilled water forming a 0.2M solution of sodium dihydrogen
-■ 'f iorthophosphate [solution 1]. 0.2 M disodium hydrogen orthophosphate was then prepared by 
adding 2.83 g disodium hydrogen orthophosphate to 100 mis of distilled water [solution 2].
28 mis of solution 1 was added to 72 mis of solution 2 forming 100 mis of phosphate buffer 
(pH 7.2). Neutral buffered formalin was then constituted by adding 80 mis of 10% formalin 
(containing 4% formaldehyde) to 120 mis of phosphate buffer. Prepared solutions were all 
stored in a refrigerator at 4®C.
6.2.62 Preparation of tissue
From the remainder of the placenta, a minimum of four random, full-thickness blocks of | |
tissue were excised and immersion fixed in 4% neutral buffered formalin for a minimum of 8 
hours and not more than 24 hours. These were processed in a standard manner for wax- 
embedding
6.2.8 Statistical analysis
7'iAll parameters were shown to approximate a normal distribution and thus quantitative data 
are shown as mean (standard deviation). Differences in mean values were assessed by an 
unpaired Student's t-test. P values <0.05 were considered significant.
:
Î
I
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6.3 RESULTS
6.3.1 Comparison of the two groups
The gestational age of the two groups was comparable; lUGR group (31.6 weeks [SD 2.6])); 
control group (30.5 weeks [SD 3.4]). Birthweight was significantly lower in the lUGR group 
(1068g [SD 333]) compared with the control group (1754g [SD 484]; p =0.001). Similarly 
there was a significant reduction in the placental weight of the lUGR group when compared 
to the controls (282g [SD 88] vs, 386g [SD 51]). There was no difference in the 
placental/fetal weight ratio between the two groups (0.25 [SD 0.07] vs. 0.27 [SD 0.09]; 
p=0.66). Four women in each group were smokers.
6.3.2 TROPHOBLAST
The mean diameter of terminal villi in the lUGR group was significantly less than in the 
control group (5.7 nm [SD 0.6] vs. 6.6 nm [SD 0.8]; p = 0.02). Terminal villi from the lUGR 
group had significantly increased numbers of syncytiotrophoblast nuclei (SN) as compared to 
the control group; 9.6 nuclei per villus cross section (SD 1.9) vs. 4.5 (SD 1.6); p < 0.001). 
Most of the SN in the lUGR group were aggregated into syncytial knots and demonstrated 
evidence of nuclear senescence (Figure 6.1). Within the lUGR cases, there was no difference 
in the number of SN when maternal pre-eclampsia was present (8.6 nuclei [SD 1.67]) or 
absent (7.8 [1.64]; p=0.47. This finding was confirmed by paraffin histology. By contrast, 
the numbers of cytotrophoblast nuclei (CN) were significantly less in the lUGR group when 
compared with the control group though again the presence or absence of maternal pre­
eclampsia did not alter the findings; CN were found in only 40% of villus cross sections in 
the lUGR group and when present only 1 CN per villus cross section was normally seen. In 
the control group 80% of villus cross sections were found to have CN and in these cases 2 
CN per villus cross section were normally seen (p < 0.01) (Figure 6.2). Sections of villus 
cytotrophoblast without nuclear profiles were excluded.
The trophoblast basal lamina (lamina densa) in the lUGR group was approximately twice as 
thick when compared with the control group (1.3 nm [SD 0.29] vs. 0.6 nm [SD 0.23]; p < 
0.001) (Figure 6.3). No obvious differences in the microvillous surface of the 
syncytiotrophoblast were identified between the two groups.
6.3.3 VILLUS STROMA
An increased density of background fibrillar material was seen within the stroma of the 
lUGR group when compared with the gestational age-matched control group and this 
difference was irrespective of the presence or absence of maternal pre-eclampsia. In 
addition, there appeared to be an increase in the number of collagen fibres in the lUGR 
group, as identified by their characteristic banding pattern. The villus stroma in the lUGR
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group contained a large number of fibroblast cells. These fibroblast-like cells which were 
arranged in parallel to the long axis of the villus, demonstrated ultrastmctural features typical 
of myofibroblasts namely an incomplete basal lamina together with intracytoplasmic bundles 
of filaments and area densae (Gabbiani & Majno 1972) [Figure 6.4]. Winding bands of basal 
lamina-like material were noted to surround these cells. By contrast, the stroma in the 
control group contained only a minimal amount of background fibrillar material, and 
collagen fibres were only occasionally identified (Figure 6.5). No myofibroblast like cells 
were identified in any of the terminal villi from the control group.
6.3.4 FETAL CAPILLARIES
In general no differences in endothelial cell structure were observed between the two groups. 
However, congestion of fetal capillaries by erythrocytes was observed in three of the XUGR 
cases, each of which was in addition complicated by pre-eclampsia. The fetal erythrocytes in 
these three cases appeared to be moulded together, and varied in their electron density. In 
places these aggregates showed signs of lysis of the erythrocyte cell membrane (Figure 6.1). 
At the light microscopic level, congestion was also more evident in the lUGR group when 
compared with the control group (4.5 fields examined [SD 1.4] vs. 0.75 fields examined [SD 
2.9]; p<0.01) Congestion was also more obvious in those lUGR cases which were in 
addition complicated by pre-eclampsia (5.8 fields [SD 2.4] vs. 3.5 fields [SD 2.9]) but this 
difference was not statistically significant.
Transmission electron microscopy demonstrated no evidence of platelet clumping within the 
capillaries in any of the lUGR cases, nor in any of the controls. A summary of the data, 
comparing terminal villi from lUGR and gestation age-matched control pregnancies is 
displayed in Table 6.1.
6.4 DISCUSSION
Until recently, the investigation of placental structure in pregnancies complicated by 
abnormal fetal growth has been hampered by the lack of a reliable method to distinguish the 
small but healthy normal fetus from one whose growth has been restricted in-utero. By 
identifying reduced umbilical artery perfusion, Doppler ultrasound distinguishes the severely 
growth-restricted fetus from the small but healthy normal one (Laurin et al. 1987; Burke et al. 
1990; McFarland, Steer & Pearce 1991). Therefore the study required, in addition to the 
identification of a small fetus with oligohydramnios, the presence of AEDFV as a diagnostic 
criterion for lUGR. Moreover, to ensure that any findings were not solely the effect of
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preterm gestation, a group of normally-grown gestational age-matched fetuses with normal 
umbilical artery perfusion were selected to serve as a control group.
Both immersion and perfusion fixation provides satisfactory villous fixation. However, 
immersion fixation is associated with considerable post-partal vessel collapse (up to 33%) 
and consequently a significant reduction in the villous volume and surface area (Burton 
Ingram & Palmer 1987) while the morphological data obtained by perfusion fixation is very 
similar to that from in-siiu biopsies of the placenta (Sen, Kaufmann & Schweikhart 1979).
The cases used in this study were therefore prepared by perfusion fixation with If
glutaraldehyde. Since free venous drainage does not significantly affect the degree of post- :|
partal vessel collapse and limits villous oedema, resulting from feto-maternal fluid shift, the 
venous outflow tracts were always punctured.
Perfusion fixation of large areas of the placenta is associated with incomplete removal of 
fetal blood and therefore suboptimal fixation. Moreover even short term ischaemia may 
significantly alter the ultrastructure of the placenta (Kaufmann 1985c). Therefore, only two 
cotyledons were perfused to limit the degree of artefact resulting from ischaemia while 
retaining an adequate sample size. Within these areas, multiple specimens were taken, 
excluding the basal and chorionic plate areas (Boyd, Brown & Stewai’t 1980).
Several major ultrastmctural differences were identified in the terminal villi from 
pregnancies complicated by XUGR when compared with gestational age-matched controls.
The mean cross-sectional diameter of the terminal villi in the lUGR group was significantly 
smaller than in the control group. These observations are in agreement with a recent light- 
microscopic study which suggested that both the mean cross-sectional area of terminal villi 
and the degree of vascularisation within them, was significantly reduced in lUGR 
pregnancies with reduced umbilical artery perfusion (Jackson et al. 1995). Other studies 
(Hitschold et al. 1993; Boyd et al. 1985) which evaluated villous diameter did not find any 
difference in the placentas of small babies, but these studies looked only at term SGA infants i|I'-;(Boyd & Scott 1985) or compared SGA pregnancies with pregnancies which were not 
matched for gestation (Hitschold et al. 1993). Since terminal villi are ideally adapted for 
diffusional exchange - because of their high vascularisation and low materno-fetal diffusion 
distance (Sen 1979) - these changes may have major functional implications for the fetus.
Fetal hypoxia has been associated with placentas which demonstrate a significant reduction ■If;in the number of terminal villi (Kaufmann et al. 1985a).
Increased numbers of syncytiotrophoblast nuclei (SN), which were usually arranged in 
clusters known as syncytial knots, were noted in the lUGR group (Jones & Fox 1977). 
These nuclei also demonstrated typical features of senescence, such as chromatin clumping
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;fand nuclear moulding, which have been described previously in the trophoblast of the normal term placenta (Martin & Spicer 1973; Jones & Fox 1977; Jones & Fox 1991). Syncytial knot 
formation, amongst other functions, is thought to be a mechanism by which aged nuclei are 
removed from the syncytiotrophoblast layer (Cantle et al. 1987; Bernischke & Kaufmann 
1990) and is indicative of placental maturity (Fox 1965). By contrast, syncytial knots were 8
rarely identified in the gestational age-matched control group. These data indicate that 
syncytiotrophoblast maturation is more advanced in the lUGR group.
The numbers of cytotrophoblast cells, identified by the presence of nuclei, were reduced in 
the lUGR group when compared with the gestational age-matched controls. These cells are 
the stem cells of the syncytiotrophoblast. During the first trimester they form a complete 
layer beneath the syncytium but with advancing gestation, they become more sparse and are 
seen only infrequently in the term placenta. Cytotrophoblast cells are incorporated into the
syncytiotrophoblast by the creation of gap junctions followed by the formation of 
intercellular bridges and subsequent fusion of the cellular membranes (Contractor et al. 1977;
Filth, Fan* & Baumann 1980). It is well known that syncytial fusion of the cytotrophoblast is 
not only a mechanism effecting syncytial growth, but is also vital for continuous functional 
regeneration of the latter; failure to incorporate cytotrophoblast into the syncytiotrophoblast 
will result in degeneration within a few days (for review see Bernischke & Kaufmann 1990).
Since the syncytium in the lUGR placentas showed degenerative changes in the presence of 
reduced numbers of cytotrophoblast cells, it is likely that this reflects reduced syncytial 
fusion resulting from a primary deficiency in cytotrophoblast cell proliferation. This 
hypotheses could be tested using markers of cell proliferation
Numerous receptors and transporter systems within the microvillus surface of the 
syncytiotrophoblast ensure adequate transfer of nutrients and waste across the feto-matemal ; |
barrier. The alterations in trophoblast structure identified in lUGR placentas may therefore 
have functional implications for placental transport. Microvillous membranes prepared from 
pregnancies complicated by lUGR at term have demonstrated a reduced activity of the 
system A amino acid transporter (Mahendran et al. 1993). Reduced circulating 
concentrations of the amino acids carried by this transporter have been found in umbilical 
venous blood from pregnancies complicated by lUGR (Cetin et al. 1990; Pardi et al. 1993).
No ultrastructural differences were observed in the appearance of the microvillus surface of 
the syncytiotrophoblast layer in the lUGR cases. However, in view of the findings which 
suggest an accelerated ageing of the syncytiotrophoblast, studies employing electron 
immunohistochemistry, or physiological studies with membrane preparations, are warranted 
to search for other potential transport defects within the trophoblast in lUGR.
Other properties of the trophoblast may similarly be affected. Trophoblast is known to 
express the constitutive form of the enzyme nitric oxide synthase (Myatt et al. 1993). The 
physiologic production of nitric oxide by villous trophoblast may prevent platelet aggregation 
in the intervillous space or may act as a second messenger between cyto and 
syncytiotrophoblast. By inference, a defect in this mechanism, as a result of premature 
ageing of the trophoblast may explain why intervillous platelet aggregation, thrombosis and 
infarction occurs in lUGR.
The basal lamina densa beneath the trophoblast layer was approximately twice as thick in the 
lUGR group when compared with the gestational age-matched controls. Furthermore, there 
was a striking increase in the density of fibrillar material and fibroblasts within the stroma 
and an increase in the number of collagen fibres present. This may be of functional 
significance since the oxygen diffusive conductance of villi is proportional to the thickness of 
both the trophoblast and stromal compartments (Mayhew, Jackson & Haas 1990).
A group of fibroblast-like cells which demonstrated ultrastructural features similar to those of 
myofibroblasts were also noted in the stroma of the lUGR terminal vilU. Myofibroblasts are 
characterised by contractile filaments, packed rough endoplasmic reticulum, nuclear 
indentations or folds and a well defined layer of basal lamina-like material separated from the 
cell membrane by a translucent area (Skalli & Gabbiani 1988). Myofibroblasts were first 
described in granulation tissue (Gabbiani & Majno 1972) where they are thought to play a 
role in wound retraction. Since then they have been identified in several "remodelling" 
situations such as lung fibrosis (Adler et al. 1981) and are involved in the stromal response to 
neoplasia (Harris & Ahmed 1977). Several groups have also suggested the existence of such 
cells in the human placenta (FeUai* et al. 1985), but convincing proof has only been found in 
the larger stem villi (Demir et al. 1992; Graf, Frank & Oney. 1992; Kohnen et al. 1993). 
Their presence in the terminal villi of lUGR placentas is unexpected; it is tempting to 
speculate that these extravascular contractile cells aie responsible for the increased deposition 
of basal lamina material such as collagen IV and laminin within the villous stroma thus 
reducing the compliance of these villi. Furthermore since myofibroblasts are contractile and 
responsive to vasoactive agents such as ANP, endothelin and angiotensin, they may as a 
consequence also alter impedance to blood flow within the fetoplacental circulation (Macai'a, 
Kingdom & Kaufmann 1993). The origin of myofibroblasts is probably variable; some 
arising from fibroblast cells and others from smooth muscle cells but the stimulus for their 
development is unclear. Several candidates such as fibroblast growth factor, platelet derived 
growth factor and transforming growth factor-B have been postulated to be stimulators of 
myofibroblast differentiation. These factors are also thought to be involved in placental 
angiogenesis. It is interesting to speculate that a derangement of normal placental 
angiogenesis might induce vascular remodelling by sequentially promoting myofibroblast
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differentiation. The circulating concentration of angiotensin n, a smooth muscle mitogen in- 
vitro (Lyall, Lever & Morton 1988), in umbilical venous blood is elevated in pregnancies 
complicated by lUGR (Kingdom et al. 1993a). This may be a further possible mechanism 
through which myofibroblasts may be recruited into the more distal parts of the fetoplacental 
circulation in lUGR.
Many of the ultrastructural changes which we have observed in these lUGR cases with 
abnormal umbilical artery perfusion have previously been reproduced in the rhesus monkey 
placenta (which is a haemochorial placenta similar to that of the human) by either fetectomy 
or by ligation of the umbilical cord (Panigel & Myers 1972). Syncytial knot formation, loss 
of cytotrophoblast, an increase in stromal collagen fibres, and a thickening of the basal 
lamina were all consistently observed in the periphery of the villous trees after a minimum of 
14 days following surgery. Since there was no fetoplacental circulation to extract oxygen, 
these manoeuvres had resulted in an elevation of uterine venous p02 by up to 80 mmHg and 
though not quantified, must also have resulted in a relative increase in intervillous p0 2 .
Similarly, examination of placentas from macerated stillborn fetuses demonstrates many of 
these features at the light-microscope level: in particular an increase in stiomal cellularity and 
the presence of collagen fibres (Fox 1968). Fetal oxygen consumption has obviously ceased
in such pregnancies, though uteroplacental perfusion continues. Therefore the changes 
observed in the human placenta following fetal death may be the result of this relative 
increase in oxygen tension within the non-perfused terminal villi; furthermore, a positive 
correlation is thought to exist between oxygen tension and collagen production by stromal 
cells (for review of oxygen effects see Kaufmann 1993). In view of these reports, the 
findings from our cases of lUGR with reduced umbilical artery perfusion would suggest that 
the oxygen tension within the terminal villi was relatively increased compared to the control 
cases. Moreover the time intervals involved suggest that this is a chronic rather than an acute 
process.
This hypothesis contradicts the generally held belief that the placenta (or to be more precise 
the terminal structures of the fetal villous trees) in addition to the fetus, is chronically- 
hypoxic in lUGR. Uteroplacental blood flow is reduced in pregnancies complicated by 
lUGR and blood returning to the lUGR fetus along the umbilical vein has a reduced oxygen 
content. However, reduced blood flow does not necessarily equate with uteroplacental 
hypoxia. One of the few reports evaluating uteroplacental oxygen content demonstrated that 
the oxygen content of intervillous blood was normal despite reduced oxygen concentrations 
in the umbilical vein (Nicolaides et al. 1986). These observations can be reconciled if there 
is either a failure of blood flow within the placenta or a failure of the fetal villous circulation 
to deliver oxygenated blood to the fetus. This conclusion is supported by data indicating a
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negligible umbilical aiterio-venous gradient for oxygen in lUGR pregnancies with grossly- 
abnormal umbilical artery Doppler waveforms. (Tyrell, Lilford & Obaid 1989; Nicolaides 
Economides & Soothill 1989). In addition, sampling of the uterine vein at the time of 
caesarean section for lUGR (Pardi et al 1992) indicates a 33% increase in oxygen content 
when compared with matched controls (from 4.46 to 5.92 mmol/L). It is therefore likely that 
the fetus is indeed centrally hypoxic because the placenta fails to extract oxygen adequately 
from the intervillous space.
Congestion of the fetal capillaries, while observed by light microscopy in a small proportion 
of control cases, was much more widespread in the lUGR cases - especially if the pregnancy 
was complicated by pre-eclampsia. Our electron microscopy studies identified this process 
in three of the pre-eclamptic cases studied. These erythrocytes varied in their electron 
density, and in places the cell membranes showed disintegration. It is therefore unlikely that 
these observations are perfusion artefacts, rather they suggest occlusion of the capillaries 
during the antenatal period. If there is prolonged antenatal capillary stasis blood flow and 
therefore oxygen transfer to the fetus will be impaired in growth retarded pregnancies - 
without the placenta itself being hypoxic at the level of the terminal villi.
The data also provides a pathologic basis for the longitudinal studies which have examined 
changes in Doppler waveforms from the umbilical artery in lUGR fetuses. The umbilical 
artery waveform can deteriorate to the point of AEDFV over a variable period of time, a 
process which generally proceeds faster if the pregnancy is also complicated by pre­
eclampsia (Ribbert et al. 1993; Arduini, Rizzo & Romania! 1993). This deterioration may be 
due to progressive congestion of capillaries within terminal villi. Serial Doppler ultrasound 
studies of the umbilical artery are likely to detect this congestive process (Morrow et al. 
1989), and may thus explain the observation from clinical studies that Doppler appears 
superior to cardiotocography for surveillance of the preterm lUGR fetus (Trudinger et al. 
1987a; Almstrom et al 1992).
In summary, several important differences in the structure of terminal villi from pregnancies 
complicated by lUGR with reduced umbilical artery perfusion have been identified. No 
evidence of hypoxic change was identified in the lUGR cases, rather the differences are 
compatible with a relative increase in oxygen tension within the terminal villi. The fetal 
hypoxia which is observed in lUGR is likely to be due to impaired oxygen transfer from the 
terminal villi to the fetus, resulting from a combination of an abnormal terminal capillary 
structure and congestion of these vessels by fetal erythrocytes. In addition, the abnormalities 
seen in the trophoblast layer could result in impaned nutrient transport across the placenta.
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Figure 6.1. Transmission electron micrograph of a terminal villus from an lUGR pregnancy
The terminal villi from lUGR pregnancies were characterised by an increased number of 
syncytial nuclei which were aggregated together in clumps (SN); few cytotrophoblast cells 
were identified (CN) and within the fetal capillaries (Fc) there was evidence of antenatal 
congestion with moulding of the fetal erythrocytes (FE) and lysis of the erythrocyte cell 
membrane
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Figure 6.2 TEM of a terminal villus from a normal preterm placenta.
The terminal villi in the gestation age-matched control placentas had significantly more 
cytotrophoblast cells (CN), less syncytial nuclei (SN) and little evidence of capillary 
congestion (Fc) when compared with the placentas from lUGR pregnancies.
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Figure 6.3 Basal lamina densa (LD) in terminal villi from an lUGR (1) and matched 
control placenta (2). The mean basal lamina densa (LD) was significantly thicker in the 
lUGR terminal villi than in the controls. In addition, basal lamina-like substance was also 
very prominent within the stroma of the lUGR placentas. (S)-syncytiotrophoblast; (C)- 
cytotrophoblast; (Fc) - fetal capillary
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Figure 6.4 Transmission electron micrograph of terminal villous stroma from an lUGR 
placenta, demonstrating the myofibroblast cell (M) in cross-section
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Figure 6.5 Villus stroma in terminal villi from an lUGR (1) and control (2) placenta. The 
villus stroma in the lUGR placentas had significantly more collagen fibres (C) and an 
increased density of background basal lamina-like material (L) when compared with villi 
from the control placentas. The control villus stroma is more highly magnified in order to 
illustrate that collagen fibres, though scanty, were indeed present.
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PARAMETER lUGR CASES PRETERM CONTROL 
CASES
MEAN VILLUS 
DIAMETER (fxM)
57 (6.0) 66 (8.0)
SYNCYTIAL NUCLEI 
NUMBER
9.6 (1.9) 4.5 (1.6)
CYTOTROPHOBLAST 1 nucleus/cross-section; 2 nuclei/cross-section;
NUCLEI NUMBER seen in 40% of sections seen in 80% of sections *
LAMINA DENSA (jiM) 1.3 (0.29) 0.6 (0.23)
VILLUS STROMA 
DENSITY
Fibroblast like cells + Fibroblast like cells 0
Fibrillar material ++ Fibrillar material +
Collagen fibres +++ Collagen fibres +
Table 6.1 Ultrastructural characteristics of terminal villi in placentas from pregnancies 
complicated by lUGR and normal gestation age-matched controls. Values are described as 
means (standard deviation), ^indicates p < 0.05
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CHAPTER 7
VILLOUS CELL 
PROLIFERATION
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7.1. INTRODUCTION
Following implantation, the early placenta intrudes through the uterine endometrium to 
penetrate maternal spiral arteries within the underlying endometrial and myométrial layers 
(Schlafke & Enders 1975). This process of invasion occurs in two distinct phases 
(Pijnenborg et al. 1980); the first, which establishes an intervillous circulation of maternal 
blood from endometrial vessels, occurs near the end of the first trimester (Hustin & Schapps 
1987); the second, in which myométrial spiral arteries are invaded, around week 18 of 
gestation. Though placental invasion to deeper layers of the uterus may cease at this stage, 
placental growth and maturation does not (Sands & Dobbing 1985); continuing fetal 
development demands increasing supplies of vital substrates and thus the placental and 
vascular surface area available for exchange must also expand. Of necessity therefore, the 
placenta must retain the capacity for cell proliferation and growth, until the fetus is delivered 
(Teasdale 1980).
It is now well established that cytotrophoblast cells alone have the capacity for replication 
and cell division, the syncytiotrophoblast being a post-mitotic tissue (Pierce & Midgeley 
1963; Tao & Hertig 1965; Weinberg et al. 1970). Within the cytotrophoblast cell population, 
there are two distinct groups of cytotrophoblast cells, though both arise from the same stem 
cell; firstly cytotrophoblast cells responsible for placental invasion (Robertson & Warner 
1974) and secondly those involved in placental growth and repair.
The mechanisms by which normal villous cytotrophoblast cells differentiate into invasive 
cytotrophoblast cells, known as extravillous or intermediate cytotrophoblast, is not known 
(Kurman, Main & Chen 1984) Their appearance coincides with the formation of decidual 
cells within the uterine stroma (Ran & Braustein 1991) and it is therefore likely that a local 
uterine or maternal endocrine signal may act as the trigger. It is these invasive 
cytotrophoblast cells which penetrate the maternal spiral arteries, converting them ikto 
flaccid in-elastic vessels, thus accommodating the increase in uterine blood flow. This 
invasive phase of cytotrophoblast cell behaviour appears to be strictly limited to the first 20 
weeks of pregnancy. It is unclear how such behaviour is so tightly regulated, though it would 
appear to be the result of an intrinsic cytotrophoblast cell programme in which invasive 
cytotrophoblast cell behaviour ceases after 20 weeks gestation (Aplin 1991).
In contrast, growth and repair of the villous tree is modulated by villous cytotrophoblast cells 
and occurs throughout gestation. During the first trimester in particular, these 
cytotrophoblast cells are numerous, forming a complete layer beneath the syncytiotrophoblast 
(Jones & Fox 1991) and demonstrating great proliferation potential (Cotte et al. 1980; Yeger 
et al. 1989). With advancing gestation, and maturation of the placenta fewer cytotrophoblast
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cells aie present but they may still be seen in 20%-40% of the villous trophoblast (Bernischke 
& Kaufmann 1990).
Increased, numbers of cytotrophoblast cells have been noted in pregnancies complicated by 
"hypoxia" in-utero (Fox 1968). Jn-vitro data obtained using villous explants would appear to 
confirm this since cytotrophoblast cell proliferation is induced in hypoxic conditions (Fox 
1970; McLennan et al. 1972).
Since umbilical venous blood from lUGR pregnancies demonstrates evidence of a low 
oxygen tension (Nicolaides, Economides & Soothill 1989) it is assumed that the lUGR 
placenta like the lUGR fetus must also be chronically hypoxic and therefore cytotrophoblast 
cell proliferation stimulated. However, we have previously shown by morphological 
assessment using TEM (chapter 6) that there is no evidence of cytotrophoblast cell 
proliferation in lUGR placentas, rather the cytotrophoblast cell population was reduced.
In order to validate the TEM findings of Chapter 6, cytotrophoblast cell proliferation was 
evaluated in both lUGR and gestational-aged matched control placentas using the 
proliferation mai'ker MIB-1. This monoclonal Ki-67 antibody reacts with a nuclear cell 
proliferation associated antigen that is expressed in all cells which are in the active phase of 
the cell proliferation cycle, and absent from quiescent cell in Go (Gerdes et al. 1983)
7.2. METHODS
7.2.1 Clinical details
Pregnancies complicated by lUGR, as defined in section 2.2.1 were identified. The clinical 
details of the 8 cases selected are shown in Table 2.1 (Case numbers 5, 10-16). All were 
delivered by caesarean section. Four pregnancies were normotensive and four were 
complicated by pre-eclampsia defined as previously (Section 2.2.1). Birthweight centiles, 
calculated from the local delivery database (Smalls & Forbes 1983) were <10th centile 
(except for case 11), the majority being <3rd centile. All the neonates, including case 11, 
showed clinical evidence of intrauterine stai vation.
For coriipai'ison purposes a control series of eight preterm pregnancies were also selected; 
these were matched for gestational age and smoking habit. Their clinical details aie shown in 
Table 2.2 (Case numbers 26, 29-35). Of the three cases which were admitted in spontaneous 
unexplained preterm labour, two were delivered by caesarean section.
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7.2.2 Collection of specimens
Placental tissue was collected at the time of delivery (Section 2.6). In addition to the TEM 
blocks obtained by perfusion-fixation, a minimum of 4 full-section (from chorionic to basal 
plate) blocks of non-perfused tissue were excised from random areas of the placenta and 
immersion fixed in 4% neutral buffered formalin as described in Section 6.2.6
7.2.3 Preparation of sections
The glass slides used for the experiments were all pre-treated with ethyl alcohol, incubated 
with 2% APES for 20 seconds, then washed in acetone and aqua dest (1 minute each). This 
improved adhesion of the tissue sections to the slides.
Serial sections (3-5 qM) of tissue were cut from the paraffin blocks, mounted on the pre- 
treated slides and incubated at 37^C overnight. The following day they were deparaffinised 
in xylene (2 x 10 minutes) and graded ethanol (100 and 96% ethyl alcohol for 5 minutes 
each). After blocking endogenous peroxidase by incubation, with 1% hydrogen peroxidase 
in methanol, the sections were washed in PBS [sol] (prepared by diluting 500 mis of PBS 
concentrate in 10 1 of distilled water). The sections were then immersed in 10 mM citric acid 
and pre-treated 4 x 5  minutes in a microwave at 600 Watts, to enhance expression of the 
antigen.
7.2.4 MIB-1 Immunohistochemistry
A commercial kit (Histostain SP Kit), based on the streptavidin-biotin reaction was used. 
Primary antibodies were diluted in PBS [dil] (prepared by dissolving one PBS tablet in 100 
mis of distilled water) with 1.5% BSA. The bound antibody was visualised using AEG.
MIB-1:
After a 20 minute incubation with 10% non-immune goat serum to eliminate background 
staining, the sections were incubated with the primary antibody, MIB-1 [dilution 1:20; (Key 
et al. 1993)] for 60 minutes. The slides were washed three times in PBS [sol] then incubated 
with the secondary biotinylated goat anti-mouse antibody for 30 minutes. After a further 
wash in PBS [sol] the sections were incubated for 5 minutes with the streptavidin-peroxidase 
conjugate then washed again in PBS [sol]. The bound antibody was visualised by incubating 
the sections with an AEG chromagen/hydrogen peroxide mixture for 15 minutes. Before 
counterstaining the sections with haematoxylin (for 3 minutes) they were washed in distilled 
water ( 2x5 minutes).
Gontrols were generated by replacing the primary antibody with PBS [sol]/1.5% BSA. The 
controls all remained negative. The antibody was being used concurrently in other studies 
into placental proliferation. These slides acted as positive controls
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7.2.5 MIB-1 Analysis
A 22 X 22 mm grid box, containing 400 squares was generated and 100 fields marked by 
random allocation. These grid boxes were placed with an identical orientation over each 
sections. For each case the 100 selected fields were examined and the numbers of positively- 
staining red nuclei (representing the number of proliferating cells) counted separately for 
both the trophoblast and villus stromal compartments (Figure 7.1).
7.2.6 Estimation of villous volume
Since the proportion of villous tissue present within each section differed widely, the villus 
cross-sectional surface of each case was estimated using a standard 20 point counting method 
as described in Section 3.2.5.2
7.2.7 Verification of methods
To ensure that an adequate sample was evaluated, 25% of the placental fields were examined 
In addition, to verify that the results were reproducible, the counts were also repeated on two 
of the cases at separate time intervals. No significant differences were found.
7.2.8 Statistical analysis
The data obtained on the number of proliferating cells were not normally distributed; these 
data were therefore first log transfonned [log(x)] before analysis and expressed as geometric 
mean (standard deviation). The data on villous volume were normally distributed and are 
shown as mean ± standard deviation. Differences between the mean values of the parameters 
measured were assessed by unpaired Student's t-test with p values <0.05 considered 
significant.
7.3 RESULTS
7.3.1 Comparison of the groups
Gestational age in the lUGR group (30.8 weeks [SD 2.4]) was similar to the control group 
(31.8 weeks [SD 2.4]). However, as expected, the birthweight of the lUGR was significantly 
lower than that of the preterm controls (1064 g [SD 334] vs. 1891g [SD 454]; p<0.05). The 
placental weight of the lUGR group was also significantly smaller than that of the controls 
(271 g [SD 98] vs. 450g [SD 31]; p<0.05). There were no significant differences in the 
placental/fetal weight ratio between the two groups. Four women in each group were 
smokers.
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7.4 DISCUSSION
As for the TEM study (chapter 6), severely growth retarded pregnancies were carefully 
identified. A group of normally-grown preterm pregnancies with normal umbilical artery 
perfusion were also selected to serve as controls. Since the two groups were appropriately 
matched for gestation placental data from the two groups were comparable.
7.3.2 Villous Volume
The proportion of villous tissue within each case is summarised in Table 7.1. There was 
significantly less villous tissue in the lUGR placentas when compared with gestational age 
matched controls (56.8% [SD 7.9] vs. 70.3% [SD 10.8]; p<0.05) but within the lUGR group, 
there was no difference between those with maternal pre-eclampsia and those without (56.5 
[SD 9.6] vs 58.25 [SD 5.9]; p=0.766).
7.3.3 MIB-1 morphometric analysis
The morphometric analysis of the MIB staining is summarised in Table 7.1. Since the 
proportion of sectional area occupied by villi was significantly lower in the lUGR group the 
nuclear counts aie expressed as numbers of positively staining nuclei per cm^ of villi in each 
case. Even after correction, the numbers of proliferating trophoblast nuclei per cross 
sectional area was significantly lower in the lUGR group as compared to the gestational age- 
matched controls (2.5 [SD 0.33] vs. 2.92 [SD 0.24]; p<0.05) (Figure 7.2). Again, within the 
lUGR group, there was no difference between those with maternal pre-eclampsia and those 
without (2.553 [0.19] vs 2.451 [SD0.46]; p=0.7).
The MIB-1 immunohistochemical study demonstrated no significant differences in the 
number of positively staining stromal cells between the lUGR group and the gestational age- 
matched control group (2.19 [SD 0.29] vs. 2.31 [SD 0.27]; p=0.37)
The number of cytotrophoblast cells within placentas from lUGR pregnancies was 
significantly reduced, even after correction for the volume of villous tissue present. Since 
cytotrophoblast cells are the germinative zone of the placenta it is by proliferation of this 
layer that new villous sprouts and thence mesenchymal villi (the precursor of all villi) are 
formed. Thus the MIB counts confirm the impression of TEM examination (Chapter 6) that 
trophoblast proliferation is reduced or impaired in placentas from pregnancies complicated 
by lUGR and AEDFV (Table 7.1). Furthermore these changes were not altered by the 
presence or absence of maternal pre-eclampsia within the lUGR group
113-
"Unexplained" intrauterine growth retardation is attributed to placental ischaemia, a 
consequence of poor trophoblast invasion and reduced utero-placental blood flow. Our 
confirmation of a reduction in cytotrophoblast cell number is therefore all the more surprising 
since based on both in-vitro and in-vivo data cytotrophoblast cell proliferation is stimulated by 
hypoxia. In-vitro, villous explants maintained in conditions of low oxygen tension (6%) show 
increased cytotrophoblast cell numbers when compared with villous explants maintained in 
identical culture conditions but with 26% oxygen (McLennan et al. 1972; Fox 1970). While 
in-vivo, cytotrophoblast cells are found in the vicinity of vasculosyncytial membranes, where 
fetal vessels come in close proximity to maternal blood. In these areas, the oxygen gradient 
from maternal to fetal blood is maximal and the oxygen tension therefore least (Bernischke & 
Kaufmann 1990). More-over, excessive numbers of cytotrophoblast cells are found in 
pregnancies complicated by pre-eclampsia, particularly those with early onset, severe 
disease, thought to be a response to placental ischaemia (Wigglesworth 1962; Fox 1965). 
Within our study there was no evidence of excessive cytotrophoblast cell proliferation in the 
lUGR pregnancies complicated by maternal pre-eclampsia, suggesting perhaps that the 
primary pathology in these cases was impaired fetal growth and the development of 
hypertension, a secondary maternal response to the fetal condition.
We found no evidence of increased cytotrophoblast cell proliferation by light or electron 
microscopy, rather our findings would suggest impaired cytotrophoblast proliferation. Had 
the number of cytotrophoblast cells been directly proportional to the volume of villous tissue, 
it could be concluded that cytotrophoblast proliferation was appropriate for the small 
placental size. However, even after correcting for the smaller villous volume, 
cytotrophoblast cell proliferation was significantly impaired. This would suggest that 
cytotrophoblast cell proliferation is specifically inhibited.
While hypoxia stimulates cytotrophoblast cell proliferation, higher oxygen tensions inhibit 
proliferation. We have previously noted evidence of impaired blood flow in terminal villi 
from lUGR pregnancies (Chapter 6). Such ante-natal vessel congestion would permit 
equilibration of fetal and maternal blood and reduce the oxygen gradient normally present 
between maternal and fetal blood, resulting in relatively high oxygen tensions being present 
within the placental villi. Since placental villi normally have a steep oxygen gradient and 
low oxygen tension, an increase in villous oxygen tension, though still within physiological 
limits, would produce relatively hyperoxic conditions and inhibit cytotrophoblast cell 
proliferation.
Reduced turnover and production of trophoblast may not only affect placental size but also 
placental function. Syncytiotrophoblast is the interface between maternal and fetal tissues 
and though gaseous transfer occurs by simple diffusion, many of the substrates necessary for
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fetal growth must be actively transported across this membrane. Without regeneration of the 
trophoblast layer, the functional capacity of the trophoblast will be diminished. Further 
investigations are required to evaluate the distribution and function of transport pathways in 
lUGR placentas.
In contrast, there was no significant difference in the number of proliferating stromal cells 
between lUGR and control placentas, once these values were corrected for villous volume. 
Stromal cells are comprised of reticular cells, fibroblasts and Hofbauer cells. Both reticular 
cells and fibroblasts are involved in mechanical support within the villous, producing 
collagen fibrils and forming channels for the passage of Hofbauer cells (Jones & Fox 1991). 
These latter cells, of uncertain origin, have a variety of functions including immunological 
activity (Bulmer & Johnstone 1984; Mues et al. 1989) and remodelling of the villous stroma 
(Castellucci et al. 1980). Though placental fibroblast proliferation rates appear to be 
predetermined or "programmed" as a function of gestational age (Fant 1991), thek functional 
activity may be modified by factors such as endothelins (Fant et al. 1992). The increase in 
stromal collagen noted previously by TEM may therefore not simply be related to stromal 
cell number but to the effect of vasoactive agents on these cells.
Immunohistochemical studies with the proliferation marker MIB-1 have confirmed that 
cytotrophoblast cell turnover is significantly reduced in lUGR placentas. Rather than 
indicating a role for placental ischaemia, these findings suggest that relatively high oxygen 
tensions develop within placental villi from lUGR placentas, inhibiting cytotrophoblast cell 
proliferation and thus impairing trophoblast formation.
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Figure 7.1 Cross-section of placental villi from a normally grown pregnancy stained with 
the proliferation marker MIB-1. Cells in the active phase of replication stain are positive for 
the antibody and are stained red. Several such cells may be seen within the trophoblast (t) 
and stroma (s) of the placental villi, (magnification x 400)
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Figure 7.2 Cross-section of placental villi from a pregnancy complicated by lUGR and 
AEDFV stained with the proliferation marker MIB-1. Actively proliferating cells stain red, 
however, these villi were characterised by an absence of positive (red) cells within the 
trophoblast (t) or stroma (s). When corrected for villous volume, the number of positively 
staining trophoblast cells was significantly less than that seen in the villi from normal 
pregnancies, (magnification x 400)
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lUGR CASES
16 65% 520 278
PRETERM CONTROL CASES
22 80% 655 135
25 83% 607 107
26 75% 676 190
27 67% 844 429
28 67% 2760 547
29 83% 995 284
30 78% 812 182
31 81% 417 100
■I
tNUMBER OF MIB-1 NUMBER OF MIB-1
illCASE NUMBER % VILLUS TISSUE POSITIVE NUCLEI IN POSITIVE NUCLEI IN
TROPHOBLAST VILLOUS STROMA
:J|
5 59% 237 49 |
10 43% 326 183 If
11 57% 535 219
12 61% 199 116
13 60% 92 86
14 64% 1172 406 l |
15 50% 250 138
I
Table 7.1 Villous volume and MIB-1 positive proliferating cell counts in trophoblast l |
and stroma of lUGR and gestational-age matched preterm control placentas.
1In each case the number of MIB-1 positive cells has been corrected for the % villus tissue 
present. There were significantly fewer proliferating cells in the lUGR trophoblast compared 
with the control trophoblast [2.5 vs. 2.9; p<0.014] but similai' numbers of proliferating stomal 
cells in both lUGR and preterm control placentas [2.1 vs. 2.3 p=0.37].
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CHAPTER 8
THE VILLOUS STROMA
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8.1 INTRODUCTION
The TEM images obtained in Chapter 6, suggested an appaient increase in the number of 
collagen fibres and the concentration of fibrillar material within the villous stroma of 
terminal villi in lUGR pregnancies. To confirm our initial obseiwations and also to evaluate 
the type of collagens involved, we submitted placental paiaffin sections from lUGR and 
gestational matched pregnancies for stromal immunohistochemical studies. In addition, since 
larger aieas of the placenta could be evaluated, we were able to assess if the changes were 
widespread throughout the placenta of lUGR pregnancies.
8.2 METHODS
8.2.1 Selection of patients
Eight women with pregnancies complicated by severe intrauterine growth retardation as 
defined in section 2.2.1 were identified antenatally. Three of the pregnancies were also 
complicated by pre-eclampsia as defined in 2.2.1; the remaining five pregnancies were 
normotensive. There were no other complicating maternal or fetal conditions. All the women 
were delivered by caesarean section. Following delivery the birthweight centiles of the 
neonates, based on a local database (Smalls & Forbes 1983), were all confirmed to be less 
than the 10th centile for gestational age. The clinical details of the cases used are given in 
Table 1.1 [Case numbers 1-7 and 20]
For the purposes of comparison, a group of 8 women with normally grown, healthy fetuses 
who were delivered prematurely were also selected. In total five of the pregnancies were 
delivered by caesarean section. The clinical details of these cases are given in Table 1.2 
[Case numbers 22-24, 28, 34, 36, 37 and 40]. Four women in each group were smokers.
8.2.2 CoUection of specimens
Tissue samples were collected, processed and embedded in paraffin as described in chapter 3 
(section 3.2.2)
8.2.3 Preparation of sections
Glass slides were prepared in the following manner; the slides were washed in ethyl alcohol, 
immersed for 20 seconds in acetone with 2% APES then washed twice (for 60 seconds each 
time) in pure acetone. Serial sections (3-5 pM) were cut from the tissue blocks obtained 
from the cases listed above and mounted on the prepared glass slides.
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The mounted sections were deparaffinised as follows; the sections were washed in distilled 
water, immersed in xylene for 10 minutes then transferred through a graded series of alcohol 
(100, 96 and 90%) for 5 minutes in each solution. After rinsing the sections with methanol, 
endogenous peroxidase was blocked by incubation with a methanol/hydrogen peroxide 
solution (60mls:lml) for 30 minutes before a further wash with PBS [sol].
8.2.4 Immunohistochemistry
The following antibodies were employed:
Polyclonal Antibodies - Fibronectin; Collagen I; Collagen U; Collagen III; CoUagen IV 
Monoclonal Antibody - Laminin
The sections for each stromal antibody were all processed simultaneously during a single run.
8.2.5 Staining with polyclonal antibodies
The sections were covered with a serum blocker (20% normal swine serum in PBS) for 20 
minutes to reduce non-specific background staining. After tipping the blocker from the 
slides, the sections were incubated with the primary antibody for 18 hours at 4°C then 
washed three times in PBS [sol] (3 x 10 minutes). A secondary antibody (swine anti-rabbit 
1:100 in 4% NSS/PBS) was then applied for 45 minutes. The sections were washed a further 
3 times in PBS [sol] (3 x 10 minutes) then incubated with peroxidase conjugated streptavidin 
(1:800 in 4% NSS/PBS) for 45 minutes. After rinsing in PBS (3 x 10 minutes), AEC was 
applied to the sections for 15 minutes. The sections were washed twice in distilled water 
then counterstained with haematoxylin for 3 minutes before mounting with coverslips.
8.2.6 Staining with monoclonal antibodies
A similar technique was used for monoclonal antibody staining with the following 
modifications: 2% BSA in PBS was used as an initial blocking solution; the secondary 
antibody applied was peroxidase conjugated rabbit anti-mouse (1:50 in 2% BSA/PBS); for a 
third layer peroxidase conjugated avadin (1:100 in 4% NSS/PBS) was used. These sections 
were similarly visualised using AEC.
Negative controls were generated for each antibody by omitting the primary antiserum and 
the specificity of the procedure verified using pre-adsorbed specific antiserum. Hepatic and 
vascular tissue, previously used in our laboratory served as positive controls.
8.2.7 Analysis of sections
The sections were all coded independently and therefore examined blind to any clinical 
information. Each section was examined qualitatively in a systematic fashion. The pattern
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and density of staining present for each antibody in terminal, intermediate and stem villi was 
noted. The scoring system for staining density was as follows; no staining 0, light staining 1, 
moderate staining 2 and dense staining 3.
8.3 RESULTS 
8.3.1 Comparison of the study groups
There was no difference between the two groups in terms of the gestational age at delivery 
(31.25 weeks [SD 3.24] vs 31.25 weeks [SD 3.28]. The birthweight of the lUGR group was 
significantly less than that of the controls (llOOg [SD 368] vs 1739g [SD 488]; p<0.05). 
Likewise the placentas from the lUGR pregnancies were significantly lighter than the 
placentas from the control cases (246g [SD 55.4] vs 448 [SD 69.4]; p<0.05)
8.3.2 Collagen Type 1
CONTROL GROUP: Collagen type I antibody staining (Grade 1) was well localised to the 
basement membranes of intermediate and terminal villi and formed a fine fibrillar network 
within the stroma of these villi (Figure 8.1). The distribution of staining was similar in stem 
villi but was more intense.
lUGR GROUP: Collagen type I antibody staining was generally more intense throughout all 
the villi of the lUGR placentas. Within intermediate and terminal villi, thick duplicated 
layers were present in the basement membrane. These merged with well defined bands 
which were also present in the villous stroma. In other areas a fairly dense homogeneous 
staining pattern was seen within the villous stroma (Figure 8.2). In stem villi the collagen I 
antibody staining formed dense sheets throughout the villous stroma .
8.3.3 Collagen Type n
CONTROL GROUP: Virtually no staining was present in any of the villi from the control 
placentas.
lUGR GROUP: Light (grade 1) staining was present around the basement membranes of 
large arteries within the stem villi. Patchy, grade 1 staining was also present within the 
stroma of stem, intermediate and terminal villi but this was variable in appearance and 
distiibution.
8.3.4 Collagen Type m
CONTROL GROUP: Grade 2 staining was identified around the vessels, the basement 
membrane, and within the interstitium of the stem villi. Intermediate and terminal villi
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showed almost no staining, but when present the staining was light and localised to the 
stroma (Figure 8.3).
lUGR GROUP; In stem villi, antibody staining was distributed in thick heavily stained 
bands around the fetal vessel walls; these bands also extended into the stromal portion of the 
villi. Virtually every intermediate and terminal villus was stained with collagen III antibody 
form ing a meshwork in the stroma and discrete layers around the fetal vessel walls (Figure 
8.4).
8.3.5 Collagen Type IV
CONTROL GROUP: Moderate staining for the antibody was present throughout the stroma 
of stem villi and around both the trophoblast and fetal vessel basement membranes. In 
intermediate and terminal villi, the staining formed a well defined line outlining the basement 
membranes of the fetal blood vessels and the trophoblast. There was minimal antibody 
staining in the stroma of these villi (Figure 8.5).
lUGR GROUP: Densely stained concentric rings of antibody staining were present in the 
stem villi around the fetal arterial vessels and extending into the villous stroma to form a 
web-like net. The same pattern of staining was also present in the intermediate and terminal 
villi such that the basement membranes of the trophoblast and fetal vessels could not be 
distinguished from the stromal antibody web of staining (Figure 8.6).
8.3.6 Collagen V, VI and V n
CONTROL GROUP: Patchy, grade 1 staining was present within the villous stroma of all 
villous classes.
lUGR GROUP: The pattern of staining was identical to that of the control group.
8.3.7 Fibronectin Antibody
CONTROL GROUP: For all villous classes, staining for this antibody was primarily seen in 
the basement membrane areas of the trophoblast and the fetal vasculature. A fine meshwork 
of fibrillar' staining was also present in the villous stroma. Within stem villi, this fibrillar 
staining formed almost a continuous sheet.
lUGR GROUP: Complete sheets of positve staining were seen in the stroma of stem villi. 
The stromal fibrillar staining pattern was identical to the control group in intermediate and 
terminal villi but was slightly more intense.
123-
8.3.7 Laminin
CONTROL GROUP: The laminin antibody formed a very thin pencil-thin outline around the 
basement membranes of both fetal vessels and villous trophoblast in all villous classes 
(Figure 8.7).
lUGR GROUP: In all villi, the basement membrane outlines around the trophoblast and 
vessel walls appeared irregular and thickened. Duplication of the laminin layer was 
identified, particularly in the trophoblast basement membrane of the terminal villi (Figure 
8.E0.
For each of the antibodies evaluated, it was impossible to distinguish any difference in the 
staining pattern of the lUGR cases which were "uncomplicated" and those which were 
additionally characterised by maternal pre-eclampsia.
8.4 DISCUSSION
Collagen is the generic name for a family of proteins which form the major fibrous 
constituent of skin, tendon, bone and the extracellular matrix. Tropocollagen, the basic 
molecule of all collagen proteins is composed of three polypeptide chains, arranged in a triple 
helix, which is cleaved from a larger precursor molecule secreted, in the placenta, from 
fibroblasts and Hoefbauer cells within the villous stroma. A complex series of steps is 
required for this process; the collagen gene is first switched on, the message then 
transcripted, translated, pre-processed, and the molecule then converted ultimately from pro­
collagen to the stable collage molecule. It is recognised that in some tissues and pathological 
states the rate of collagen production can be significantly stimulated or altered at one, or 
many of these sites.
Within the placenta, collagenous and non-collagenous proteins are major constituents of the 
villous stromal matrix and basement membranes. The extracellular villous matrix was 
previously thought to be an inert tissue, but it is now clear, that by vaiying the proportions of 
matrix proteins present, stractural and functional properties of the extracellular space may be 
altered (Hay 1981). Alterations therefore, to the composition of the villous stroma has major 
functional implications for the feto-placental unit. Having demonstrated by TEM (Chapter 
6) that the basement membrane lamina densa was thickened in lUGR pregnancies and that 
the villous stroma appeared to contain increased amounts of collagen material, we wished to 
confirm these findings and establish the types of collagens/non-collagens involved. The 
staining patterns of all the collagens subtypes previously identified within placenta (Amenta
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et al. 1986) and the two non-collagenous glycoproteins fibronectin and laminin were 
examined.
Collagen I is the main structural component of the villous stroma and is the major collagen 
present within the mature term placenta. Collagen I antigens are localised almost exclusively 
on the thick cross-banded collagen fibers which can be visualised by TEM (Boselli et al. 
1981; Clark et al. 1982; Martinez-Hernandez 1984) and are distributed within the stroma, 
particularly around blood vessels. Increased staining for collagen I antibody was present 
within the villous stroma of terminal villi from the lUGR placentas, forming almost a 
homogeneous mass within the stroma. A relative increase in collagen I content, particularly 
within stem villi (Locci et al. 1993) may increase placental vascular impedence and so 
contribute to the development of abnormal Doppler waveforms.
Antibodies against collagen III are located on thin, non-cross-banded fibers (Amenta et al. 
1986) within the interstitium and are often closely associated with collagen I fibers. Not 
surprisingly therefore, the pattern of collagen III antibody staining closely mirrored that of 
collagen I antibody. It is likely that the increase in background fibrillar material, which was 
noted in the villous stroma of terminal villi from lUGR pregnancies (Chapter 6), was due to 
an increase in collagen III. The functional relevance of this finding is uncleai'.
Collagen IV and laminin are both normally located within the basement membrane, laminin 
in the lamina rara and collagen IV preferentially in the lamina densa (Martinez-Hernandez & 
Amenta 1983). While both these components showed increased staining in the basement 
membrane, surprisingly, significant staining was also present within the villous stroma. 
Collagen IV and laminin are only occasionally noted in the villous stroma of normal 
placentas and are thought to be a consequence of villous remodelling; basement memebrane 
material being deposited into the villous stroma, prior to digestion and removal (Amenta et 
al. 1986).
Within other organs, vascular re-modelling is associated with significant increases in 
collagen production. Pulmonary arteries have been shown to actively stimulate collagen 
production in primary pulmonaiy hypertension, though the initial stimulus for this is not yet 
recognised (Botney et al. 1993). Furthermore in chronic hypoxia, increased collagen 
production is seen in both large and small arterial vessels and is additionally associated with 
neomuscularisation of non-muscularised vessels (Rabinovitch et al. 1986). Significantly, 
prior treatment with a collagen inhibitor dramatically reduces the degree of pulmonary 
hypertension which ensues (Kerr et al. 1987).
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We have shown previously that the terminal villous and vascular network present in the 
placentas of lUGR pregnancies are structurally very abnormal (Chapter 5). A depleted 
capillary vascular network cannot cope with the increasing volume of placental blood 
necessary to meet the demands of the growing fetus. In response to the increased blood 
volume processed, it is possible that vascular remodelling is initiated in a similar manner to 
that seen in the lungs, thus resulting in an increased deposition of collagen IV and laminin 
around the vascular basement membranes and within the villous stroma.
In conjunction with this, myofibroblast cells, which we have previously demonstrated within 
terminal villi from lUGR placentas, are also involved in tissue remodelling and produce basal 
lamina material. The presence of these cells in terminal villi from lUGR placentas may 
indicate further that "remodelling" is occurring and provide an additional source of interstitial 
basal lamina substances.
Thickening and duplication of the basal lamina have been noted previously in pregnancies 
complicated by pre-eclampsia (Fox 1968b), diabetes mellitus (Okudaira et al. 1966) and 
maternal smoking (Van der Veen & Fox 1982; Van der Velde et al. 1985). Since basal 
laminal substances are produced by epithelial cells, its density in the placenta, is thought to 
correlate with the number of cytotrophoblast cells present (Jones & Fox 1980). Thus 
increased basal lamina thickening in pre-eclampsia was related to the increased numbers of 
cytotrophoblast cells seen in the placentas of affected pregnancies. However, we were 
unable to demonstrate any difference between the lUGR pregnancies with and without pre­
eclampsia, though it is acknowledged that the numbers within each of our groups may be too 
small to detect these changes. Likewise we were unable to show any difference in the 
appearance of the basal lamina between smokers and non-smokers in our study. Although, 
Van der Velde (1985) previously demonstrated thickening of the basal lamina amongst his 
group of smokers, this was not associated with increased numbers of cytotrophoblast cells. It 
is clear therefore that multiple factors mediate the regulation of basal lamina production.
Since we and others have shown that the volume of terminal villi present in placentas from 
lUGR pregnancies is significantly less than that present in normal control cases, it is not 
possible from these studies to assess if the increased staining present is simply a feature of 
the reduced villous volume leading to an increased collagen concentration, the direct result of 
increased collagen production, or the effect of a failure in collagen degradation.
Collagen production is known to be stimulated by enviromental factors such as increased 
oxygen tension and vascular stasis (Fox 1968a; Paningel & Myers 1972). We have 
previously demonstrated evidence to indicate that both vascular stasis and relative hyperoxia 
occur within terminal villi from lUGR placentas (Chapters 6 and 7). Outside the placenta,
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collagen production is known to be stimulated by growth factors, notably, transforming 
growth factor B (TGF-B) but others such as TGF-9 and epidermal growth factor (EGF) are 
also involved. TGF-B 1 is released from platelets during platelet activation (Sporn & Roberts 
1986) and has been noted not only to induce collagen synthesis, particulaly collagen type I 
synthesis, but also to inhibit cell proliferation (Fine et al. 1987; Creely et al. 1992). Though 
TGF-B 1 appears to be expressed primarily in the syncytiotrophoblast and not the placental 
villous core during normal pregnancy (Dungy et al. 1991) indicating a potential role in 
placental invasion, its distribution and function in pathological pregnancies has not yet been 
evaluated. In addition, since it is recognised that platelet turnover is increased in pregnancies 
complicated by lUGR (Van den Hof 1990), activation of this system may well occur in 
lUGR pregnancies. Increased expression of TGF-B in early pregnancy, resulting perhaps, 
from a maternal cytokine or inflammatory stimulus may contribute both to the inhibition of 
villous proliferation and the promotion of collagen production.
Alternatively the relative increase in collagen may reflect a failure in collagen degradation. 
In view of its stability, collagen is almost exclusively degraded by the collagenase enzyme. 
Basic fibroblastic growth factor (b-FGF) promotes collagenase production and in addition, is 
a potent stimulator in neovascularisation (Rifkin & Moscatelli 1989). There is a clear failure 
of vascular growth in the placentas of lUGR pregnancies and the excess collagen present, 
which compounds problems for the feto-placental unit, may simply be an added feature, 
reflecting poor vascular developeraent due to a lack of growth factor stimulation.
Further studies which quantify collagen content per villous volume and evaluate collagen 
messenger RNA are clearly needed to answer these questions and distinguish the relative 
contribution of these potential pathways to the features we have demonstrated. Only as these 
issues are addressed can our findings be reliably interpreted.
Irrespective of the methods by which these changes are demonstrated, the potential for long 
term "remodelling" must not be ignored. Barker (1992) and others have shown clearly that 
the fetal enviroment may programme future patterns of disease. Increased collagen 
production and neomuscularisation are classical pathological features of extra-uterine 
hypertension. If the changes we have demonstrated in the placenta of pregnancies 
complicated by lUGR are mirrored in the fetal systemic circulation the precursor lesions of 
adult hypertension may well be established by the time of birth.
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Figure 8.1 Collagen Type I antibody staining in a normal preterm placenta
Staining for collagen type I antibody was well defined to the villous and vascular basement 
memebranes (B) of the intermediate (IM) and terminal (T) villi, (magnification x 4(X))
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Figure 8.2 Collagen type I antibody staining in a placenta from a pregnancy complicated 
by lUGR and abnormal umbilical artery Doppler waveforms.
The antibody staining formed thick bands in both the basement membranes (B) and villous 
stroma (S) of (T) villi, (magnification x 400)
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Figure 8.3 Collagen type III antibody staining in a placenta from a normal preterm 
control pregnancy.
Antibody staining was primarily associated with the villlous and vascular basement 
membranes in stem villi. In the intermediate (EM) villi antibody staining was minimal in the 
villous stroma and formed a pencil line associated with the basement membrane, 
(magnification x 400)
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%Figure 8.4 Collagen type IIII antibody staining in villi from an lUGR pregnancy
Collagen III antibody staining formed a dense meshwork in the villous stroma (S), even 
within terminal (T) villi, (magnification x 400)
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Figure 8.5 Collagen type IV antibody staining in villi from a normal preterm control 
pregnancy.
Grade 2 antibody staining was localised to the villous and vascular basement membranes 
within terminal (T) and intermediate (IM) villi, (magnification x 400)
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Figure 8.6 Collagen type IV antibody staining in villi from an lUGR pregnancy
Dense staining was present throughout the villous stroma of terminal (T) villi, forming a 
homogeneous sheet of staining in some villi, (magnification x 400)
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Figure 8.7 Laminin antibody staining in normal preterm placental villi
Grade 1 staining for the laminin antibody was present, forming a thin pencil line, around all 
basement memebranes (B) in all villous classes; (T) - terminal villi, (magnification x 400)
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Figure 8.8 Laminin antibody staining in villi from an lUGR pregnancy
The antibody staining for laminin was more intense in the basement membranes of all villous 
classes of the lUGR villi: (T) - terminal villi, (magnification x 400)
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CHAPTER 9
GENERAL DISCUSSION 
AND 
CONCLUSIONS
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9.1 REVIEW
The severely growth restricted fetus is characterised antenatally by abnormal umbilical artery 
Doppler waveforms and biochemical evidence of both hypoxia and intrauterine starvation 
(Nicolaides, Economides & Soothill 1989; Economides & Nicolaides 1989; Nicolini et ah 
1990). Since intrauterine growth restriction is not only a leading cause of perinatal mortality 
but is also linked with the development of adult cardiovascular and endocrine disease 
patterns (Barker 1992; Hinchcliff et al. 1992; Rona, Gulliford & Chinn 1993), it is imperative 
that we understand the mechanisms which underlie abnormal fetoplacental blood flow; 
manifest as abnormal umbilical artery Doppler waveforms and ensuing intrauterine 
hypoxia/starvation. In so doing we may establish the pathophysiology of intrauterine growth 
restriction which would thus allow us to develop well directed programmes to prevent and/or 
treat this condition.
The current thinking on the origins of lUGR may be summarised as follows: Impaired 
trophoblast invasion of the maternal spiral arteries (Shepherd & Bonner 1976; Brosens, 
Dixon & Robertson 1977; Khong et ah 1986) is thought to result in poor maternal blood flow 
to the placental bed. As a consequence, the maternal supply of oxygen and nutrients to the 
fetus is presumed to be deficient and fetal growth thus restricted. Under such circumstances, 
the placenta like the fetus is exposed to these adverse conditions, but several questions 
remain unresolved. The "deficient substrate supply theory" does not explain the development 
of abnormal umbilical artery Doppler waveforms in severely growth restricted pregnancies. 
Furthermore, although the lUGR fetus is hypoxic and has reduced concentrations of amino 
acids, blood samples from the placental bed of normal and lUGR pregnancies shows no 
difference in the concentrations of oxygen present (Nicolaides et ah 1986). In addition, 
simultaneous measurements of maternal and fetal amino acids concentration ratios would 
suggest that the maternal concentrations of amino acids are identical for both lUGR and 
control pregnancies, and indicate that it must therefore be the transfer of these substrates to 
the fetus which is impaired in lUGR pregnancies and not the maternal substrate supply 
(Economides et ah 1989).
Since the feto-placental circulation is not innervated, abnormal umbilical artery Doppler 
waveforms can only be generated by vasomotor agents or alterations in placental vascular 
anatomy. Currently, there is no conclusive evidence to suggest a primary vasomotor basis 
for abnormal Doppler (Macara, Kingdom & Kaufmann 1993), though obviously these agents 
may compound the effects of other factors. Anatomical studies have focused on the number 
of small stem arterioles and demonstrated reduced numbers of these vessels thought to result 
from progressive vessel occlusion by platelet emboli or ischaemic sclerosis. Later animal 
studies have since confirmed that loss of the placental vascular bed can induce similar 
Doppler changes to those seen in lUGR pregnancies (Trudinger et ah 1987b; Morrow et al
137-
1989b). However, since stem villi are not primarily involved in villous gas and nutrient 
transfer, the anatomical theories proposed for abnormal Doppler would not explain the 
presence of fetal hypoxia. Moreover, platelet emboli have never been seen in any portion of 
the vascular tree in human lUGR placentas and the number of small arterioles has never been 
related to the rest of the lUGR placental vascular tree to determine if these changes might 
reflect more widespread hypovascularisation and not simple isolated vessel occlusion.
The original observations from lUGR studies indicated that trophoblast invasion of the 
maternal spiral arteries was deficient but failed to address the question of why this might 
occur. Spiral artery invasion occurs secondary to placental growth and therefore the findings 
of impaired trophoblast invasion would suggest that primary placental growth and 
development is deranged in lUGR pregnancies. Under such circumstances, the villous 
surface area for substrate transfer would be significantly depleted and substrate deficiency 
ensue. Moreover, since villous and vascular development are intimately linked, 
hypovascularisation might also ensue, thus altering vascular impedance, and the umbilical 
arteiy Doppler waveform within the placental bed.
This thesis investigated various aspects of placental anatomical structure in pregnancies 
complicated by lUGR and AEDFV, in order to evaluate if such anatomical changes might 
occur and thus contribute to the biochemical status of the growth restricted fetus and the 
development of increased placental vascular resistance.
9.2 REDUCED STEM VILLOUS VESSEL NUMBERS - VESSEL 
OBLITERATION OR A FAILURE OF VASCULAR DEVELOPMENT ?
In chapter 3, using the antibody, anti a-smooth muscle actin, we were able to demonstrate 
that there was no difference in the relative proportions of small and large villous vessels 
between lUGR and gestational age-matched control placentas. Specifically, we were unable 
to identify any selective loss of vessels in the 20-90jiM interval which might support the 
vessel obliteration theory of abnormal Doppler. The reduced numbers of tertiary stem villous 
arterioles reported previously must therefore simply reflect a generalised impairment of 
vascular development in the lUGR placenta and not the specific loss of small arterioles by 
occlusion and subsequent obliteration.
The reduction in arterial vessel number was not secondary to depleted numbers of stem villi 
since proportionately, the villous volume of stem villi was similar in both groups. Therefore 
vascular growth and development must be specifically impaired in lUGR placentas. 
However, we also demonstrated that the villous volume of peripheral villi was significantly
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reduced in the lUGR cases and thus villous growth, at least at the level of intermediate and 
terminal villi, must also be modified in pregnancies complicated by lUGR.
localised within the endothelial cells of the placental microvascular circulation and within the 
fibroblasts/smooth muscle cells of larger vessels (Holmgren et al. 1991). Suppression of the
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9.3 THE LOSS OF PERH>HERAL VILLI - SIMPLE NUMERICAL REDUCTION 
OR PRIMARY PLACENTAL MALDEVELOPMENT?
i
In order to establish if the reduction in peripheral villous volume was due solely to depleted 
numbers of normal villi or secondary to abnormal patterns of peripheral villous development, 
we examined the three-dimensional structure of peripheral villi and the capillaries within 
them using scanning electron microscopy of tissue and microvascular casts. Placentas from 
normally grown pregnancies were composed of multiple small bud-like terminal villi 
containing a highly branched network of short, highly coiled capillary loops. Large dilated 
areas, sinusoidal dilatations, were present throughout the capillary loops; these reduce 
vascular impedance and thus improve materno-fetal exchange. In sharp contrast, the casts 
from pregnancies complicated by lUGR were characterised by relatively few, extremely 
elongated unbranched, uncoiled villi which contained capillary loops of similar dimensions. 
Sinusoidal dilatations were virtually absent from these loops. Since terminal villous buds I
and terminal capillary loops arise passively during the second and third trimesters of 
pregnancy as a result of excessive capillary growth, the vascular casts from these lUGR |
pregnancies which demonstrated a lack of capillary loops, further confirmed that vascular 
development was impaired in lUGR pregnancies. Our findings were all the more interesting 
since it is well established that hypoxia stimulates profuse capillary and villous growth |
(Bacon et al. 1984; Scheffen et al. 1991). The deficient capillary network of the lUGR i
vascular casts suggests that these lUGR placentas did not develop in an hypoxic environment |
and the fetal hypoxia which occurs in the growth restricted fetus must therefore arise at a 
higher level. I
Ï
9.4 REGULATION OF PLACENTAL VILLOUS AND VASCULAR GROWTH
Recent work has highlighted the role of growth factors in placental angiogenesis. Platelet 
derived growth factor (PDGF), a dimeric protein, with two polypeptide subunits designated 
A and B which has been shown to act both as a mitogenic (Bar et al. 1989) and a chemotactic 
factor for vascular endothelial cells (Westermark et al. 1990). PDGF-B corresponds to the c- 
sis gene. High concentrations of both PDGF-B genes and PDGF-receptor genes have been I
proliferation B-phenotype in placental vessels, perhaps through maternal or paternal genetic 
imprinting, could therefore modify or inhibit normal placental angiogenesis.
Vascular endothelial derived growth factor (VEGF), also known as vascular permeability 
factor (VPF), is another member of the PDGF family and though produced in cells close to 
the vascular network is targeted to vascular endothelial cells (Dvorak et al. 1991) where it 
promotes mitogenesis and fibroblast migration (Sengar et al. 1993). It is thus a potent 
angiogenic factor. Interestingly, hypoxia upregulates the production of VEGF in~vitro 
(Shweiki et al. 1992), which may in part explain the hypervascularisation seen in hypoxic 
conditions such as pre-eclampsia and high altitude. The regulation and expression of these 
and other agents, such as interleukin-6, angiogenin and transforming growth factor B (TGF- 
B), in normal placental angiogenesis obviously wai'rants further investigation. Thereafter, the 
possible contribution of these factors to the pattern of capillary growth seen in lUGR 
pregnancies may be established.
New placental villi arise by the proliferation of cytotrophoblast cells which form new villous 
columns or villous sprouts. These obtain a stromal core and following vascularisation are 
classified as mesenchymal villi, the precursor of all villous types. Since first trimester 
cytotrophoblast cells are known to demonstrate a greater proliferation potential than their 
third trimester counterparts (Yeger et al. 1989) this process would appear to be governed by 
gestational age, suggesting that cytotrophoblast cell proliferation is intrinsically programmed 
or regulated.
A wide variety of growth factors and genetic regulators are now recognised to influence 
normal cytotrophoblast cell proliferation. Amongst the proto-oncogenes investigated, c-myc 
gene expression directly correlates with cytotrophoblast cell proliferation (Kelly et al. 1983; 
Klein and Klein 1986). Moreover, c-myc gene expression is maximal during the early first 
trimester and declines dramatically as gestational age advances (Ohlsson & Pfeifer-Ohlsson 
1986), in keeping with the concept of rapid cytotrophoblast proliferation during the first 
trimester. Though not entirely proven, since the c-myc gene demonstrates features similai" to 
many transcriptional factors (Johnson & McKnight 1989), it is likely that c-myc mediates cell 
proliferation by augmenting post-receptor gene transcription. The c-sis proto-oncogene, 
identified as the B-chain of PDGF, acts via growth factor receptors and is a potent growth 
stimulator. Though both the c~sis and the PDGF-A chain gene are expressed in placenta 
throughout pregnancy, PDGF-A appears to be restricted to proliferative cytotrophoblast cells 
in the first trimester but remains actively expressed in the mesenchymal stroma until term. 
Holmgren et al. 1991; Jackson et al. 1994). PDGF-B or the c-sis gene is co-expressed with 
the c-myc gene in first trimester proliferative cytotrophoblasts (Goustain et al. 1985) and has 
been shown in vitro to effect proliferation of term cytotrophoblast cells also (Holmgren,
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unpublished data). In addition, the invasive cytotrophoblast cells found in the maternal 
decidua likewise express this gene and its receptor (Franklin et al. 1993).
Other growth factors must also be involved in this complex network since the absence of a 
functional insulin like growth factor-2 (IGF-2) gene in mice may also impair placental 
growth (DeChiara et al. 1990). IGF-2 is highly expressed in human proliferative 
cytotrophoblast cells (Ohlsson et al. 1989a) and is thought to modulate cytotrophoblast 
proliferation via the developmentally regulated IGF-1 receptor (Ohlsson et al. 1989b). It is 
not yet clear however, whether one specific factor is predominant in stimulating 
cytotrophoblast proliferation or all interact together, in specific sequence to activate this 
pathway.
It is likely that inhibitory factors are also necessaiy for normal placental development, thus i
preventing excessive villous growth. Glucocorticoids inhibit cell proliferation through 
suppression of the c-myc proto-oncogene (Reed, Nowell & Hoover. 1985) and induce ageing 
of the trophoblast (Wellman & Volk 1972). Receptors for glucocorticoids are abundant in 
term cytotrophoblasts (Robinson et al. 1988) and their increasing expression with advancing i
gestation may be one mechanism by which cytotrophoblast cell proliferation is inhibited in 
later pregnancy.
Normal placental growth and development requires both maternal and paternal genetic input 
(Solter 1988; Surani et al. 1988). Excessive trophoblast tissue, hydatidiform mole, is formed 
in pregnancies aiising from paternal chromosomes alone (Kajii & Ohama 1977). In contrast, 
pregnancies comprised from only maternal genomic material may implant but fail to survive 
beyond midgestation, presumably because despite early implantation, placental development 
does not progress sufficiently to support fetal life.
In addition to these trophoblast genes, expression of other genes may likewise be regulated 
by the specific suppression or induction of portions of the maternal and paternal genome; for 
example, mice heterozygous for paternally deleted IGF-2 gene produced very small placentas 
while those with the maternally deleted genome showed little effect (DeChiara, Robertson 
&Estratiadis 1990). It is clear therefore that cytotrophoblast proliferation, and therefore 
placental/vascular growth may be significantly altered by placental gene expression.
■
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9.5 ULTRASTRUCTURE OF TERMINAL VILLI - IS THERE EVIDENCE OF 
PLACENTA HYPOXIA IN lUGR ?
IaSince these cast findings were unexpected, we examined the ultrastructure of terminal villi 
for evidence of changes typical of hypoxia and found none. In contrast these villi had 
changes compatible with relatively high intravillous oxygen tensions; reduced numbers of 
cytotrophoblast cells, increased stromal collagens and clumping of the syncytiotrophoblast 
nuclei. Thus these findings suggest that increased oxygen tension may be present in the fetal 
placenta in lUGR. The increase in intravillous oxygen tension would suggest relative stasis 
of the fetal blood in the terminal capillary network thus permitting equilibration of the two 
circulations. In addition, the failure of cytotrophoblast cell proliferation, and thus the lack of 
new syncytiotrophoblast may have functional implications for placental transport.
These ultrastiuctural changes were not limited to the small aieas of the placenta examined by 
TEM. In chapters 7 and 8 immunocytochemistry was used to evaluate the stromal collagen 
and cytotrophoblast cell proliferation patterns, previously identified by TEM, in additional 
areas of these placentas and confirmed that these changes were widespread throughout the 
lUGR placentas.
9.6 SUMMARY OF PLACENTAL STRUCTURE IN lUGR
Our results would suggest that villous and vascular development is deranged in the placentas 
of pregnancies complicated by lUGR and the lack of maternal spiral artery trophoblast 
invasion noted many years ago, may simply reflect this primary problem. The deficiency in 
placental villous turnover was confirmed by the MIB-1 studies in chapter 7 and the lack of 
villous tissue dramatically visualised by the tissue casts SEM images of chapter 5.
In order to obtain sufficient nutrients to meet the metabolic demands of normal growth and 
development, the fetus must process increasing volumes of blood through the placenta. This 
is only possible by a compensatory fall in placental vascular impedance with the rapid 
increase of the placental vascular network and the extensive growth of the placental villous 
surface area. If the growth retarded fetus is to survive and maintain placental blood flow, 
despite the severely depleted villous and vascular network we have shown, fetal ai'terial 
blood pressure is likely to rise and systemic peripheral resistance increase. These early 
adaptations to increased fetal blood pressure in-utero may predispose the fetus to develop 
persistent systemic hypertension and cardiac disease in later adult life and explain some of 
the histological changes seen.
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However, in-utero, though an increase in arterial pressure may maintain placental blood flow 
at reasonable levels, the arterio-arterial vessels within the placenta are liable to become 
patent. Since the poorly developed terminal capillary network we have demonstrated offers a 
relatively high resistance pathway, blood may be shunted in significant quantities through 
these low resistance arterial shunts, thus bypassing the sites of maximal materno-fetal 
exchange within the terminal capillary network. As in the lung, shunting of blood through 
relatively "unventilated" portions of the placental tree will result in mixing of well- 
oxygenated and poorly-oxygenated blood, thus lowering the total oxygen concentration of 
blood in the umbilical vein. Such events would explain how the lUGR fetus can be hypoxic 
though oxygen concentrations in the placenta and uterine bed remain within normal levels.
In addition therefore, though maternal oxygen therapy may improve the umbilical vein p02 
of the small fetus bom at high altitude, it is less likely to be of any benefit to the lUGR fetus 
(Ribbert, Lingen &Visser 1991).
Since the villous surface area, particularly that of the peripheral viUi, is significantly reduced 
and the syncytiotrophoblast shows evidence of "ageing" as shown in chapter 6, the lUGR 
fetus may be substrate deprived both as a result of malfunction of the transporter proteins 
within the syncytiotrophoblast and/or depletion in the number of transporter systems 
available. In addition, poor blood flow through the terminal capillary network, evidenced by 
ante-natal capillary congestion, and the possible shunting of blood through arterial 
anastomoses will compound these problems, limiting further the nutrient resources available 
to the fetus.
*
9.7 INTRAUTERINE GROWTH RETARDATION - FUTURE DIRECTIONS
The findings we have demonstrated would suggest that abnormal expression and/or function 
of candidate growth factors and oncogenes is responsible, at least in part, for the alterations 
in villous and vasculai” growth patterns in the lUGR placenta. Future work should therefore 
investigate the role of agents such as PDGF, VEGF, c-myc and c-jun which modulate normal 
placental angiogenesis and cytotrophoblast proliferation in pathological growth retarded 
pregnancies. In addition, since it is clear that the function of genes may be altered by the 
pattern of maternal and paternal inheritance (eg. IGF-2 gene in mice), the effects of maternal 
and paternal disomy on placental phenotype must also be established. Clearly the functional 
capacity of the abnormal terminal villi we have demonstrated, must also be determined since 
for example, the transporter systems within the syncytiotrophoblast may not only be depleted 
in number but may also be functionally abnormal. The availability of tn-situ methods to 
localise not only the receptors for these proteins but to actually measure m-RNA expression
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may facilitate quantification of transporters, while membrane preparations from affected 
pregnancies could permit actual function to be evaluated.
It is clear from our findings that severe lUGR is not a condition acquired by the fetus in late 
pregnancy but the reflection of fundamental alterations in basic placental implantation and 
development. In view of this, any attempts to address the underlying pathophysiology of 
severe lUGR must focus not on the mid-gestation fetus but rather on the factors regulating 
the development of the early placenta and conceptus.
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